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and! development! has! proven! difficult.! GH! can! act! either! systemically! via! the!
stimulation!of!liver!insulin!like!growth!factor!(IGF)R1,!or!locally!via!activation!of!the!
GH!receptor! (GHR).!Furthermore,! the! local! actions!of!GH!may!be! IGFR1!dependent!
(indirect)! or! independent! (direct).! ! Suppressor! of! cytokine! signalling! 2! (SOCS2)!has!
been! identified! as! an! important! regulator! of! GH! signalling! via! the! JAK/STAT!
pathway.! The! SOCS2! knockout! (Socs2&/&)! mouse! is! characterised! by! its! overgrowth!
phenotype!despite!no!elevation!in!systemic!GH!and!IGFR1!levels.!It!therefore!offers!a!
valid!and!novel!model! to! investigate! the! local!effects!of!enhanced!GH!signalling!on!
the!skeleton.!!
The! work! presented! in! this! thesis! investigates! the! Socs2&/&! mouse! model! to! better!
understand!the!actions!of!local!GH!on!longitudinal!bone!growth!and!bone!accrual.!Ex*
vivo*metatarsal!organ!cultures,!osteoblast!cultures,!and!in*vivo!approaches!are!used!to!
unravel! the!mechanisms!of!GH!action!on! the! skeleton.!This! thesis! also! explores! the!
potential!of!SOCS2!as!primary!mediator!of!inflammatory!induced!bone!loss!through!
the!utilisation!of!the!dextran!sulphate!sodium!(DSS)!model!of!colitis.!!!!!!!!








signalling.! Male! Socs2&/&! mice! are! shown! to! have! a! greater! enhancement! of! cortical!





as! the! primary! SOCS! protein! regulating!GH! signalling! in! primary! osteoblasts.! The!
JAK/STAT!pathway! is!confirmed!as! the!key!signalling!pathway! targeted!by!SOCS2.!
Despite! this! enhanced! signalling! there! is! little! evidence! presented! in! this! thesis! to!
suggest! that! GH! actions! on! osteoblasts! and! ultimately! bone! mass! are! mediated!
through!increased!Igf1!expression.!!!!
GH!treatment!is!shown!to!be!anabolic!to!bone!of!young!juvenile!Socs2&/&!!mice,!but!not!
WT! mice.! This! increase! in! bone! mass! is! associated! with! increase! bone! pRSTAT5!
signalling,! but! no! increase! in! Igf1! levels! indicating! that! GH! may! have! IGFR1!
independent! effects! in! the! Socs2&/&! mouse!model.! GH! treatment! of! young!mice! also!
reveals! an! age! and! sex! specific! effect! of! GH! action! where! GH! does! not! stimulate!
growth!until! approximately! 3!weeks!of! age.! From!3!weeks!of! age,!WT! female!mice!
show!increased!growth!in!response!to!GH,!but!males!do!not.!The!increased!growth!is!
associated!with!increased!pRSTAT5!signalling!and!increased!bone!area.!!!!!!!!!
This! thesis! also! confirms! SOCS2! a! critical! mediator! of! bone! loss! associated! with!
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connective! tissue!with!many!well! established! functions.! It! provides! supports! and!





and! fibroblast! growth! factor! (FGF)R23! (Lee* et* al.! 2007;! Guntur! &! Rosen! 2012).! As!




Calcified! bone! is! made! up! of! a! crystalline! complex! of! calcium! and! phosphate!














of! this! is! located! in! the!shaft!of! long!bones! (diaphysis)!surrounding!the!medullary!
cavity.! The! building! block! of! cortical! bone! is! the! osteon.! Osteon! comprises! of!







The! remaining! 20%! of! skeletal! mass! comprises! of! trabecular! bone.! This! is! a! less!
dense! osseous! tissue! found! primarily! at! the! ends! of! long! bones! (epiphyses).! The!
functional! units! of! trabecular! bone! are! trabeculae,! which! unlike! cortical! bone! are!
highly! porous.! These! trabeculae! form! a! three! dimensional! network! of! bony!
processes! arranged! along! lines! of! stress! (Fig.! 1.1).! This! arrangement! makes!
trabecular! bone! less! stiff! and! more! elastic! than! cortical! bone.! As! a! result,! it! is!

















cortical! bone! is! located! primarily! in! the! diaphysis! ! ! B.! Electron! microscope! image!
highlighting! the!3D! trabecular!network!within! the! lumbar!spine!of!a!41!year!old!male.! !C.!
Image! of! a! single! osteon! concentric! circles! of! compact! bone! that! surround! an! inner!

















skull,! mandible! and! clavicle.! During! embryogenesis,! neural! crestRderived!
mesenchymal! cells! condense! into! compact! nodules.! These! cells! differentiate! into!
osteoblasts! and! start! to! secrete! matrix.! Mineralisation! of! this! matrix! results! in! a!




The! majority! of! bones,! including! all! long! bones,! develop! through! the! process! of!
endochondral!ossification!(Fig!1.2).!This!is!also!an!essential!process!during!postnatal!
longitudinal! bone! growth! and! fracture! healing.!Mesenchymal! cells,! derived! from!
somites!(give!rise!to!axial!skeleton)!and!somatopleure!(give!rise!to!the!appendicular!
skeleton),! proliferate! and! condense! into! compact! aggregates! that! produce! an!
extracellular! matrix! (ECM).! The! ECM! is! initially! rich! in! fibronectin! and! type! I!
collagen,!aiding!the!condensing!process!(Dessau*et*al.!1980;!Olsen*et*al.!2000).! !This!
initial! process! is!mediated! by! the! adhesion!molecules!NRcadherin! and! neural! cell!
adhesion! molecule! (NRCAM)! which! regulate! cellRcell! and! cellRECM! interactions!
(Delise! &! Tuan! 2002).! The! transcription! factor! Sox9! also! has! a! vital! role! in! this!
process!and!in!the!absence!of!Sox9!mesenchymal!cells!fail!to!condense!(Akiyama*et*
al.! 2002).! Within! the! newly! formed! aggregates,! cells! undergo! differentiation! into!










expand.!Coinciding!with! this,!perichondrial! cells!on! the!periphery!of! the! template!
differentiate!into!osteoblasts.!These!cells!produce!osteoid!that!mineralises!to!form!a!
bony!collar!(periosteum),!supporting!new!bone!growth.!Chondrocytes!in!the!centre!
of! the! template! begin! to! hypertrophy! and! the! primary! ossification! centre! forms,!
with! blood! vessels! containing! osteoclasts,! (section! 1.4.1),! osteoblast! precursors!
(section!1.4.2),!and!bone!marrow!penetrating!the!bony!collar,!accessing!the!cartilage!
template.! The! primary! ossification! centre! expands! as! a! result! of! osteoclastic!
resorption!of!cartilage!ECM,!and!osteoblastic!formation!of!bone!(Mackie*et*al.!2011).!
Similar! mechanisms! are! responsible! for! the! formation! of! a! secondary! ossification!
centre! within! the! epiphyseal! region.! Between! the! primary! and! secondary!
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Schematic! representation! of! endochondral! ossification.! Mesenchymal! stem! cells! (A)!!
condense! to! form! the! cartilage! anlagen! comprising! of! preRchondrocytes! (B).! These! cells!
differentiate! and! secrete! ECM.! At! this! point,! a! bony! collar! is! formed! by! osteoblasts! to!
support!growth!(C).!Chondrocytes!in!the!centre!hypertrophy!(D).!Invasion!of!blood!vessels!
allows! infiltration! of! osteoblasts! and! osteoclasts! leading! to! formation! of! the! primary!
ossification!centre!(E).!The!primary!ossification!centre!expands!throughout!the!diaphysis!to!










long! bones.! It! consists! of! chondrocytes! embedded! in! a! proteoglycan! and! collagen!
type!II!rich!ECM!(Mackie*et*al.!2011).!These!cells!are!arranged!into!vertical!columns!
that! run!parallel! to! the!direction!of!growth.!The!growth!plate! can!be!divided! into!
different! anatomic! zones,! representing! different! stages! of! chondrocyte!maturation!
(Fig! 1.3).! ! A! chondrocyte! will! “move! through”! each! stage! while! being! held! in! a!
spatially! fixed! location! by! longitudinal! and! transverse! septa! (Hunziker! 1994;!







The! resting!zone,! situated!closest! to! the!epiphysis,! contains!a!pool!of!unorganised!
chondrocytes!embedded!in!large!volumes!of!ECM!(Hunziker!1994)!(Fig.!1.3).!These!
cells! are! derived! from! chondrocyte! progenitor! cells! residing! in! the! groove! of!
Ranvier,!adjacent!to!the!resting!zone!(Melrose*et*al.!2008).!Chondrocytes!within!the!
resting! zone! contain! high! lipid! levels,!many! cytoplasmic! vacuoles! and! synthesise!
only! low! levels! of! proteoglycans! and! collagen! type! II! (Burdan* et* al.! 2009).! These!





Chondrocytes! within! the! proliferative! zone! adopt! a! flattened,! oblate! appearance,!







of! ECM! (consisting! mainly! of! collagen! type! II! and! proteoglycans)! within! the!




Chondrocytes! within! the! hypertrophic! zone! cease! proliferation! and! undergo!
hypertrophy! (Fig.! 1.3).! ! Compared! to! cells! within! the! proliferative! zone,!
hypertrophic! cells! have! a! 5R10! times! larger! intracellular! volume,! and! a! 5! fold!
increase! in! cell! height! (Hunziker* et* al.! 1987;! Farnum* et* al.! 2002).! Some! of! this!
increase! (~20%)! can! be! attributed! to! an! increase! in! organelle! size,! including!





in! secretion! of! matrix! proteins! including! collagen! type! X! (Sommer* et* al.! 1996).!
Budding! of! the! plasma! membrane! causes! release! of! matrix! vesicles! into! the!
surrounding! ECM.! These! vesicles! possess! a! number! of! proteins! responsible! for!
mediating!mineralisation,!including!both!intravesicular!(orphan!phosphatase!1)!and!
extravesicular! phosphatases! (ALP! and! ectonucleotide!
pyrophosphatase/phosphodiesterase! 1),! and! calcium! channelling! and! binding!
proteins! (annexins)! (Harmey* et* al.! 2004;! Yadav* et* al.! 2011;! Millan! 2013).! These!
specialised!proteins! lead! to! the!accumulation!of! calcium!and! inorganic!phosphate,!
resulting!in!the!nucleation!of!mineral!within!the!matrix!vesicle.!The!mineral,!upon!
rupture! of! the! matrix! vesicle,! is! then! released! into! the! extracellular! environment!
where! it! expands! along! the! collagen! fibrils! primarily! through! the! actions! of! ALP!








osteoclasts! (section! 1.4.1)! and! osteoblast! precursors! (section! 1.4.2).! During!
hypertrophy,! chondrocytes! release! a! number! of! factors! which! promote! vascular!
invasion! (vascular! endothelial! growth! factor)! and! influx! of! osteoblasts! and!




The! rate! of! longitudinal! bone! growth! differs! between! species,! with! mammals!
considered! to! have! a! comparatively! slow! growth! rate.! Indeed,! growth! rate! of! the!
proximal! tibia! in! humans! (0.04mm/day),! rabbits! (0.39mm/day),! and! rats!
(0.22mm/day)! is! considerably! less! than! that! observed! in! chickens! (0.86mm/day)!
(Kember! 1972;! Kember! &! Sissons! 1976;! Kember! 1985;! Kirkwood* et* al.! 1989).! The!
growth! rate! is! dependent! on! a! number! of! factors! including! cellular! proliferation!
within! the! proliferative! zone,! cellular! enlargement! within! the! hypertrophic! zone,!
and!ECM!synthesis!(Wilsman!et*al.!1996)..!Increased!width!of!the!proliferative!zone!
and!increased!rate!of!proliferation!both!enhance!longitudinal!growth!rate!(Farnum!
&! Wilsman! 1993;! Wilsman* et* al.! 1996).! Changes! within! the! hypertrophic! zone,!
including!rate!of!hypertrophy!and!final!cell!volume,!is!!the!primary!determinant!of!
bone! growth.! Hypertrophic! cell! size! accounts! for! ! approximately! 60%! of!
endochondral!bone!growth!(Wilsman*et*al.!1996).!!!
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Endochondral! bone! growth! is! a! tightly! regulated! process! (Hunziker* et* al.! 1994;!
Farnum* et* al.! 2002).! Endocrine! factors! such! as! thyroid! hormone,!
oestrogens/androgens,! glucocorticoids,!vitamin!D,! and! leptin!have!all! been! shown!
to! regulate! chondrocyte! maturation,! and! subsequently! longitudinal! bone! growth.!
Aside!from!endocrine!factors,!there!is!also!autocrine!and!paracrine!(local)!regulation!
from! factors! such! as! Indian! HH,! bone! morphogenic! protein,! fibroblast! growth!






be! found! in! the! following! reviews! (Van!Der! Eerden* et* al.! 2003;! Kronenberg! 2003;!
Nilsson* et* al.! 2005).! Longitudinal! growth! is! also! governed! by! the! surrounding!
mechanical! environment.! Longitudinal! growth! is! governed! by! the! HueterR
Volkmann! law! (Villemure* &! Stokes! 2009).! This! law! states! that! bone! growth! is!
inhibited! by! mechanical! compression! on! the! growth! plate! and! accelerated! by!
growth!plate! tension.! !This!plays!a!key!role! in! the!determination!of!bone!size!and!
partly!explains!why!some!bones!are!longer!than!others.!Without!exception,!the!most!
potent!stimulator!of!longitudinal!bone!growth!is!the!GH/insulinRlike!growth!factor!1!
(IGFR1)! axis.! The! importance! of! this! axis! is! evident! as! numerous! conditions! (e.g!
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Aside! from! longitudinal! growth,! bone! is! constantly! renewing! and! remodelling! in!
response! to!mechanical! and! hormonal! stimuli.! ! During! skeletal! development,! the!
process! of! modelling! transforms! bone! shape.! ! In! response! to! physiological! and!
mechanical! stresses,! bone! architecture! is! remodelled! to! endure! the! forces! that! it!
encounters!(Clarke!2008).!The!process!of!bone!remodelling!serves!to!maintain!bone!
strength! by! removing! microRdamaged! bone! and! replacing! it! with! new! healthy!
tissue.!The!process!also!acts!to!maintain!mineral!homeostasis,!as!the!removal!of!old!
bone! results! in! a! release! of! calcium! (Hadjidakis! &! Androulakis! 2006).! Bone!
modelling! is! a! result! of! bone! resorption! and! formation! working! independently.!
Conversely,! in! bone! remodelling,! bone! resorption! and! formation! take! place! as! a!
coupled! process! within! a! basic! multicellular! unit! (BMU).! ! The! remodelling! cycle!










Osteoclasts! account! for! less! than! 1%! of! bone! cells.! They! are! giant!multinucleated!
cells! responsible! for! bone! resorption.! These! cells! are! derived! from! the!monocyteR
macrophage! lineage,! originating! from! hematopoietic! stem! cells! (Sommerfeldt! &!
Rubin!2001).!During!the!initiation!phase!of!bone!remodelling,!osteoclast!precursors!
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Schematic! representation! of! the! bone! remodelling! process.! (A)! Activation! –! mechanical!
stimulation! (yellow! lightening)! results! in!upregulation!of!RANKL!by!bone! lining!cells.! (B)!
Resorption! R! osteoclast! precursors! differentiate! and! begin! to! resorb! bone.! (C)! Reversal! R!
osteoclasts!die!by!apoptosis,!while!mononuclear!cells!(reversal!cells)!prepare!the!surface!for!
osteoblasts!to!commence!bone!formation!(Hadjidakis!&!Androulakis!2006).!(D)!Formation!R!







osteoclasts! are! highly!migratory,! polarised! cells! that! produce! lysosomal! enzymes!
(Sommerfeldt! &! Rubin! 2001).! Two! key! cytokines! responsible! for! regulating!
osteoclast! differentiation! and! function! are! RANKL,! and! macrophage! colony!
stimulating!factor!(MRCSF).!These!factors!drive!proliferation!of!osteoclast!precursors!
and! differentiation! and! survival! of! mature! osteoclasts.! Osteoclast! function! is!
inhibited!by!osteoprotegrin! (OPG)!which! is!produced!by!osteoblasts! and!acts! as! a!





specific! structure!which! anchors! the! cell! to! bone,! creating! a! resorption! site! sealed!
from!the!extracellular!space!(Vaananen!&!Horton!1995).!Within!this!newly!formed!
resorption! lacuna,! the! bone! resorbing! surface! of! the! osteoclast! forms! a! ‘ruffled!
border’! of! microvilli.! The! ‘ruffled! border’! secretes! H+! ions! which! acidify! the!
resorption! lacunae,! dissolving! the!mineral! component! of! bone.! This! results! in! the!
release!of!calcium!and!phosphorus!into!the!bloodstream.!!Decreased!pH!also!allows!
secretion!of!enzymes!responsible!for!degradation!of!the!organic!component!of!bone.!
These! include! the! lysosomal! enzymes,! cathepsin! K! and! tartrateRresistant! acid!
phosphatase! (Hill! 1998! Hadjidakis! &! Androulakis! 2006;! Clarke! 2008).! Matrix!
metalloproteinases!(MMPs);!produced!by!osteoclasts;!also!play!an!important!role!in!





cells.! They! are! cuboidal! in! shape,! and! possess! a! wellRdeveloped! endoplasmic!










of!MSCs! to! the! osteoblast! lineage! involves! a! number! of! key! transcription! factors,!
including! runtRrelated! transcription! factor! 2! (Runx2,! also! referred! to! as! Cbfa1),!
Osterix! (Osx)!and!βRcatenin!(Komori!2006).! !Both!Runx2&/&! and!Osx&/&!mice!display!a!
complete!lack!of!ossification,!producing!only!a!cartilaginous!skeleton!(Komori*et*al.!
1997;!Nakashima*et*al.!2002).!During!late!stage!differentiation,!Runx2!acts!to!inhibit!
maturation! thus! maintaining! an! immature! osteoblast! supply! (Komori! 2006).! Osx!
expression!is!lost!in!Runx2&/&!mice,!but!Runx2*is!not!lost!in!Osx&/&*mice.!This!indicates!
that!Osx!works!downstream!of!Runx2!(Nakashima*et*al.!2002;!Nishio*et*al.!2006).!βR
catenin! (via! the!Wnt!pathway)! is! essential! for!osteoblast! lineage!differentiation.! In!
cases! of! βRcatenin! deficiency! mesenchymal! cells! are! unable! to! differentiate! into!




During! the! formation! phase! of! remodelling,! osteoblasts! are! located! at! the! bone!
surface!where!their!primary!function!is!to!lay!down!ECM,!composed!mainly!of!type!
I! collagen! (osteoid).! Type! I! collagen! accounts! for! around! 90%! of! the! organic!
component! of! bone.!Aside! from! the!production!of! collagen,! osteoblasts! synthesise!
and! secrete! proteoglycans! and! nonRcollagenous! proteins! (Sommerfeldt! &! Rubin!
2001;! Long! 2012).! These! nonRcollagenous! proteins! including! osteocalcin,! ALP! and!
osteopontin,! regulate! the! formation! and! propagation! of! mineral! (Kornak! 2011;!
Millan! 2013).! The! mineralisation! of! bone! through! the! accumulation! of! calcium!
phosphate,! in! the! form! of! hydroxyapatite,! produces! a! hard! but! lightweight!
composite!material.!Recently,!osteocalcin!has!also!been!shown!to!act!as!a!hormone!
in! the!body,!regulating! insulin!release!by!the!pancreas.!As!osteocalcin! is!produced!
solely!by!osteoblasts,!it!is!now!understood!that!bone!can!act!as!an!endocrine!organ!





mineralisation,! the! osteoblast!undergoes! one!of! three! fates.! It! becomes! an! inactive!
bone! lining! cell,! undergoes! apoptosis,! or! becomes! encased! in! osteoid! and!
differentiates! into! an! osteocyte! (Dallas! &! Bonewald! 2010).! Bone! lining! cells! are!
involved! in! the! activation! of! bone! remodelling.! Typically,! mechanical! loading! or!
microRfracture! leads! to! the! stimulation! of! quiescent! bone! lining! cells! to! increase!
surface!expression!of!RANKL.!!Expression!of!RANKL!is!however!also!regulated!by!





Osteoblast!differentiation! is!under! tight! regulation!at!both!a!hormonal! (endocrine)!
and!local! (autocrine/paracrine)! level.!Although!beyond!the!scope!of! this! thesis,! the!
main! regulators! of! osteoblast! differentiation! are! outlined! in! a! number! of! elegant!
reviews! (Yamaguchi* et* al.! 2000;!Hughes* et* al.! 2006).! The! regulation! of! osteoblasts,!




Osteocytes! are! terminally! differentiated! osteoblasts! embedded! in! the! bone.! They!
make! up! approximately! 90%! of! cells! in! adult! bone.! Osteocytes! are! smaller! than!
osteoblasts! due! to! loss! of! a! number! of! cytoplasmic! organelles.! They! reside! in!
lacunae! within! the! mineralised! bone! matrix! (Aubin! 1998).! These! cells! form! long!
dendritic! processes! which! travel! through! the! canaliculi! of! bone! connecting!
osteocytes!to!other!osteocytes!as!well!as!osteoblasts,!osteoclasts!and!bone!lining!cells!
(Bonewald! 2007! Seeman! 2008).! Dendritic! processes! are! constantly! extending! and!







The! recognised! function! of! osteocytes! is! to! convert! mechanical! stimuli! into! a!
biological!response.!!!MicroRdamage!to!bone!results!in!the!apoptosis!of!closely!lying!
osteocytes.! This! results! in! the! release! of!RANKL,! stimulating! osteoclast! formation!
and!activity!(Bonewald!2011;!Kular* et*al.!2012).!Mice! lacking!RANKL!in!osteocytes!
have! an! osteopetrotic! bone! phenotype! due! to! deficiencies! in! bone! resorption!
(Nakashima*et*al.!2011).!Osteocytes!also!produce!sclerostin!(a!late!osteocyte!marker)!
which! is!an! inhibitor!of!Wnt!signalling!and!bone! formation.!Through! inhibition!of!




with! homologies! to! endopeptidase! on! the! X! chromosome! (PHEX),! dentin! matrix!
protein! 1! (DMPR1),!matrix! extracellular! phosphoglycoprotein! (MEPE),! and!FGFR23!
(Bonewald!2011).!Expressed!highly!in!osteocytes,!DMPR1!and!PHEX!regulate!FGFR23!




GH! is! a! peptide! hormone! produced! by! somatotrophic! cells! within! the! anterior!
pituitary.!GH!regulates!a!host!of!physiological!processes,!including!somatic!growth!
and! development,! and! carbohydrate! and! lipid! metabolism! (Giustina* et* al.! 2008;!
Perrini* et* al.! 2010;! Vijayakumar* et* al.! 2010).! GH! releases! from! the! pituitary! is! not!
continuously,!but!pulsatile.! In!humans! these!pulses!occur!every!3R5!hours.!Studies!
on!mice!have!shown!that!there!is!a!sexual!dimorphism!in!GH!release!with!peak!GH!
concentrations! recorded! every! 2.5! hours! in! male! and! every! 1.4! hour! in! females!
(Macleod! et* al,! 1991).! ! To! ensure! optimal! GH! secretion,! somatotrophic! cells! are!
regulated! by! a! number! of! factors.! The! synthesis! and! release! of! GH! is! primarily!
controlled!by!the!positive!regulator!R!growth!hormone!releasing!hormone!(GHRH),!





binds! to! a!GHRbinding! (GHBP)!protein,! comprising!of! the! extracellular!domain!of!





binding! to! the! GHR.! ! Functional! GHRs! are! present! on! numerous! cell! types,!




The!GHR!is!a!single!membrane!spanning!receptor.! It! comprises!of! two!fibronectin!




comprising! of! one! GH! and! two! GHRs! (Frank! 2001;! Brooks* et* al.! 2008).! The!
subsequent!events! that! lead! to! receptor!activation!are! still! a!matter!of!debate.! It! is!






ICD.! These! act! as! binding! sites! for! proteins! containing! a! Src! homology! 2! (SH2)!
domain,!and! initiate!downstream!signalling!(Waters* et*al.!2006;!Brooks* et*al.!2008).!
There!are!several!pathways!responsible!for!mediating!GH!action.!These!include!the!
signal! transducer! and! activator! of! transcription! (STAT)! pathway,! the! mitogenR
activated! protein! kinase/extracellular! signalRregulated! kinases! (MAPK/ERK)!









STAT1,! 3,! and! 5! proteins! are! activated! by! GH! (Ram* et* al.! 1996;! Herrington* et* al.!
2000).!!These!proteins!reside!in!the!cell!cytoplasm!until!they!bind!to!JAK2!proteins,!
through! their! SH2! domain.! ! Phosphorylation! of! specific! tyrosine/serine! residues!
present! on! the! CRterminus! on! the! STAT! proteins,! results! in! homoR! or! heteroR
dimerisation,!and!migration!into!the!nucleus,!activating!gene!transcription!(Fig.!1.5)!
(Han* et* al.! 1996;! Smit* et* al.! 1996;! Herrington* et* al.! 2000).! STAT1! and! 3! can! form!
homodimers! and/or! heterodimers!which! bind! to! the! sis! inducible! unit! of! the! c&fos!
gene! (Herrington* et* al.! 2000;! Zhu* et* al.! 2001).! Whereas! Stat1&/&! mice! show! few!
abnormalities! in! relation! to! growth,! Stat3&/&! mice! are! embryonic! lethal,! and! it! is!






STAT5! signalling! is! crucial! in! mediating! GH! action.! Stat5ab&/&! mice! show! similar!
growth! retardation! to! Ghr&/&! mice.! STAT5b! mutations! in! humans! result! in! severe!
growth!deficiency,! similar! to!GHR!mutations! (Kofoed* et* al.! 2003).!As!Stat5b&/&!mice!
show!no!elevation!in!IGFR1!levels!following!GH!stimulation,!it!is!likely!that!the!GH!
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Schematic! representation!of!GH!signalling!via! the! JAK/STAT!pathway.!GH!binding! to! the!
GHR!results! in! JAK2!activation!and! the!phosphorylation!of! tyrosine! residue!binding! sites.!












growth! and! determinant! of! peak! bone! mass! during! puberty! (Venken* et* al.! 2007;!
Callewaert* et* al.! 2010).! Initially,! postnatal! growth! is! considered! GH! independent!
(Liu!&!LeRoith!1999).!Consequently,!growth!of!Ghr&/&!and!GHRH!receptor!(GHRHR)!
(lit/lit)!mice! are! comparable! to!WT!mice! until! ~2!weeks! of! age! (Eicher! &! Beamer!
1976;!Lupu*et*al.!2001).!The!onset!of!the!GH!deficiency!phenotypes!coincide!with!a!
period! of! rapid! growth! during! which! male! and! female! growth! rates! diverge! (as!
measured!by!weight!gain),!with!exaggerated!growth!in!males!(Liu!&!LeRoith!1999;!
Lupu* et* al.! 2001).!The!anabolic! changes! in! skeletal!morphology!are! also!greater! in!
males!at!this!stage!(Lupu*et*al.!2001;!Seeman!2001).!This!sexually!dimorphic!process!
is! thought! to! be! largely! mediated! by! STAT5b! signalling.! ! Stat5b&/&*male! mice! are!
growth!retarded,!whereas!females!are!not!(Udy*et*al.!1997;!Teglund*et*al.!1998).!This!
sex! specific! action! is! not! shared!with! the! STAT5a! isoform,! which! alone! has! little!





There! are! a! number! of! proteins! responsible! for! the! regulation! of! the!GH! induced!
JAK/STAT! signalling.! These! include! protein! tyrosine! phosphatases! (PTPs),! and!




GH,! SHPR1! binds! to! and! inhibits! phosphorylated! STAT5b! and! JAK2! (Ram! &!
Waxman!1997).!Like!SHPR1,!PTPR1b!associates!directly!with!JAK2,!but!can!also!bind!
directly! to! the! phosphorylated! intracellular! domain! of! the! GHR,! leading! to!
dephosphorylation.!PTPRH1!also!binds! to! the!phosphorylated!GHR!(Pasquali* et* al.!












1! negatively! regulates! GH! secretion! directly,! or! through! the! stimulation! of!





Systemic! IGFR1! is! synthesised! primarily! in! the! liver! under! the! regulation! of! GH!
(Melmed!1999;!Yakar* et* al.! 1999;!Sjogren* et* al.! 1999).! In!circulation,! the!majority!of!




Although! there! are! six! IGFBPs! (IGFBP1R6),! only! IGFBP3! and! 5! form! part! of! the!
ternary! complex! (Twigg!&! Baxter! 1998;! Boisclair* et* al.! 2001;! Le! Roith* et* al.! 2001).!
IGFBP3! is! highly! abundant! in! circulation,! with! the! majority! of! IGFR1! forming! a!
ternary!complex!with!this!protein.!Only!~1%!of! IGFR1!circulates!as!a! free!hormone!
(Giustina* et* al.! 2008).! ! Similar! to! IGFR1,! hepatic! IGFBP3! and! ALS! synthesis! are!
regulated!by!GH!(Clemmons!1998;!Boisclair*et*al.!2001).!Als&/&!and!Igfbp3&/&!mice!have!
decreased!serum!IGFR1!levels,!highlighting!the!importance!of!the!ternary!complex!in!
increasing! IGFR1!halfRlife! (Yakar* et* al.! 2009).! IGFBP1,!2,!4,!and!6!also!bind! to! IGFs,!
but! do! not! form! a! ternary! complex! (Holly! &! Perks! 2006).! In! addition! to! their!









IGFR1! and! IGFR2! binds! to! the! IGFR1! receptor! (IGFR1R),! a! transmembrane! tyrosine!
kinase!receptor!(Liu*et*al.!1993).!The!IGFR1R!comprises!of!a!tetramer!containing!two!
extracellular!αRsubunits!and!two!membrane!spanning!β!units.!The!binding!of!IGF!to!
the! αRsubunits! results! in! conformational! changes! that! stimulate! intrinsic! tyrosine!
kinase!activity!on! the! intramembranous!β! subunits.!This! leads! to! the!activation!of!
various! intracellular! substrates,! including! insulin! receptor! substrate! (IRS)R1! and! R2!
and!Shc!proteins.!These!substrates!mediate!the!effects!of!the!IGFs!(Adams*et*al.!2000)!
(Fig.! 1.6).! In! relation! to! bone! and! the! growth! plate,! IRSR1! is! expressed! in!
chondrocytes! and! osteoblasts,! whereas! IRSR2! is! expressed! in! osteoblasts! and!
osteoclasts,! but! not! chondrocytes.! Irs2&/&! mice! show! an! uncoupling! of! bone!
remodelling! with! decreased! bone! formation! and! increased! resorption,! with! no!
changes! to! the! growth! plate! (Akune* et* al.! 2002).! ! Irs1&/&! mice! also! have! decreased!
bone! formation! due! to! a! reduction! in! osteoblast! proliferation! and! differentiation.!
Osteoclasts! however! remain! unaffected.! Unlike! Irs2&/&! mice,! Irs1&/&! mice! have!
decreased! growth! plate!width! and! chondrocyte! number! (Ogata* et* al.! 2000).! IGFR1!
binding!to!the!IGFR1R!initiates!a!number!of!signalling!pathways,!including!the!IRSR1!
mediated!PI3K/AKT!pathway,!and!the!Shc!mediated!MAPK/ERK!pathway!(Laviola*
et* al.! 2007).! AKT! signalling! has! important! roles! in! cell! proliferation,! growth,! and!
differentiation!in!numerous!cells!throughout!the!body!(Peng*et*al.!2003).!Specifically,!
inhibition! of! the! PI3K/AKT! pathway! hinders! longitudinal! growth! of! mouse!
metatarsals,!highlighting!an!important!role!for!this!pathway!in!endochondral!bone!
growth!(MacRae*et*al.!2007).!The!AKT!signalling!pathway!can!also!block!apoptosis,!
through! activation! of! Sos!which! in! turn! activates! Ras! (a! GPTase).! This! initiates! a!
kinase! cascade! leading! to! the! inactivation! of! the! proRapoptotic! protein! BclR2R
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IGFR1! binding! to! the! IGFR1R! creates!multiple! docking! sites! (P)! for! intracellular! substrates,!
including!Shc!and!IRS1/2!proteins.!!Shc!binds!to!the!ICD!of!the!IGFR1R.!Grb2!binding!to!Shc!
forms! a! complex! with! Sos! (a! guanine! nucleotide! exchange! factor).! The! formation! of! this!















GH! is! an! important! regulator! of! postnatal! development,! but! has! no! apparent!
embryonic! role.! Ghr&/&! mouse! growth! is! indistinguishable! from! WT! until!
approximately!2!weeks!of!age,!at!which!point!the!mice!start!to!show!signs!of!growth!
retardation!(Lupu*et*al.!2001).!GHR!deficiency!results!in!reduced!bone!growth!as!a!
result! of!decreased!growth!plate! chondrocyte!proliferation,! and!decreased! cortical!
expansion! (Sims* et* al.! 2000;! Sjogren* et* al.! 2000;! Lupu* et* al.! 2001).! Conversely,!
overexpression! of! GH! results! in! increased! longitudinal! growth! and! increased!
cortical!crossRsectional!area!(Oberbauer*et*al.!1992;!Eckstein*et*al.!2004).!The!effects!of!
GH! may! however! be! mediated! through! IGFR1,! as! postnatal! Ghr&/&! mice! have!





al.! 1993;! Liu* et* al.! 1993).! IGFR1! continues! to! play! a! crucial! role! in! postnatal!
development!as!is!evident!from!the!growth!retardation!observed!in!Igf1&/&!mice!(Liu*
et*al.!1993;!Wang*et*al.!1999b;!Lupu*et*al.!2001).!At!the!level!of!the!growth!plate,!Igf1r*





















synthesis! in! cartilage.! ! It! was! established! that! GH!was! unable! to! exert! its! effects!
directly,!and!instead!functioned!through!a!secondary!messenger.!Originally!termed!
somatomedin,!this!intermediary!was!later!identified!as!IGFR1!(Daughada!&!Reeder!
1966;!Daughada* et* al.! 1972;!Garland* et* al.! 1972;!Klapper* et* al.! 1983).!As! a! result,! it!
became!widely!accepted! that!GH!acts!by! stimulating!production!of!hepatic! IGFR1,!
subsequently!acting!as!an!endocrine!factor!to!stimulate!target!tissues!including!the!
growth!plate! and!bone! (Fig.! 1.7A).! IGFR1!has! since!been! found! to! be! expressed! in!
numerous! tissues! throughout! the! body,! indicating! that! it! may! not! only! have! an!
endocrine!role,!but!also!an!autocrine/paracrine!role! (Dercole* et*al.!1984;!Murphy* et*
al.!1987).!Furthermore,!the!GHR!is!expressed!in!numerous!cells!types,!and!GH!has!
been!shown!to!regulate!IGFR1!expression!in!a!number!of!tissues!(Nilsson*et*al.!1986;!
Lowe* et*al.!1988;! Isgaard* et*al.!1989;!Ballesteros* et*al.!2000).!Direct! injections!of!GH!
into!cartilage!of!hypophysectomised!rats!increases!longitudinal!growth,!whereas!the!




































































‘dual! effector! theory’.! Originally! proposed! to! describe! the! action! of! GH! on!
adipocytes,!the!dual!effector!theory!proposes!that!GH!acts!to!recruit!progenitor!cells!
within! the! resting! zone! into! a! proliferative! state,! as! well! as! stimulating! IGFR1,!
promoting! clonal! expansion! (Green* et* al.! 1985;! Nilsson* et* al.! 1986;! Isaksson* et* al.!
1987;! Ohlsson* et* al.! 1992).! Initially,! GH!was! shown! to! stimulate!multiplication! of!
cells!within!the!resting!zone!of!the!growth!plate,!whereas!IGFR1!did!not!(Ohlsson*et*
al.! 1992).! IGFR1! has! since! been! shown! to! stimulate! proliferation! of! resting! zone!
chondrocytes,!but!to!a!lesser!extent!than!GH!(Hunziker*et*al.!1994).!Resting!zone!size!
is!increased!in!states!of!Igf1!deficiency,!yet!decreased!in!GhrR/R!mouse.!This!indicates!
a!possible! IGFR1! independent! role! for!GH!on!germinal!cells! (Wang* et* al.! 2004).! ! In!
support!of! this,! tibial!growth! is!retarded! in!both!Ghr&/&!and! Igf1&/&*mice.!A!reduction!
that!is!more!pronounced!in!the!double!Ghr/Igf1*knockout!(Lupu*et*al.!2001).!Studies!
on! Igf1&/&! !mice! suggest! that! IGFR1! acts!predominantly! to! increase!hypertrophic! cell!
size,!with!minimal!effects!on!cell!proliferation!(Wang!et*al.*1999).!The!importance!of!
IGFR1!in!mediating!GH!action!on!hypertrophic!chondrocytes!is!further!suggested!by!
the!reduction! in!chondrocyte!hypertrophy!observed! in! Igf1&/&!mice!despite!elevated!
GH!levels!(Wang!et*al.!2004)!!!
!
Interestingly,! more! recent! studies! found! that! Igf1! mRNA! expression! is!
predominantly! located! in! the! surrounding! perichondrium! and! bone,! with!
comparatively! low!expression! in! any!of! the! growth!plate! zone.!This! suggests! that!











1999;! Sjogren* et* al.! 1999).! This! cast! doubt! on! the! importance! of! systemic! IGFR1! in!
regulating!bone!growth.!Furthermore,!reductions!in!systemic!IGFR1!levels,!achieved!
by! disruption! of! the! IGFR1! serum! complex,! produced! similar! results! (Yakar* et* al.!
2009).! These! murine! models! have! however! been! called! into! question! due! to!
incomplete!and!progressive!deletion!(via!albuminRCre!method!of!gene!deletion)!!of!
liver! Igf1,! long! after! the! critical! post! weaning! growth! spurt! (Stratikopoulos* et* al.!
2008).! Hepatic! IGFR1! has! been! shown! to! significantly! contribute! to! growth!
(Stratikopoulos*et*al.!2008;!Wu*et*al.!2009;!Elis*et*al.!2010).!Therefore!the!importance!
of!systemic!IGFR1!in!regulating!bone!growth!remains!a!matter!of!debate!(Fig.!1.7C).!!
The! importance! of! local! IGFR1! is! well! established;! targeted! deletion! of! Igf1! in!





systemic! IGFR1! levels! results! in! a! catabolic! cortical! bone!phenotype,!with!minimal!
effects! on! trabecular! bone! (Sjogren* et* al.! 2002;! Yakar* et* al.! 2002).! Conversely,!
overexpression!of!IGFR1!in!hepatocytes!is!anabolic!to!cortical!bone!(Elis*et*al.!2010).!
The! effects! of! locally! derived! IGFR1! are! clear! from! the! targeted! overexpression! of!
Igf1! to! osteoblasts!where! it! has! anabolic! effects! on! trabecular! bone,!with!minimal!
alteration!to!cortical!bone!(Zhao*et*al.!2000).!!Taken!together,!these!findings!suggest!












central! SH2!domain,! sandwiched!between! a! conserved!CRterminal! domain!named!
the! SOCS! box,! and! a! variable! NRterminal! domain.! ! SOCS1! and! 3! contain! an!
additional! kinase! inhibitory! region! in! the! NRterminal! domain! (RicoRBautista* et* al.!
2006;! Croker* et* al.! 2008)! (Fig.! 1.8).! There! are! a! number! of! mechanisms! by! which!
SOCS! proteins! regulate! cytokine! signalling.! SOCS1! and! 3,! unlike! other! SOCS!
proteins!are!able!to!act!as!kinase!inhibitors,!inhibiting!JAK!activity!(Krebs!&!Hilton!
2001;!Greenhalgh!&!Hilton!2001;!RicoRBautista*et*al.!2006)!Through!the!SH2!domain,!
SOCS! proteins! are! able! to! competitively! bind! to! the! tyrosine! residue! recruitment!
sites! in! the! cytoplasmic! domain! of! the! cytokine! receptor.! This! inhibits! STAT!
attachment! and! signalling! (Ram!&!Waxman!1999;!Krebs!&!Hilton!2001;!Pass* et* al.!
2012).!There!is!also!evidence!to!suggest!that!SOCS!proteins;!through!the!SOCS!box;!
act!as!adapter!molecules,!linking!signalling!proteins!to!the!proteasome!(Zhang*et*al.!
1999)! (Fig.! 1.9).! SOCS1R3! and! CIS! proteins! are! expressed! in! numerous! tissues!
throughout!the!body.!These!proteins!form!a!negative!feedback!loop,!regulating!the!
cytokines!that!induce!their!expression,!including!GH!(Starr*et*al.!1997;!TolletREgnell*
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Schematic! representation! of! the! mechanisms! by! which! SOCS! proteins! regulate! GH!
signalling.! SOCS1! binds! to! JAK2,! inhibiting! its! phosphorylation.! SOCS3! binds! to! the!
membrane!adjacent! to! JAK2!and! inhibits! JAK2!activity.! SOCS2!has! two!possible!modes!of!
actions.! SOCS2! binds! to! specific! tryrosine! residues! on! the!GHR,! blocking! STAT5! binding.!


















to! placental! defects! and! poor! circulatory! network! in! the! developing! embryo!
(Roberts*et*al.!2001).!SOCS3!levels!are!low!in!adult!tissues,!but!expression!is!high!in!
foetal! livers! which! coincides! with! an! EPORdependent! stage! of! erythropoiesis!
(Marine* et*al.!1999a;!Krebs!&!Hilton!2001).!Hematopoietic!progenitors! from!Socs3&/&!
mice!have!enhanced!responsiveness!to!a!number!of!cytokines.!SOCS3!deficient!mice!




Unlike! SOCS1,! 2,! and! 3,! CIS! knockout! mice! have! no! reported! phenotype!
abnormalities!(Marine*et*al.!1999a).!Overexpression!of!CIS!however!results! in!a!20R
30%!decrease! in!weight,! a! reduction! in!major!urinary!protein! (MUP)! levels,! and!a!





SOCS2! expression! is! found! in! a! number! of! tissues,!with! high! levels! found! in! the!
liver!and!heart! (Starr* et*al.!1997;!TolletREgnell* et*al.!1999).! It!has!been!implicated!in!
the!regulation!of!a!number!of!factors!including!GH,!tumor!necrosis!factor!(TNF)!Rα,!
prolactin!(PRL),!leukaemia!inhibitory!factor!(LIF),!and!IGFR1!(Minamoto*et*al.!1997;!
Dey* et* al.! 1998;! Greenhalgh* et* al.! 2005;!MacRae* et* al.! 2009).! SOCS2! regulates! PRL!
induced! STAT5! signalling! in! the! mammary! gland! (Harris* et* al.! 2006),! EGFR!
signalling! in! a! PC12! (adrenal! gland)! cell! line! (Goldshmit* et* al.! 2004),! and! LIF!
induced!STAT3!signalling!in!a!myeloid!leukaemia!cell!line!(Minamoto*et*al.!1997).!!







in* vivo*however! is! negligible,! and! prevention! of! premature! lethality! of! the!Socs1&/&!
mice!does!not! result! in!an!overgrowth!phenotype! (Alexander* et* al.! 1999).!Prenatal!
lethality! in!Socs3&/&!mice!makes! it! difficult! to! deduce! a! potential! role! for! SOCS3! in!
regulating! GH! action! in* vivo* (Horvat! &! Medrano! 1998;! Roberts* et* al.! 2001).* The*
ablation! of! SOCS2! results! in! an! overgrowth! phenotype! due! to! deRregulated! GH!
signalling! (Greenhalgh* et*al.!2005;!Metcalf* et*al.!2000;!MacRae* et*al.!2009).!At!birth,!
the! mice! are! indistinguishable! from!WT! littermates.! From! 3! weeks! of! age! Socs2&/&!
mice!show!increased!growth.!By!12!weeks,!male!mice!are!approximately!40%!larger!
than!male!WT.!!SOCS2!null!females!also!show!increased!growth,!although!this!is!not!
to! the! same! extent! as! males! (Metcalf* et* al.! 2000).! ! The! overgrowth! phenotype! is!
characterised!by!an!increase!in!body!weight!due!to!an!increase!in!skeletal!size!and!a!
proportional!increase!in!size!of!most!organs.!Increased!local!production!of!Igf1!in!a!






Socs2&/&! phenotype! is! dependent! on! endogenous! GH.! Furthermore,! the! gigantism!
phenotype! is! rescued!with! the!addition!of!exogenous!GH!(Greenhalgh* et* al.!2005).!
The!phenotype!observed!with! the!ablation!of!SOCS2! is! similar! to! that!observed! in!
high! growth! (hg)! mice.! These! mice! develop! an! overgrowth! phenotype! due! to! a!
spontaneous!500kb!deletion!in!mouse!chromosome!10,!containing!the!SOCS2!allele!
(Horvat!&!Medrano!2001).!A!noticeable!difference!between! the! two!models! is! that!
hg!mice!show!increased!levels!of!systemic!IGFR1,!whereas!SOCS2!null!mice!do!not!
(Metcalf* et* al.! 2000;!Horvat! &!Medrano! 2001;! Lorentzon* et* al.! 2005;!MacRae* et* al.!
2009).! This! suggests! that! the! overgrowth! phenotype! observed! in!Socs2&/&!mice! is! a!










the! overgrowth! phenotype! of! Socs2&/&*mice.! ! This! phenotype! is! lost! when! crossed!
with! a! Stat5b&/&! mouse! (Greenhalgh* et* al.! 2002a).! Furthermore,! in! the! absence! of!
SOCS2,! STAT5! signalling! is! enhanced! in! response! to! GH! in! a! number! of! tissues!
(Greenhalgh* et* al.! 2002a;! Pass* et* al.! 2012).! Similar! to! results! obtained! in* vivo,!
overexpression! of! SOCS2! in* vitro! leads! to! an! increase! in! GH! induced! STAT5!
dependent!gene!transcription.!It!has!been!proposed!that!this!is!due!to!the!ability!of!
SOCS2! to! block! SOCS1! and! 3,! the! more! potent! GH! inhibitor! (Favre* et* al.! 1999;!
Piessevaux* et* al.! 2006).! The!mechanism! by!which! SOCS2! regulates! GH! signalling!
remains!unclear.!Deleting! tyrosine! residues!present!on! the!GH!receptor! (Y487!and!
Y595)! results! in! cessation! of! the! inhibitory! action! of! SOCS2! on! GH! signalling!
(Greenhalgh* et* al.! 2005;!Uyttendaele* et* al.! 2007).!As!Y595! is! also! a!binding! site! for!
STAT5,! SOCS2!may! act! to! block! STAT5! attachment,! and! therefore! GH! signalling!
(Smit* et* al.! 1996).!Other! studies!have!however! shown!Y487! and!Y595!bind!STAT5!
with! a! low! affinity! compared! to! other! tyrosine! motifs,! Y534,! Y566! and! Y627!
(Uyttendaele* et* al.! 2007).! ! SOCS2! may! alternatively! act! as! an! ubiquitin! ligase,!
promoting!the!ubiquitination!and!degradation!of!the!GHR!(RicoRBautista*et*al.!2006;!
Vesterlund* et* al.! 2011).! The! conserved! SOCS2! box!motif! binds! Elongins! B! and! C.!






















and! chondrocyte! proliferation! within! the! growth! plate! (Pass* et* al.! 2012).!
Examination! of! older!mice! reveals! increased! long! bone! length! at! 7! and! 12!weeks!
(Metcalf* et* al.! 2000;! MacRae* et* al.! 2009).! ! The! increase! in! growth! plate! width!
observed!in!Socs2&/&!mice!is!the!result!of!an!increase!in!size!of!both!the!proliferative!
and!hypertrophic!zones!(MacRae!et*al.!2009;!Pass!et*al.!2012).!It!is!unknown!if!this!is!
the! result!of! an! increase! in! chondrocyte! cell! size!or!number.!However,! analysis!of!
the!liver!and!muscle!suggest!that!increased!organ!size!in!Socs2&/&!mice!is!the!result!of!
increased! cell! number! and! not! an! increase! in! cell! size! (Metcalf! et* al.! 2000).! This!





et* al.! 2009).! Nevertheless,! the! analysis! of! bone! in! these! studies! has! produced!
opposing! results.!Male!Socs2&/&!mice!have!decreased! cortical! parameters! and!BMD,!
whereas! female! Socs2&/&*mice! have! increased! cortical! area! and! trabecular! volume,!
with! no! changes! to! BMD! (Lorentzon* et* al.! 2005;! MacRae* et* al.! 2009).! The! latter!








growth.! It’s! specific! role! in! longitudinal! growth! and! bone! turnover! has! however!
been!questioned.!!Bone!length!is!reduced!in!Stat5ab&/&!mice.!Despite!this,!there!is!no!
decrease! in! growth! plate! width.! Similar! results! are! found! in! relation! to! bone!
remodelling.! !Cortical!bone!width! is!decreased,!but!a!number!of!other!parameters!




As! described! in! section! 1.6.4! SOCS2! is! an! important! regulator! of! GH! signalling!
forming!part!of!a!negative!feedback!loop.!There!is!now!also!emerging!evidence!that!
SOCS2!may!be!a!key!mediator!regulating!GH!signalling!in!response!to!a!number!of!





signalling.! It! is! well! established! that! osteoblasts,! as! well! as! growth! plate!
chondrocytes! express! the! oestrogen! receptors! (ERRα,! and! ERRβ)! and! androgen!
receptor! (AR)!(Van!Der!Eerden* et*al.!2002;!Nilsson* et*al.!2003;!Borjesson* et*al.!2010;!
Almeida* et* al.! 2013).! Although! it! is! recognised! that! both! androgen! and! oestrogen!
exert! effects! on! these! cells! via!GH/IGFR1! independent!mechanisms,! this! is! beyond!
the!scope!of!this!thesis!and!have!been!extensively!reviewed!elsewhere!(Nilsson*et*al.!




The! ERRα! is! vital! in! mediating! oestrogen’s! up! regulation! of! SOCS2.! This! was!







expression! in! response! to! oestrogen! stimulation! is! associated!with! decreased! GH!
induced!STAT!signalling.!This!response! is!abrogated! in! the!absence!of!SOCS2,!but!
not!SOCS1!or!3!(Leung*et*al.!2003).!Interestingly,!oestrogen!has!also!been!shown!to!
increase! SOCS2! ubiquitination! and! degradation! in! human! osteoblast! cells.! This!
resulted! in!an!upregulation!of!GHRinduced!STAT5! signalling!and!gene!expression!
(Bolamperti* et* al.! 2013).!Androgens! stimulate!SOCS2!expression! in!prostate! cancer!





to! induce! the! synthesis! of! ketone! bodies;! the! principal! source! of! energy! during!





serum! IGFR1! levels! (Inagaki* et* al.! 2008).! Recently,! FGFR21! has! also! been! shown! to!




There! is! a! growing! body! of! evidence! that! factors! involved! in! inflammation! are!
linked! with! those! critical! for! bone! turnover! (Lorenzo! 2000).! A! number! of!
inflammatory!disorders!such!as!inflammatory!bowel!disease!(IBD),!coeliac!disease,!
uremia,!and!rheumatoid!arthritis!(RA),!are!associated!with!osteoporosis!(Jensen*et*al.!





The! aetiology! of! bone! loss! is! multifactorial,! and! includes! vitamin! D! and! calcium!
deficiency,! prolonged! glucocorticoid! use,! decreased! gonadal! function,! and!
inflammatory!activity!(Tilg*et*al.!2008;!Ali*et*al.!2009).!During!inflammation,!there!is!
an! increase! in! levels! of! proRinflammatory! cytokines,! including! interleukin! (IL)R1β,!
ILR6,!and!TNFα!(Rogler!&!Andus!1998;!Mak*et*al.!2006;!SanchezRMunoz*et*al.!2008).!
ILR6! and! TNFα! transgenic!mice! have! severe! alterations! in! cortical! and! trabecular!
bone.!This!is!associated!with!decreased!osteoblast!and!increased!osteoclast!function!





ILR1β,! ILR6! and! TNFα! are! recognised! to! have! direct! effects! on! regulating! bone!
turnover! (Thomson* et* al.! 1986;! Taichman! &! Hauschka! 1992;! Kuroki* et* al.! 1994;!
Gilbert* et* al.! 2000;! Zhang* et* al.! 2001).! One! of! the! factors! governing! bone! loss! in!
inflammatory! conditions! however! is! the! interference! of! the! systemic! and! tissueR
levels!of!GH/IGFR1!signalling.!An!increase!in!proRinflammatory!cytokines!observed!
in! inflammatory! conditions! is! often! associated! with! GH! resistance.! This! is!
characterised!by!normal!GH!secretion!with!decreased!systemic!IGFR1!levels!(Tenore*
et*al.!1977;!Lang*et*al.!1997;!Denko!&!Malemud!2004).!ILR6,!TNFα,!and!ILR1β!have!all!
been! implicated! in! altering! systemic! IGFR1! levels.! ILR6! overexpression! reduces!
systemic! IGFR1! levels,! but! GH! levels! remain! unchanged! (Kitamura* et* al.! 1995;!
DeBenedetti*et*al.!1997).!In!these!mice!IGFR1!levels!are!rescued!by!ILR6!neutralisation!
(De! Benedetti* et* al.! 2001).! ! TNFα! and! ILR1β! treatment! in* vitro! decreases! GHR!
synthesis! and! subsequently! IGFR1! production! in! hepatocytes! (Wolf* et* al.! 1996).!











the! specific!mechanisms!driving!GH!resistance.!These!also!provide!an! insight! into!
tissue! levels!of!GH!resistance! in!states!of! inflammation.!A!number!of!studies!have!
shown! the! STAT5! pathway! to! be! central! in! GH! resistance! associated! with!
inflammation.!Lipopolysaccharide!(an!inducer!for!systemic!inflammation)!decreases!
GH! induced! STAT5! phosphorylation! and! IGFR1! expression! in! liver! and! skeletal!
muscle! of! rats.! Altered! SOCS! expression! in! these! animals! indicate! that! SOCS!
proteins!may!be!responsible! for!mediating! the!GH!resistance!observed! (Lang* et*al.!
2003;!Chen* et* al.!2007;!Chen* et* al.!2009).!Similar! results!were!reported! in! the! IL10R/R!
model!of!colitis.!These!mice!are!characterised!as!having!decreased!BMD!and!IGFR1!
levels,! associated!with! the!down! regulation! of! hepatic!GHR!and! reduced! STAT5b!
activation.! TNFα! treatment! down! regulates! GHR! abundance! preventing! GH!
induced! STAT5! activation! in! hepatocytes! from! colitic! mice.! TNFα! neutralisation!
restores!GH!activation!of!STAT5!and!serum!IGFR1!levels!(Difedele*et*al.!2005).!ILR1β!
also! reduces! GH! induced! STAT5! activation! in! rat! hepatocytes! through! the! up!
regulation! of! SOCS3! (Boisclair* et* al.! 2000).! Although! STAT! signalling! was! not!
measured,!an!inverse!relationship!exists!between!Socs2!(a!wellRestablished!regulator!
of!GH!induced!STAT!signalling)!and!Igf1!expression!in!skeletal!muscle!from!uremic!
mice! (Greenhalgh* et* al.! 2002a;! Cheung* et* al.! 2008).! Taken! together! these! results!





that! result! in! growth! retardation! including! growth! hormone! deficiency! (GHD),!
Turner!syndrome,!and!PraderRWilli!syndrome!(Bang!et*al.!2012).!Recombinant!hGH!







children! found! that! approximately! 28%! of! participants! do! not! respond! to! GH!
therapy! (Bang! et* al.! 2011).! There! is! therefore! the! need! to! investigate! possible!
alternatives!that!may!increase!the!efficacy!of!GH!treatment!or!acts!as!an!alternative!
therapy.!To!achieve!this!there!is!need!first!to!fully!understand!the!mechanism!of!GH!




mouse! models,! and! human! conditions.! A! comprehensive! review! by! Yakar! and!
colleagues! outlines! a! number! of!mouse!models! for! GH! and! IGFR1! deficiency! and!
their! human! counterparts! (Yakar! et* al.! 2010).! An! example! of! this! is! the! defects!
observed! in! Snell! and! Ames! dwarf! mice! which! have! blunted! GHR! activity! are!
similar! to! the!clinical! characteristics!of!Laron!syndrome! in!humans! (Smeets!&!van!
BuulROffers! 1983;! Heiman! et* al.! 2003;! Laron! 2004).! Similarities! between! mouse!
models!of!inflammation!and!human!cases!highlight!the!importance!of!the!GH/IGFR1!
axis! in! regulating! growth! during! chronic! inflammation.! Both! humans! are!murine!
models!are!characterised!by! increased!GH!resistance!during! inflammation!(Tenore!
et* al.! 1977,! Katsanos! et* al! 2001,! Harris! et* al.! 2009).! More! recently,! at! the! Endo!














for! GH! on! bone,! however! the! mechanisms! involved! remain! largely! undefined.!
Therefore,! the! aim! of! this! studentship! was! to! establish! the! local! mechanisms! of!










3. Investigate! the! mechanisms! of! SOCS2! regulation! of! GH! induced! bone!
growth!in*vivo.!!!
!


























in!osteoblast!medium! in!a!humidified!atmosphere! (37°C,!5%!CO2).!To!passage! the!
cells,! they!were!initially!rinsed!in!αRMEM.!TrypsinRethylenediaminetetraacetic!acid!
pH! 7(EDTA)! was! used! to! detach! the! cells! from! the! culture! flask.! Addition! of!
osteoblast! medium! inactivated! the! trypsin,! and! cells! were! then! pelleted! by!
centrifugation!at!1000g!for!5mins.!Supernatant!was!removed!and!cells!resuspended!
in! osteoblast!medium.!Cells!were! counted! using! a! haemocytometer! and! plated! in!





and! counted! as! described! in! section! 2.2.1.! They! were! then! suspended! in! a! 50/50!
solution!of!freezing!medium!and!osteoblast!medium!in!cryovials!(Corning,!Surrey,!





in! a! drop!wise!manner.! Centrifugation! at! 1000g! for! 5mins! removed! the! dimethyl!









Under! sterile! conditions!primary!osteoblasts!were! isolated! from!calvaria!dissected!
from! 3R5! day! old!mice,! sacrificed! by! decapitation,! using! a! protocol! adapted! from!
(Zhu* et* al.! 2011).!All! solutions! used!were! sterilise! filtered! through! a! 0.20zm! filter!
and!heated!to!37°C.!In!brief,!dissected!calvaria!were!digested!in!1mg/ml!collagenase!
type!II!(Worthington!Biochemical!Cooperation,!UK)!in!Hank’s!balanced!salt!solution!
(HBSS)! for! 10mins! with! agitation.! This! removed! fibroblasts! and! marrow! cells.!
Subsequent!digestions!at!37°C!in!1mg/ml!collagenase!in!HBSS!(45mins),!4mM!EDTA!
in! PBS! (10mins)! and! 1mg/ml! collagenase! in! HBSS! (45mins)! all! with! agitation,!
produced!3! fractions!of! cells.! Each!population!was!washed! in!phosphate!buffered!
saline! (PBS),!HBSS,!and!PBS,! respectively! then!centrifuged!at!2000g! for!5mins!and!





Isolation!of!metatarsals!was! complete! following!an!established!method! (Pass* et* al.!




three! metatarsals! isolated! from! each! foot! under! a! dissecting! microscope! under!
sterile! conditions.!All! solutions!were! sterilise! filtered! through! a! 0.20zm! filter! and!








medium! or! postnatal! metatarsal! medium! (depending! on! age! at! extraction).!
Metatarsals!were!cultured!1!bone!per!well!in!24Rwell!plates!(Costar).!.!!Medium!was!
changed!every!2R3!days.!Culture!plates!containing!metatarsals!were!incubated!in!a!
humidified! atmosphere! (37°C,! 5%!CO2)! for! up! to! 13! days.! !Metatarsal! length!was!
measured!at!the!same!time!as!medium!change.!Metatarsals!were!measured!between!
the!proximal!to!distal!articulation!surfaces!through!the!middle!of!the!bone!!using!a!
Nikon! eclipse! TE300! microscope! with! digital! camera! attached,! using! Image! Tool!






The! SOCS2! overexpression! plasmid! (pEFRFLAGRI/mSOCS2)! and! control! plasmid!
(pEFRFLAGRI)!were!kingly!obtained!from!Prof.!D.!Hilton!(The!Walter!and!Eliza!Hall!
Institute! for! Medical! Research,! Parkville,! Victoria,! Australia).! The! plasmids! had!
been!previously!used!by!Dr!Chloe!Pass!(University!of!Glasgow)!to!assess!the!effects!
of! SOCS2!overexpression! in!ATDC5! chondrocyte! like! cells! (Pass* et* al.! 2012).! Since!
these!two!plasmids!did!not!have!resistance!to!any!antibiotic!that!would!be!suitable!
for! selection! during! transfection,! they! were! coRtransfected! with! pcDNA3.1(+)!




Glycerol! stocks! of! the! three! plasmids! were! kindly! obtained! from! Dr! Chloe! Pass.!
DNA!concentration!and!quality!were!assessed!using!a!nanodrop!spectrophotometer!
(Thermo! Scientific,! UK).! Purity! was! assessed! by! the! ratio! of! wavelengths!






added! to! 200ml! liquid! lysogeny! (LB)Rbroth! containing! 100zg/ml! ampicillin.! This!












SDS! was! achieved! by! the! addition! of! 10ml! chilled! neutralisation! buffer! P3.! The!
lysate! was! added! to! a! QIAfilter! cartridge! and! incubated! for! 10mins! at! room!
temperature.! The! lysate! passed! into! a! sterile! tube! removing! the! precipitate.!
Endotoxins! were! removed! by! the! addition! of! 2.5ml! endotoxin! removal! buffer,!
inversion,! and! incubation! for! 30mins! on! ice.! The! lysate! was! then! added! to! a!




15000g! for! 90mins! at! 4°C.! Supernatant!was! removed! and!pellet!washed!with! 70%!















and! 43.95zl! H2O.! For! EcoR1,! Nhe! I,! and! Pst! I! reaction! volumes! were! 1zl! DNA!
(1zg/zl),!0.25zl!enzyme,!2.5zl!buffer,!and!21.25zl!H2O.!All!reactions!were!incubated!
for! 1hr! at! 37°C! followed! by! 25mins! at! 65°C.!DNA! fragments!were! run! on! a! 1.8%!
agarose/1xTBE! (Ambion,! Cambridge,! UK)! gel! containing! 0.5ug/ml! ethidium!
bromide.!5x!blue!loading!buffer!(5:1)!(New!England!Biolabs,!Herts,!UK)!was!added!
to!each!sample!to!aid!loading.!Electrophoresis!was!carried!out!at!160V!in!a!gel!tank!
containing! TBE! buffer.! Hyperladder! 1! (Bioline)! was! used! as! a! molecular! weight!




MC3T3! cells! were! transfected! using! FuGene! 6! (Roche).! FuGene! 6! (6zl)! was!
incubated! with! 92.5zl! OptiMEM! (used! for! lipid! infections)! for! 5mins! at! room!
temperature.! DNA! containing! the! plasmids! pEFRFLAGRI! or! pEFRFLAGRI/mSOCS2!
were!then!added!along!with!pcDNA3.1(+)! (to!give!antibiotic!resistance)!at!a!ratio!of!
5:1!(1.25zl!and!0.25zl,!respectively).!This!ensured!that!there!was!optimal!chance!that!
if! pcDNA3.1(+)! was! transfected! then! the! other! two! plasmids! would! also! be!
transfected.!The! resulting! transfection!reagent!was! incubated!at! room!temperature!
for!15mins!before!being!carefully!added!to!MC3T3!cells! (70%!confluency)!cultured!
in! antibiotic! free! osteoblast! medium.! Cells! were! maintained! in! a! humidified!
atmosphere!(37°C,!5%!CO2)!for!6hrs!and!then!the!medium!was!changed!to!normal!
osteoblast!medium.!Following!48hrs! the!medium!was! changed!again! to!osteoblast!







To! ensure! that! colonies!were! grown! form! a! single! cell! population,! individual! cell!
position! was! marked! and! proliferation! tracked.! Once! a! colony! had! reached! a!
desirable! size! they! were! isolated! by! trypsinisation! within! a! cloning! ring! (8mm! x!





















DNA!was! extracted! from! earclips! taken! from! 3R4!week! old!mice! using! a!DNeasy!
blood! and! tissue! kit! (Qiagen,!Crawley,!UK)! following!manufacturer’s! protocol.! In!








steps.! The! DNA! was! finally! eluted! in! a! lowRsalt! buffer! and! passes! through! the!
membrane.! DNA! concentration! and! quality! were! assessed! using! a! nanodrop!






10x!NH4! buffer! (Bioline,! London,!UK);! 1.125zl! 50mM!MgCl2! (Bioline),! 2.5zl! 2mM!
dNTPs! (Invitrogen);! 0.5zl! 20pmol/zl! forward! and! reverse! WT! primers;! 15.625zl!
nuclease! free!H2O;! 0.25zl! 5U/zl! BioTaq!DNA!polymerase! (Bioline).! The! PCR!was!
performed!under!the!following!conditions!on!a!DNA!Engine!Dyad!machine!(Peltier!
Thermal! Cycler,! BioRRad! Laboratories,! Hertfordshire,! UK)! –! 3mins! at! 94°C!
(denaturing),! 35! thermocycles! consisting! of! 20s! at! 94°C! (denaturing),! 20s! at! 50°C!






thermocycles! consisting! of! 1mins! at! 92°C! (denaturing),! 1min! at! 58°C! (annealing),!
and!1min!at!72°C!(extension).!There!was!a!final!step!of!10mins!at!72°C.!
!












Mice! received! a! subcutaneous! injection! of! 10mg/kg! calcein! diluted! in! sodium!





From!14!days!of! age!mice! received! subcutaneous! injection!of! recombinant!human!
GH!(rhGH)!(3mg/kg)!(a!generous!gift!from!Professor!Faisal!Ahmed)!twice!daily!for!
14!days.!Vehicle! treated!animals! received!an! injection!of! sterile!H2O.! Injection! site!
was! changed! each! time! to! minimise! discomfort! to! the! animal! and! local!
inflammation.! GH! administration!was! spaced! the!maximum! time! part!within! the!





and! collected! in! serum! Z/1.3! tubes! (Greiner! BioROne,! Gloucestershire,! UK),!
promoting! clotting.! Samples! were! left! on! ice! for! 30mins! and! then! centrifuged! at!
1000g!for!10mins.!Supernatant!was!removed,!aliquoted,!and!stored!at!R80°C.!The!left!








before! being! sacrificed! by! cervical! dislocation.! Liver! and! tibiae! were! quickly!









MicroRCT! imaging! was! carried! out! with! guidance! from! Professor! Rob! van’f! Hof.!
This!was!used!to!assess!trabecular!architecture!and!cortical!geometry!of!bone.!Bones!
samples!were!stored!in!H20!at!R20°C!and!thawed!prior!to!scanning.!In!chapters!4!and!
6! (bones! from!DSS! induced! colitis! study)! tibiae! ! were! scanned! using! a!microRCT!
system! (Skyscan! 1172! XRray! microtomograph,! Bruker! Corporation,! Kontich,!
Belgium).! In! chapter! 5! and! 6! (bones! from! Il10R/R! study)! femurs! and! tibiae! were!
scanned! using! a! microRCT! system! (Skyscan! 1272! XRray! microtomograph,! Bruker!
Corporation,!Kontich,!Belgium).!The!methods!outlined!below!focus!of!the!use!of!the!
Skyscan!1172.!!Specific!changes!to!analysis!are!outlined!in!the!material!and!methods!
sections! of! each! results! chapter! (sections! 4.4.2,! 5.4.2,! and! 6.4.1).! For! analysing!
trabecular! bone! parameters,! high! resolution! scans! with! an! isotropic! voxel! size! of!
5zm! were! acquired! (60kV,! 0.5mm! aluminium! filter,! 0.6°! rotation! angle! between!







taken! for! analysis! of! cortical! bone,! using! the! articulation! with! the! fibula! as! a!
standard!reference!point.!CTAn!software!(Bruker)!was!used!to!analyse!appropriate!
parameters.! A! region! of! interest! was! selected! for! trabecular! analysis! to! ensure!
cortical!bone!was!not!included!in!trabecular!analysis!(Fig.!2.1B).!This!stage!was!not!







surrounding! soft! tissue,! a! threshold!was! set,! remaining! consistent! in! all! samples.!
Calcium! hydroxyapatite! phantoms! of! a! known! density! were! scanned! using! the!








deflection.!Each!bone!was! tested! to!point!of! failure!which!was! identified! from! the!
loadRextension! curve! (Fig.! 2.2)! as! the! point! of! maximum! load.! The! remaining!
parameters!were! calculated! from!a!polynomial! curve! fitted! to! the! rising! region!of!
the! loadRextension! curve! in! Sigmaplot! (Systat! Softwatre! Inc.,! San! Jose,! USA).! The!





























A.!Representative! images! in!Data!Viewer! of! proximal! tibia! and!midshaft! (both! showing! 3!
























































































were! dehydrated! through! increasing! concentrations! of! ethanol! R! PBS! for! 45mins,!
50%!ethanol! for! 2hrs,! 70%!ethanol! for! 2hrs,! 80%!ethanol! for! 2hrs,! 96%!ethanol! for!
2hrs,!100%!ethanol!for!3hrs,!100%!ethanol!for!3hrs.!Fat!was!then!removed!from!the!
sample! through! 2! washes! in! xylene! for! 1hr! and! 12hrs.! Samples! were! added! to! a!
filtration! solution! under! vacuum! (89%! liquid! Methylmethacylate! (MMA),! 10%!
dibutyl! phthalate! (increases! plasticity),! 1%! perkadox)! for! 5mins.! Samples! were!
stored! for!1!week!at!4°C.!Bones!were!embedded! in!MMA!in!an!air! tight!holder! to!
reduce!oxygen! levels! (oxygen!slows!setting!of!MMA).!Care!was! taken! to!keep! the!
orientation!of!the!tibia!similar.!Samples!were!left!in!a!30°C!water!bath!for!48hrs!then!
mounted!on!cassettes!and!5zm!sections!cut!using!a!Leica!RM2265!microtome!(Leica!




Staining! recipes! can! be! found! in! appendix! I.! Slides! embedded! in! MMA! (section!
2.4.9)!were! stained!with! Von!Kossa! (stains! calcium! deposits! black! and! cytoplasm!
light! pink)! and! paragon! (stains! nucleic! acids! blue! and! polysaccharides! purple).!
Before!staining!resin!was!removed!by!methoxyethyl!acetate!(MEA)!and!rehydrated!















Primary! osteoblasts! were! rinsed! in! ice! cold! PBS! to! remove! excess!medium.! Cells!
were! then! scraped! in!200zl!PBS,!pelleted!and! stored!at! R80°C.!RNA!was!extracted!
using! a! Qiagen! RNeasy! kit,! according! to! manufacturer’s! instructions.! In! brief,!
samples! were! initially! homogenised! in! the! presence! of! a! denaturing! buffer,!
inactivating! RNases.! Addition! of! ethanol! provided! optimal! binding! conditions! to!






additional! phenol/guanidineRbased! sample! lysis! step! which! facilitates! the!
breakdown! of! fatty! tissues.! RNA! was! then! extracted! through! the! addition! of!
chloroform! and! run! on! spin! columns.! Liver!was! initially! homogenised! in!QIAzol!
Lysis!Reagent!(RNeasy!Lipid!and!Tissue!kit)!using!a!hand!held!homogeniser!(ColeR
Parmer! Instruments! Ltd,! London! UK).! Bone! samples! were! submerged! in! liquid!
nitrogen! and! homogenised! using! a! mortar! and! pestle! followed! by! a! hand! held!
homogeniser!in!QIAzol!Lysis!Reagent.!RNA!was!stored!at!R80°C.!
!
Metatarsals! were! grouped! (3R4! bones)! to! make! one! sample.! RNA! was! extracted!
using! Trizol! reagent! following! manufacturer’s! protocol.! In! brief,! metatarsals! are!
homogenised! in! 200zl! of! Trizol! using! the! hand! held! homogeniser.! 40zl! of!
chloroform! was! added! to! the! samples! and! shaken! vigorously.! Following! 3mins!
incubation! the! samples! were! centrifuged! at! 12000g! for! 15mins! at! 4°C.! RNA! was!
extracted! from! the!upper!aqueous!phase!and!added! to!100zl!of! 100%! isopropanol!







Wash! was! discarded! and! pellet! allowed! to! air! dry! (~5mins),! before! being!
resuspended!in!50zl!RNaseRfree!H2O.!!!!!!!
RNA! concentration! and! quality! of! all! samples! were! assessed! using! a! nanodrop!
spectrophotometer! (Thermo! Scientific,! UK).! Purity! was! assessed! by! the! ratio! of!
wavelengths!260nm/280nm,!where!~2.0!was!considered!optimal.!Samples! from!the!





enzyme! reverse! transcriptase.! RNA! samples! (10zl)! were! incubated! with! 2zl! of!
random! primers! (1:60,! (Invitrogen)! from! 10mins! at! 70°C! (DNA! Engine! Dyad!
machine)!and!immediately!cooled!on!ice.!A!master!mix!was!used;!composed!of!4zl!
5xFirst! strand! buffer,! 2zl! dithiothreitol! (DTT)! (0.1M)! (Invitrogen),! 1zl!
deoxyribonucleotide!triphosphate!(dNTP)!(10mM),!and!1zl!Superscript!II!RNase!H!
enzyme! (200U/zl).! 8zl! of! the!master!mix!was! added! to! each! sample.! The! reverse!
transcription! was! performed! under! the! following! conditions! on! a! DNA! Engine!






reverse! primer! (10pmol/zl;! MWG! Eurofins! London,! UK)! or! 1zl! primer! assay!
(0.5zM;! Invitrogen)! and! 4zl! NFW! was! added! to! 25ng! cDNA! (5zl).! FastStart!
Universal!SYBR!Green!Master!Mix!contains!a!fluorescent!dye!which!binds!to!double!
stranded! cDNA!generating! a!quantifiable! readout! for! amplified! cDNA! levels.!The!
qPCR!was!performed!under!the!following!conditions!on!a!Stratagene!Mx3000P!PCR!






at! 72°C! (elongation).! Fluorescence! levels! were! measured! during! each! elongation!
step.!A!dissociation!curve!was!generated!after!each!run!to!assess!primer!specificity!
with! a! single! peak! indicating! one! amplified! product.! Reactions! containing! H2O!
instead!of!cDNA!sample!were!used!as!a!negative!control.!
!
To! initially! test! primer! efficiency,! cDNA! samples! known! to! express! the! gene! of!
interest! were! serially! diluted! and! run! with! the! sample! programme! as! described!
above! producing! a! standard! curve.! Primers! were! considered! acceptable! if! the!
standard! curve! had! an! R2! value! between! 0.90! and! 1.00,! with! an! amplification!
efficiency! between! 90R110%! (Fig! 2.3A).! To! confirm! specificity! of! new! primers! the!
product!was! run!on! a! 1.8%!agarose!gel! and!visualised! as! outlined! in! section! 2.4.3!
(Fig.! 2.3B).! qPCR! products! from! un! tested! primers! were! sent! to! Edinburgh!
Genomics! (University! of! Edinburgh)! for! sequencing! to! confirm!primer! specificity.!!
NCBI! Blast! was! used! to! match! product! sequence! with! sequence! of! interest.!!
Information!on!primers!can!be!found!in!Appendix!II.!
!
Analysis! of! qPCR! was! carried! using! MxPro! software! (Cheshire,! UK).! Gene!
expression!was! initially! normalised! to! a! house! keeping! gene!Gapdh* (unless! stated!
otherwise).!Gapdh*was! selected! using! a! gNorm! kit! (Primer!Design,!UK).! This! test!
was! completed! on! RNA! from! bone! samples! and! tested! an! array! of! common!
housekeeping! genes! to! ensure! that! their! expression!was! not! altered! by! genotype.!




































Primary!osteoblasts!and!MC3T3!cells!were! rinsed! in! ice! cold!PBS! twice! to! remove!
excess! medium.! Generally,! 2! wells! were! combined! for! 1! sample.! Depending! on!
protein! of! interest,! cells! were! scraped! in! either! Phosphosafe! extraction! reagent!
(Novagen,!Merck!Biosciences,!Nottingham,!UK)!containing!0.15!x!volume!protease!
inhibitor!cocktail!(Roche,!Burgess!Hill,!West!Sussex,!UK)!!or!RIPA!buffer!containing!
0.15! x! volume! protease! inhibitor! depending! on! protein! of! interest.! Detection! of!
phosphorylated! (pR)! proteins! such! as! pRSTATs,! pRAKT,! and! pRERK1/2! required!
scraping!in!Phosphosafe,!whereas!cells!used!for!the!detection!of!SOCS!proteins!were!




were! submerged! in! liquid! nitrogen! and! homogenised! using! a! mortar! and! pestle.!





discarded.! Protein! content! was! determined! using! a! DS! protein! assay! (BioRRad!
Laboratories,! Herts,! UK).! This! assay! is! similar! to! the! Lowry! assay.! Protein!
undergoes!a!reaction!with!an!alkaline!copper!tartrate!solution!which!reduces!Folin!
reagent! producing! a! blue! colour.! Standards! were! made! using! lyophilised! bovine!
plasma!gamma!globulin!protein,!2mg/ml!(BioRRad)!diluted!in!the!same!solution!that!
protein! was! extracted! in.! Each! reaction! was! carried! out! in! a! 96Rwell! plate.! All!
samples!were! carried! out! in! duplicate.! Initially,! 25zl! Reagent!A’! (containing! 20zl!














to! a! solution! of! LDS! sample! buffer! (3:1)! and! sample! reducing! reagent! (10:1,!
Invitrogen).! Samples!were! denatured! at! 70°C! for! 10mins.! The! denatured! proteins!
were! chilled!on! ice! for! 1min!before!being! loaded!onto!preRcast! 3R8%!Tris! –Acetate!
((pR)STATs,!(pR)!Akt,!and!(pR)!ERK1/2)!or!10%!BisRTris!gels!(SOCS)!(both!Invitrogen)!
(unless! stated! otherwise).! Gels! were! run! in! a! Novex! Gel! Tank! (Invitrogen)!
containing!1x!Tris!Acetate!or!1x!MOPS!running!buffer,!respectively.!All!blue!protein!
standards! were! used! as! molecular! weight! markers! (All! Blue,! BioRRad,! Hemel!
Hempstead,!UK).!AntiRoxidant!was!added!to!the!centre!compartment!of!the!tank!to!
preserve! reduced! proteins! (2.5zl/ml;! Invitrogen).! Proteins! were! separated! by!
electrophoresis!at!200V!for!40mins.!!!!!!!!!!!
!
Protein! was! transferred! onto! a! HyboundRECL! nitrocellulose! membrane! (GE!
Healthcare,!Amersham),! sandwiched!between! transfer! buffer! (Appendix! I)! soaked!




and! blocked! at! room! temperature! for! 1hour! in! 5%!BSA! (Albumin,! Bovine! Serum,!
Fraction!V)! in!TBS/T.! Following! this! stage! the!nitrocellulose!was! incubated!at! 4°C!
overnight!with!the!primary!antibody!diluted!in!TBS/T.!The!nitrocellulose!was!then!
washed! again! in! TBS/T! before! being! incubated! at! room! temperature! for! 1.5hours!












Restore! Plus! Stripping! buffer! (Thermo! Scientific)!was! used! to! strip! nitrocellulose.!
Stripping! buffer! was! incubated! with! nitrocellulose! for! up! to! 30mins! at! 37°C!
followed!by!up!to!1hr!at!room!temperature.!Probing!with!the!appropriate!secondary!





containing! a! 22mmx22mm! glass! coverslip! (Scientific! Laboratory! Supplies,!
Yorkshire,! UK).! At! the! end! point! of! experiment!medium!was! aspirated! and! cells!
fixed! in! 4%! paraformaldehyde! for! 15mins.! Cells! were! washed! in! PBS! (3x5mins)!
before!being!permeabilised!in!ice!cold!100%!methanol!for!5mins!at!R20°C.!Following!
a!5mins!wash!in!PBS!cells!were!blocked!in!blocking!buffer!(1xPBS,!5%!normal!goat!
serum,! 0.3%! triton!XR100)! for! 1hr.! Blocking! solution!was! aspirated! and! cells!were!
incubated! with! primary! antibody! diluted! in! antibody! dilution! buffer! (1xPBS,! 1%!
BSA,!0.3%!Triton!XR100)!overnight!at!4°C.!Primary!antibody!was!removed!and!cells!!
were!washed! in!PBS! (3x5mins).! The! fluorochromeRconjugated! secondary! antibody!
diluted! in! antibody! dilution! buffer! was! added! to! the! cells! for! 90mins! at! room!










Statistical! analysis! was! completed! using! SigmaPlot! (v11.0)! (Systat! Software! Inc.,!
London,! UK).! ! For! comparisons! involving! 2! independent! variables! data! were!
analysed! using! a! 2! way! ANOVA! for! which! suitable! postRtests! for! multiple!













































effects! on! longitudinal! growth! (Le!Roith* et* al.! 2001).!At! a! systemic! level,!GH! acts!
indirectly! through! IGFR1,!which! is!produced!by! the! liver.!At! a! local! level! (growth!
plate!cartilage),!GH!activates!the!GHR!and!regulates!chondrocyte!function!via!IGFR1!
dependent!(indirect)!or!independent!(direct)!mechanisms!(Gevers*et*al.!2002b).!The!
phenotypic! analysis! of!Ghr&/&! and! GHRH! receptor! knockout! (Ghrhr&/&)*mice! reveal!
reductions!in!body!weight!and!growth!retardation!(Wajnrajch*et*al.!1996;!Sims*et*al.!
2000;!Greenhalgh* et* al.! 2005).!A! comparable!phenotype! is!present! in!humans!with!
severe!primary!IGFR1!deficiency,!characterised!by!insensitivity!to!GH!(Laron!2004).!
Similar!growth!deficiencies! are! reported! in!global! Igf1R/R! and! Igf1rR/R!mice! (Liu* et* al.!
1993;! Lupu* et* al.! 2001;! Mohan* et* al.! 2003).! The! relative! contributions! of! GH’s!








components! of! the! ternary! complex! to!which! IGFR1! binds! in! circulation,! systemic!
IGFR1!levels!were!virtually!undetectable!(2.5%!of!WT!IGFR1).!Despite!this,!these!mice!
only! exhibited! a! 6%! decrease! in! body! length.! This!was! comparable! to! that! of! the!
ALSKO!mice!alone,!which!had!a!60%!reduction!in!IGFR1!levels!(Yakar*et*al.!2009).!It!
has!been!proposed!that!a!threshold!concentration!of!systemic!IGFR1!is!required!for!
normal!growth,! as!ALSKO+LID!mice! (85R90%! reduction! in! systemic! IGFR1)!have!a!
significant!reduction!in!linear!growth!(Yakar*et*al.!2002).!In!addition,!when!hepatic!













Alternative! strategies! to! distinguish! between! systemic! and! local! IGFR1! effects! on!
linear! bone! growth! have! involved! the! targeted! deletion! of! Igf1! in! epiphyseal!
chondrocytes.! These! mice! had! a! 40%! reduction! in! cartilage! Igf1! expression! and!
normal!serum!IGFR1!levels!(Govoni*et*al.!2007a).!Linear!growth!was!reduced!by!27%!
between!2!and!4!weeks!of!age,!highlighting!that!local!chondrocyteRproduced!IGFR1!
is! an! important! regulator!of! longitudinal!growth.!Whilst!highly! informative,! these!
studies!fail!to!address!the!possibility!of!GH!actions!on!longitudinal!growth!that!are!
independent! of! downstream! IGFR1! effects.! Ghr/Igf1rR/R! ! mice! have! a! more! severe!




Socs2&/&* mice! (Metcalf* et* al.! 2000;! MacRae* et* al.! 2009).! SOCS2! is! expressed! by!
epiphyseal! chondrocytes,! and! is! a! recognised! negative! regulator! of!GH! signalling!
via!inhibition!of!the!JAK/STAT!pathway!(Hilton!1999;!Greenhalgh*et*al.!2002;!FloresR
Morales* et* al.! 2006;! RicoRBautista* et* al.! 2006;! Pass* et* al.! 2009).! These! mice! are!
characterised! by! increased! growth,! including! increased! long! bone! length,!without!
elevated!systemic!levels!of!IGFR1!or!GH!(Metcalf*et*al.!2000;!Greenhalgh*et*al.!2005;!
MacRae* et* al.! 2009).! ! It! can! therefore! be! assumed! that! local! direct! and/or! indirect!
(IGFR1!mediated)!effects!of!GH!are!driving!this!increased!linear!bone!growth.!!
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WT! metatarsals! do! not! respond! to! GH! due! to! an! increase! in! Socs2! expression.!



























Metatarsals! were! isolated! from! 17! day! old! embryos! or! postnatal! day! 3! pups! as!
described! in! section! 2.2.4.! rhGH!and! rhIGFR1! (both!Bachem,!Merseyside,!UK)! and!
rmIGFR2! (R&D! systems,!Minneapolis,!USA)!were! added! at! 100ng/ml.! ! 1zM!NVPR
AEW541! (IGFR1R! inhibitor)! was! added! 16! hours! prior! to! the! addition! of! GH.! As!
NVPRAEW541! was! diluted! DMSO,! an! equivalent! concentration! of! DMSO! was!
added!to!control!groups.!!!Culture!plates!containing!metatarsals!!were!incubated!in!
a! humidified! atmosphere! (37°C,! 5%! CO2),! for! up! to! 13! days.! Metatarsals! were!






Embryonic! day! 17!metatarsals!were! stored! in! 80%! ethanol! following! 12! days!GH!
treatment.!Metatarsal! embedding,! staining,! and! sectioning!were! completed! by! the!
Easter!Bush!Pathology!Department,!University! of!Edinburgh.! In! brief,!metatarsals!
were! demineralised! in! 10%! EDTA! for! 2! days.! Samples!were! embedded! using! the!
following!protocol!–!70%!ethanol!for!1hr,!95%!ethanol!for!1hr,!5!washes!in!absolute!
ethanol! for! 1hr! each,! and! 2!washes! in! xylene! for! 1hr! each.! Finally,! samples!were!
embedded!in!paraffin!wax!for!4hrs,!wax!changed!every!1hr.!5zm!sections!were!cut!
and!mounted!on!polysine! slides! (Thermo!Scientific,!UK).! ! Sections!were!dewaxed!
and! dehydrated! through! graded! alcohol! solutions,! immersed! in! Harris!
haematoxylin,! followed!by!1%!eosin,!before!being! cleared!and!mounted! in!DePeX!
(VWR,!Lutterworth,!UK).!A!minimum!of!4!metatarsals!per!group!(control!and!GH!
treated)! were! measured! at! x10! magnification! to! calculate! the! widths! of! the!
proliferating!and!hypertrophic!chondrocyte!zones!as!a!percentage!of!the!total!length!





attached,! using! Image! Tool! (Image! Tool! version! 3.00)).! Proliferative! and!
hypertrophic! zones!were! defined! from! cell!morphology.! ! !Multiple! sections!were!




At! defined! time! points! following! GH! treatment! RNA! was! extracted! from!
metatarsals!as!described!in!section!2.5.1.!cDNA!was!prepared!as!outlined!in!section!
2.5.2,! and! qPCR! analysis! completed! as! detailed! in! section! 2.5.3.! Results! were!





days!GH!treatment!and!stored!at! R80°C.! IGFR1!and!IGFBP3!levels! in!were!assessed!!
by! ELISA! (Quantikine,! R&D! Systems,! Minneapolis,! MN,! USA)! according! to!




Six! and! 17!week! old!male!WT! and! Socs2R/R! mice! received! an! injection! of! 10mg/kg!
calcein! solution! as! described! in! section! 2.4.4.! Tibiae,! fixed! overnight! in! 4%!
paraformaldehyde! (PFA)! were! embedded! in! methylmethacrylate,! stained! and!
sectioned!as!described!in!sections!2.4.9!&!2.4.10.!!
!
Calcein! is! taken! up! by! newly! mineralised! bone! and! can! therefore! be! used! to!
determine!longitudinal!bone!growth!rate.!This!is!calculated!as!the!distance!between!
the! chondroRosseous! junction! and! calcein! labelling! front! using! a! Leica! DMBR!







sections! were! measured,! and! an! average! bone! formation! rate! calculated.! Bone!




6!week! old!WT! and!Socs2&/&!mice.!At! 17!weeks! of! age,! 5!WT! and! 3!Socs2&/&! growth!





by! Seema! Jasim,! an!MSc! student! (University! of! Edinburgh)! completing! a! project!
within! the! laboratory.! !Tibiae!were!dissected! from!7!week!old!male!WT! (n=4)!and!
Socs2&/&! mice! (n=3).! Bones! were! briefly! immersed! in! 4%! aqueous! (wt./vol.)!
polyvinylalcohol! (PVA;! Grade! GO4/140,! Wacker! Chemicals,! WaltonRonRThames,!
UK),! chilled!by!precipitate! immersion! in!nRhexane! (BDH,!Poole,!UK;!grade! low! in!
aromatic! hydrocarbons)! and! stored! at! R800C.! Using! optimal! cutting! temperature!
(OCT)! embedding! medium! (Brights,! Huntingdon,! UK),! 30zm! thick! longitudinal!
sections! of! the! proximal! tibia! were! cut! at! R30oC! (Brights,! OT! model! cryostat),!
mounted!on!Superfrost!Plus!slides!(Fischer!Scientific,!Chicago,!IL)!before!storage!at!R
80°C.! ! Slides! were! briefly! thawed! as! described! previously! (Nilsson* et* al.! 2007;!
Staines* et* al.! 2012),!and! then!dehydrated! in!graded!solutions!of!ethanol! (70%,!95%!
and! 100%)! with! sections! kept! under! a! xylene! droplet! throughout! the!
microdissection.! The! entire! growth! plate! was! dissected! free! from! the!
perichondrium,!the!secondary!ossification!zone!and!the!primary!spongiosa.!Growth!
plates!from!both!tibae!of!each!mouse!were!pooled!in!2.88zl!βRmercaptoethanol!and!
400zl! Solution! C! (0.322g! guanidine! thiocyanate,! 377zl! nuclease! free! water,! 23zl!











Statistical! analysis! was! completed! on! software! described! in! section! 2.7.! For!
metatarsal! growth,! experimental! data!were! analysed!using! a! repeated!measures! 2!























in! the!regulation!of!GH!action!on!endochondral!bone!growth! (Pass* et* al.!2012).!To!




7! revealed! an! increase! in! Socs2,! but! not! Socs1! and! 3! expression! in! GH! treated!
metatarsals! (17–fold,! p<0.01)! (Fig.! 3.1B).! Socs2&/&! metatarsals! showed! significantly!
increased! growth! in! response! to! GH! from! day! 7! (p<0.05),! and! had! grown! 23%,!
(p<0.001)! and! 25%! (p<0.001)! more! than! untreated! bones! by! days! 9! and! 12!
respectively! (Fig.! 3.1C).! Untreated! metatarsals! from! WT! and* Socs2&/&! animals!
displayed! similar! growth! rates! (Fig.! 3.1D).! This! indicates! that! GH! stimulation! is!
required!to!up!regulate!Socs2*expression,!which!subsequently!inhibits!growth.!!
!
Treatment! with! IGFR1,! stimulated! growth! of! WT! and! Socs2&/&! metatarsals! (Fig.!













Figure! 3.1! SOCS2! regulation! of!GH! induced! longitudinal! growth! of! embryonic!
metatarsals!
A.!WT! and!C.!Socs2&/&! E17!metatarsal! growth! in! response! to!GH!or! IGFR1! (both! 100ng/ml)!






















In!Socs2&/&!metatarsals,! following!12!days!GH! treatment! the!PZ! size!decreased!as! a!
percentage! of! the! total! unRmineralised! tissue! (control! –! 74%,! GH! –! 64%;! p<0.05).!
There!was!an!associated!increase!in!HZ!(control!R!25%,!GH!–!36%;!p<0.05)!(Fig.!3.2).!!
These!data!show!that!in!the!absence!of!a!growth!response!to!GH!(as!observed!with!
WT!metatarsals)! the! composition! of! the! growth! plate! remains! unchanged.!When!
linear! bone! growth! is! stimulated! in! Socs2&/&*metatarsals! challenged! with! GH,! the!
width! of! the! HZ! increased.! This! suggests! that! GH! promotes! linear! growth! by!
eliciting!its!effects!on!the!hypertrophic!chondrocytes.!
!
3.5.3! Experimental! setup! for! mRNA! and! conditioned! medium! analysis! of!
embryonic!metatarsals!in!response!to!GH!!
To! determine!whether!GH! action! on!Socs2&/&!metatarsals!was! a! result! of! increased!
IGFR1!levels,!transcript!and!conditioned!medium!was!analysed!from!WT!and!Socs2&/&*
bones!following!GH!treatment.!GH!induced!linear!growth!was!initially!observed!in*
Socs2&/&! metatarsals! following! 5! days! GH! treatment! (p<0.05)! and! by! day! 7,! GH!
stimulation!had!resulted!in!15%!increase!in!growth!(p<0.01).!A!similar!stimulation!of!
linear!growth!was!not!observed!in!WT!metatarsals!(Fig.!3.3).!Following!12!days!GH!
















Figure! 3.2! SOCS2! regulation! of! GH! induced! alternation! in! proliferative! and!
hypertrophic!zone!proportions!of!embryonic!metatarsals!!
A.! The! percentage! of! unRmineralised! tissue! containing! cells! in! the! proliferative! zone! or!
hypertrophic! zone! following! 12! days! GH! (100ng/ml)! treatment! in! WT! and! Socs2&/&! E17!
metatarsals.!Data!are!presented!as!mean!±!SEM!(n≥5).!Significance!from!untreated!(control)!
metatarsals! denoted! by! *p<0.05.!B.! Representative!H&E! sections! from!WT! and!Socs2&/&! E17!













Figure! 3.3! Experimental! setup! for! mRNA! analysis! of! embryonic! metatarsals! in!
response!to!GH!!
WT!and!Socs2&/&!E17!metatarsal!growth! in!response! to!GH!(100ng/ml)!over!a!12!day!period.!



















Expression! levels! of! Igf1*did!not! increase! in!WT!and!Socs2&/&!metatarsals! following!
both!7!and!12!days!GH!treatment!(Fig.!3.4).!!
!
Conditioned! medium! was! collected! from! WT! and! Socs2&/&! metatarsal! cultures!
following! 5,! 7,! and! 12! days! GH! treatment.! At! allRtime! points! protein! analysis!







































Day! Treatment!! !! WT!(ng/ml)! ! Socs2&/&(ng/ml)!
5! Control! ! 2.4! ±! 0.48!! ! 2.7! ±! 0.59!!
! GH! ! 2.1! ±! 0.23!(0.595)! ! 2.6! ±! 0.26(0.857)!
7! Control! ! 6.4! ±! 0.86! ! 3.3! ±! 0.39!
! GH! ! 4.0! ±! 0.70!(0.066)! ! 2.8! ±! 0.28!(0.292)!
12! Control!! ! 11.6! ±! 1.16!! ! 9.9! ±! 0.90!






















of! 6! and! 17! week! old! male!WT! and! Socs2&/&! mice.! Scale! bar! =! 50! zm!B.! Calcein! labelling!
highlighting!linear!bone!growth!rate!of!proximal!tibia!from!6!and!17!week!old!male!WT!and!
Socs2&/&! mice.! Linear! growth! rate!measured! from! calcein! label! to! chondroRosseous! junction!
(red! arrows).! Scale! bars! =! 100zm!C.! Igf1!mRNA!expression! levels! in!growth!plates!microR


























Age! Genotype! Growth!Plate!! ! Linear!Bone!Growth!
! ! Width!(cm)! ! Rate!(cm/day)!
6!weeks! WT! ! 183.4! ±! 10.61! ! 36.8! ±! 1.57!
! Socs2&/&* ! 203.2! ±! 3.93! ! 44.5! ±! 1.80a!
17!weeks! WT! ! 57.4! ±! 2.26! ! nd!
! Socs2&/&* ! 61.3! ±! 6.5! !! nd!
Table! 3.2! Increased! linear! bone! growth! rate! in! 6! week! old!male! Socs2&/&!
mice!!
Quantification! of! static! and! dynamic! histomorphometry! of! the! proximal! tibia!
growth!plates!of!6!and!17!week!old!male!WT!and!Socs2&/&!mice.!!!






3.5.6! The! effects! of! GH! treatment! on! IGFBP3! production! by! embryonic!
metatarsals!!
GH!is!also!a!major!regulator!of! IGFBP3! levels! (Clemmons!1998).!Following!7!days!
GH! treatment,! expression! levels! of! Igfbp3! were! unaltered! in! WT! and! Socs2&/&!
metatarsals! (Fig.!3.6).!At!day!12,!WT!metatarsals!continued!to!show!no! increase! in!
Igfbp3* expression! in! response! to! GH.! Conversely,! at! this! point* Igfbp3* expression!




were!more! responsive! to!GH.! Increased! IGFBP3! level!were! noted! at! day! 5! (186%;!
p<0.01),! 7! (334%;! p<0.01),! and! 12! (123%;! p<0.001)! (Table! 3.3).! The! transcript! and!
protein! analysis! carried! out! here! highlights! an! important! role! for! SOCS2! in! the!
regulation!of!GH!induced!IGFBP3!levels.!!!
!
3.5.7! The! effects! of! GH! treatment! on! Socs2&/&! embryonic! metatarsals! in! the!
presence!of!an!IGFX1R!inhibitor!






compound,!failed!to! inhibit! IGFR1! induced!autophosphorylation!of! the!IGFR1R!and!
downstream!AKT! activation! (Fig.! 3.7A).! NVPRAEW541! (NVP),! a! selective! IGFR1R!







Preliminary! studies! were! carried! out! on! WT! metatarsals! to! determine! a!
concentration! of! NVP! that! would! inhibit! IGFR1! activity,! without! being! toxic.!
Metatarsals!were! cultured! in! the! presence! of! 1,! 2,! 3,! or! 4zM!NVP! for! 5! days.!All!
treatment!groups!showed!significantly!less!growth!than!the!nonRtreated!group!(Fig.!
3.7B).! It! was! observed! that! concentrations! of! 3! and! 4zM!NVP! almost! completely!




further! 4! days.! Metatarsals! treated! with! 3! and! 4! zM! NVP! showed! no! signs! of!
recovery!following!its!removal,!yet!those!treated!with!2!zM!NVP!continued!to!grow!
at! a! similar! pace! to! when! inhibited.! Metatarsals! treated! with! 1zM! NVP! showed!
inhibited! growth!until! day! 7,! and! then! showed! enhanced! growth! (Fig.! 3.7B).! This!
indicated!that!at!the!higher!concentrations!NVP!(3!and!4zM)!were!possibly!toxic!to!
the! bones!whereas! at! 1zM! the! growth! inhibitory! effects!were! reversible! after! the!
inhibitor! was! removed.! Aside! from! highlighting! an! appropriate! concentration! of!
inhibitor!to!use!for!future!studies,!these!data!also!showed!the!importance!of!IGFR1R!
signalling!in!the!growth!of!metatarsals.!!
As! observed! in! WT,! Socs2&/&! metatarsals! treated! with! NVP! (1zM)! showed!


























Day!! Treatment!! !! WT!(ng/ml)! !! Socs2&/&*(ng/ml)! ""
5! Control! ! 9.0! ±! 1.43! ! 8.2! ±! 1.35! !
! GH! ! 9.7! ±! 1.41!(0.727)! ! 23.5! ±! 5.76(0.002)! !
7! Control! ! 12.2! ±! 1.68! ! 5.2! ±! 0.94! !
! GH! ! 19.7! ±! 4.57!(0.155)! ! 22.6! ±! 3.34(0.004)! !
12! Control!! ! 25.0! ±! 5.09! ! 22.2! ±! 3.51! !
!! GH! !! 39.8! ±! 3.69(0.050)! !! 49.6! ±! 1.89(<0.001)! !!
Table! 3.3! Enhanced! IGFBP3! protein! levels! in! Socs2&/&! embryonic! metatarsal!
cultures!following!GH!treatment!!!



































stimulatory! effects! of!GH! are! ablated! in! the! presence! of! an! IGFR1R! inhibitor! (Fig.!
3.7),!and!IGFR1!levels!are!not!increased!in!GH!treated!metatarsals!(Fig.!3.4!&!Table!
3.1)!IGFR2!was!assessed!for!its!responsiveness!to!GH.!No!elevation!was!observed!in!
Igf2! mRNA! levels! in!WT! and! Socs2&/&! metatarsals! following! 7! days! GH! treatment!









in! IGFR2! levels! (Table! 3.4),! metatarsals! were! treated! with! exogenous! IGFR2! to!
establish! whether! it! could! stimulate! longitudinal! growth.! IGFR2! was! added! at! an!
equimolar!concentration!to!IGFR1!which!has!been!shown!to!be!a!potent!stimulator!of!
longitudinal! growth! (Fig.! 3.1).! IGFR2! treatment! significantly! increased! growth! of!
Socs2&/&!metatarsals! from!day! 5! (8.3%;!p<0.05)! to! 12! (11.1%;!p<0.01)! (Fig.! 3.8B).! The!
enhanced!growth!by!IGFR2!was!considerably!less!than!that!observed!following!IGFR
1!treatment,!which!resulted!in!a!28.4%!increase!in!growth!by!day!12.!!This!indicates!
that! whilst! IGFR1! and! IGFR2! can! both! stimulate! linear! growth,! IGFR1! is! the! more!






















Figure! 3.8! Increased! Igf2! mRNA! expression! levels! in! Socs2&/&! embryonic!
metatarsals!following!GH!treatment!
A.! Igf2!mRNA!expression! levels! in!WT!and!Socs2&/&!E17!metatarsals! following!7!or!12!days!
GH! (100ng/ml)! treatment.! Data! are! presented! as! mean! ±! SEM! (n=3! groups! of! 3R4! pooled!
bones)!relative!to!untreated!(control)!samples.!Significance!from!untreated!(control)!samples!






Day!! Treatment!! !! WT!(ng/ml)! !! Socs2&/&*(ng/ml)!
12! Control!! ! 7.0! ±! 1.39! ! 1.7! ±! 0.34!
!! GH! !! 8.4! ±! 0.97!(0.426)! !! 17.1! ±! 1.72(<0.001)!
Table! 3.4!Enhanced! IGFX2! protein! levels! in!Socs2&/&! embryonic!metatarsal!
cultures!following!GH!treatment!!











determine! if! there! were! prenatal! and! postnatal! differences! of! GH! action! on!
metatarsals,! a! postnatal! metatarsal! model! was! established.! Initially,! metatarsals!
were! extracted! from!WT! and* Socs2&/&! animals! at! 3! and! 4! days! postnatal! (PN3! and!
PN4),! and! growth! assessed! over! a! 12! day! period.! Independent! of! genotype,! a!
correlation! between! age! of! animal! at! extraction! and! linear! growth! was! observed!
(Fig.! 3.9).! By! day! 12,! WT! PN3! and! PN4! metatarsals! had! grown! 60%! and! 52%,!









metatarsals! (section! 3.5.1! &! Fig.! 3.10).! ! GH! treatment! failed! to! stimulate! WT!
metatarsal! growth! over! the! 12! day! culture! period! (Fig.! 3.10A).! Similar! to! E17!WT!
metatarsals,!the!failure!of!GH!to!stimulate!growth!was!likely!the!result!of!increased!
SOCS2! levels.! Transcript! analysis! of! metatarsals! at! day! 12! revealed! a! 4.2! fold!
increase! in! Socs2* expression* in! GH! treated! metatarsals! (p<0.05).! Socs1! and! 3*
expression!were!unaffected!by!GH!treatment!(Fig.!3.10B).!Socs2&/&!metatarsals!showed!
significantly! increased! growth! in! response! to! GH! from! day! 7! (p<0.01),! and! had!
grown! 12%,! more! than! untreated! bones! by! days! 9! and! 12! (p<0.001)! (Fig.! 3.10C).!











































Figure! 3.10!SOCS2! regulation! of!GH! induced! longitudinal! growth! of! postnatal!
metatarsals!!
A.!WT!and!C.!Socs2&/&!PN3!metatarsal!growth!in!response!to!GH!(100ng/ml)!treatment!for!12!
days.! Data! are! presented! as! mean! ±! SEM! (n=12).! Significance! from! untreated! (control)!
metatarsals!denoted!by!a!p<0.01,!b!p<0.001.!Dotted!lines!indicate!point!at!which!Igf1,*Igfbp3,!
and! Igf2*mRNA!expression! levels!were!measured! section! 3.5.11.!B.!Socs1,!2,! and!3!mRNA!
expression! levels! in!WT!metatarsals! following!12!days!GH! (100ng/ml)! treatment.!Data! are!









3.5.11!Altered! IGFX1,! IGFX2! and! IGFBP3! production! by! postnatal!metatarsals! in!
response!to!GH!!
The! effect! of! GH! treatment! on! Igf1,! Igfbp3* and! Igf2* expression! in! postnatal!
metatarsals! was! largely! similar! to! that! observed! in! prenatal! metatarsals! (sections!
3.5.4,!3.5.6!&!3.5.8).!Twelve!days!GH!treatment!did!not!stimulate!Igf1!expression!in!







Socs2&/&*metatarsals!was!not! associated!with! an! increase! in! IGFR1! levels! (Table! 3.5).!!
At!day!12,!GH!treatment!enhanced!IGFR1!levels!(49%)!in!WT!metatarsals,!despite!no!
increase! in!growth! (Fig.!3.10!&!Table!3.5).!No!significant! increase!was!observed! in!
GH!treated!Socs2&/&!samples!(Table!3.5).!!
!
IGFBP3! levels! were! elevated! in! conditioned! medium! from! GH! treated! WT!
metatarsals!at!both!7!and!12!days!(Table!3.5).!GH!treated!Socs2&/&!metatarsals!did!not!
have!increased!IGFBP3!levels!at!7!days,!however!the!increase!in!protein!levels!was!
highly! exaggerated! at! 12! days! ! (WT! 172%! (p<0.001);!Socs2&/&! 262%! (p<0.01))! (Table!
3.5).!!
!
At!day!7,! IGFR2! levels!were!significantly! increased!to!a!similar! level! in!GH!treated!



















A.! Igf1* B.! Igfbp3* C.* Igf2* mRNA! expression! levels! in! WT! and! Socs2&/&! PN3! metatarsals!
following!12!days!GH!(100ng/ml)!treatment.!Data!presented!as!mean!±!SEM!(n=3!groups!of!






















! ! ! WT! ! Socs2&/&*
Day!! Treatment!! ! ! IGFX1!(ng/ml)!
7! Control!! ! 3.4! ±! 0.24! ! 4.6! ±! 0.54!
! GH! ! 3.5! ±! 0.71!(0.937)! ! 4.4! ±! 0.67!(0.845)!
12! Control!! ! 7.3! ±! 0.91! ! 10.5! ±! 2.08!
!! GH! !! 10.9! ±! 1.20!(0.036)! !! 13.6! ±! 1.7!(0.272)!
! ! ! IGFBP3!(ng/ml)!
7! Control!! ! 5.4! ±! 2.16! ! 21.1! ±! 7.2!
! GH! ! 16.5! ±! 4.68!(0.047)! ! 40.0! ±! 10!(0.173)!
12! Control!! ! 14.5! ±! 4.86! ! 35.9! ±! 18.4!
!! GH! ! 39.4! ±! 5.00(0.007)! ! 130.0! ±! 28.2(0.019)!
! ! ! IGFX2!(ng/ml)!
7! Control!! ! 3! ±! 0.37! ! 3.1! ±! 0.87!
! GH! ! 10.9! ±! 3.17(0.004)! ! 10.7! ±! 1.49(0.001)!
12! Control!! ! 5.6! ±! 0.8! ! 7.0! ±! 1.66!
!! GH! ! 11! ±! 1.61(0.014)! ! 12.9! ±! 1.93(0.047)!
Table!3.5!Altered!protein!levels!in!WT!and!Socs2&/&!postnatal!metatarsal!cultures!
following!GH!treatment!!!










As! hypothesised,! in! this! chapter! SOCS2!was! identified! as! a! key! regulator! of! GH!
induced! longitudinal!bone!growth.!Only! in! the!absence!of!SOCS2!was!GH!able! to!
stimulate! longitudinal!growth!of!metatarsals.!Ex*vivo! and! in*vivo! results!presented!
here!are!in!conflict!with!the!understanding!that!GHs!effects!on!the!growth!plate!are!
mediated!through!the!upregulation!of!IGFR1.!The!increase!in!IGFR2!and!IGFBP3!gene!
and! protein! levels! in! response! to! GH! offer! a! possible! alternative! to! the! current!
dogma.!!!!
!
The! ex* vivo* metatarsal! culture! method! offers! a! valid! model! to! investigate!
endochondral! bone! growth! (Mushtaq* et* al.! 2004;!MacRae* et* al.! 2007;! Chagin* et* al.!
2010).! The! ability! to! grow!metatarsals! in! long! term! cultures!without! foetal! bovine!
serum!allows! for! the!manipulation!of!medium!conditions!and! investigation!of! the!
effects!of!various!treatments.!The!present!study!has!focussed!on!the!effects!of!GH!in!
promoting! longitudinal! growth! of!metatarsals.! Recently,! it! has! been! reported! that!








SOCS2! levels.! Similar! results!have!been!observed! in!primary! chondrocyte! culture,!
where!GH!was!shown!to!stimulate!SOCS2!levels!(Pass*et*al.!2012).!The!importance!of!
SOCS2! in! regulating! GH! action! has! previously! been! reported.! ! In! the! absence! of!








effects! of! IGFR1! on! linear! bone! growth.! IGFR1! treatment! increases! metatarsal!
proliferation,!hypertrophic!cell! size!and!subsequently!growth! (Mushtaq* et*al.!2004;!
MacRae*et*al.!2006a;!MacRae*et*al.!2007;!Chagin*et*al.!2010).!SOCS2!may!also!have!an!
important!role!in!regulating!IGFR1!signalling.!GH!and!IGFR1!stimulation!of!collagen!
in! intestinal! mesenchymal! cells! is! regulated! by! SOCS2! (Fruchtman* et* al.! 2005).!
Furthermore,! SOCS2! is! able! to! bind! to! the! IGFR1R! and! potentially! regulate!
downstream! STAT3! signalling! (Dey* et* al.! 1998;! Zong* et* al.! 2000).! However,! the!
current! observation! that! WT! and! Socs2&/&! metatarsals! respond! similarly! to! IGFR1!
confirms! previous! studies,! and! ! indicates! that! SOCS2! does! not! regulate! IGFR1!
actions!on!endochondral!bone!growth!(Fig.!3.1!A&C)!(Pass*et*al.!2012).!In!addition!to!
this,! endogenous! IGFR1!was!detected! in! the!conditioned!medium!of!untreated!WT!
and!Socs2&/&!metatarsals!at!numerous!stages!of!growth!(Table!3.1).!As!IGFR1!has!been!
demonstrated!to!enhance! linear!growth! in!a!number!of!studies,!endogenous! levels!
are!presumed!to!play!an!important!role!in!growth!(Mushtaq*et*al.!2004;!MacRae*et*al.!
2007;!Pass*et*al.!2012).!!If!SOCS2!did!regulate!IGFR1!signalling,!an!increase!in!Socs2&/&!




GH/IGFR1! may! play! a! role! in! chondrocyte! proliferation,! differentiation,! and!
hypertrophy!(Lupu*et*al.!2001;!Gevers*et*al.!2002a;!Parker*et*al.!2007).!!The!germinal!
zone! of! the! growth!plates! are! significantly! enlarged! in! Igf1&/&!mice,! supporting! the!
idea! that! GH! stimulates! longitudinal! bone! growth! directly! (by! stimulating! the!
differentiation! of! growth! plate! precursor! cells),! and! indirectly! (by! inducing! Igf1*
expression! in! differentiating! chondrocytes! which! then! inRturn! stimulate! clonal!
expansion)! (Isaksson* et* al.! 1987;!Wang* et* al.! 1999a;!Wang* et* al.! 2004).!Current!data!
highlights! that!GH! is! able! to! stimulate! linear!growth!by! increasing! the! size!of! the!
HZ!(Fig.!3.2).!Care!must!be! taken! in! the! interpretation!of! these! results.! ! It!appears!





(WT)! levels! by! the! addition!of!GH.!This!however!may!not!be! the! case,! as! slightly!
variations! in! the! time! of! metatarsal! extraction! may! have! large! effects! on! initial!
metatarsal!size.!As!females!are!only!plug!checked!once!daily! it! is!possible! that! the!
starting!point!of!the!experiment!can!vary!up!to!a!much!as!half!a!day.!!To!fully!assess!
the! difference! between! nonRtreated! WT! and! Socs2&/&! metatarsals! numerous! litters!
would! have! to! be! examined.! It!must! also! be! noted! that! fixation! solutions! such! as!
PFA! have! been! shown! to! cause! shrinkage! artefacts! due! to! the! high! osmolarity! of!
these! solutions! (Loqman! et* al.! 2010).! It! is! generally! understood! that! IGFR1! acts!
mainly!on!the!HZ,!although!it!is!expressed!throughout!the!growth!plate!(Wang*et*al.!
1999a).!While!the!actions!of!IGFR1!on!the!HZ!are!established,!there!is!some!dispute!
over! its! action! on! the! PZ! as! proliferation! rate! and! zone! size! are! reported! to! be!
normal!or!decreased!in!Igf1R/R!mice!(Wang*et*al.!1999a;!Lupu*et*al.!2001).!!
!
The! intimate! relationship! between!GH! and! IGFR1!makes! it! difficult! to! distinguish!
between! direct! GH! actions,! or! those! resulting! indirectly! through! IGFR1.! Tibial!
growth!is!reduced!in!both!Ghr!and!Igf1*null!mice.!This!becomes!more!severe!in!the!
double!Ghr/Igf1!mutants,! inferring! that!GH!and! IGFR1!have! independent! functions!
(Lupu*et*al.!2001).!In!agreement!with!this,!Ghr&/&!mice!show!a!much!greater!reduction!
in! longitudinal! bone! growth! compared! to! Igf1&/&! (Wang* et* al.! 2004).! IGFR1! levels!
however!increase!in!response!to!GH!within!the!PZ,!suggesting!a!regulatory!role!for!
GH! on! IGFR1! (Nilsson* et* al.! 1986).! The! present! study! demonstrates! that! despite!
normal! IGFR1! gene! and! protein! expression! levels! in! Socs2&/&* E17! metatarsals,! GH!
enhances!bone!growth!(Fig.!3.3,!3.4!&!Table!3.1)!.!This!indicates!that!not!only!is!GH!
unable!to!regulate!IGFR1!levels,!but!also!that!the!growth!promoting!effects!of!GH!are!
independent! of! IGFR1.! This! was! supported! by! the! observation! of! normal! Igf1!
















for! metatarsals,! this! experiment! would! have! benefited! from! more! work! being!
carried!out!on!determining! the! toxicity!of! the!drug.!Although!metatarsals! showed!
increased!growth!on!the!removal!of!1zM!NVP,!this!may!have!been!due!to!catch!up!





expressed! highly! in! a! variety! of! tissues! in! the! embryo! and! neonatal,! but! is!
subsequently!downRregulated! (Parker* et* al.!2007;!Lui* et* al.!2008).!Disruption!of! the!
Igf2!gene!has!negative!effects!on!longitudinal!growth!(Mohan*et*al.!2003).!It!is!widely!







In! the!present! study,! IGFR2! levels! increased! in! response! to!GH! (Fig.! 3.8A!&!Table!
3.4).!It!is!possible!that!the!increase!in!linear!growth!observed!in!Socs2&/&!metatarsals!is!
a! result! of! elevated! IGFR2! levels.! IGFR2! has! previously! been! shown! to! stimulate!










out! a! comprehensive! study! assessing! the! effects! of! IGFR2! on! metatarsal! growth,!
however!further!work!on!this!would!be!highly!informative.!!




it! functions! to! control! tissue! IGF! concentrations,! and! reduces! bioavailability!
(Clemmons! 1998).! Depending! on! incubation! time! and! dose,! it! can! inhibit! or!
potentiate!the!actions!of!IGF’s!(Demellow!&!Baxter!1988;!Stewart*et*al.!1993;!Bagi*et*
al.! 1994).! IGFBP3! has! also! been! shown! to! have! proRapoptotic! functions! on!
chondrocytes! (independent!of! IGFs),!which!are! likely!mediated! through! their!own!
cell! surface! bound! receptors! (Oh* et* al.! 1993;! Spagnoli* et* al.! 2002).! The! complex!
relationship!between!IGF’s!and!IGFBP3!make!it!difficult!to!deduce!what!its!role!may!
be! in! this! system.!As! there! appears! to! be! a! correlation! between! increased! IGFBP3!
and!increased!growth!in!response!to!GH,!it!is!unlikely!that!the!effects!of!IGFBP3!are!
inhibitory.!!!!!
The! foetal! metatarsal! culture! method! is! used! as! a! highly! physiological! model! to!
study! longitudinal!growth.!This! is!because! the!growth! rate!of! embryonic!bones! in!
culture!is!similar!to!that!found!in*vivo*(Scheven!&!Hamilton!1991;!Coxam*et*al.!1996;!
Mushtaq*et*al.!2004;!Pass*et*al.!2012).!The!term!highly!physiological!must!however!be!
used!with! some! caution.! The!metatarsal! organ! culture!method! does! not! take! into!
account!the!possibility!of!mechanical!stress!on!these!bones!which!may!have!an!effect!







growth,! studies!were! carried!out!on!E17!and!PN3!metatarsals.!Current! results! are!
similar!to!those!previously!published,!clearly!showing!that!the!growth!of!postnatal!
metatarsals!is!less!than!prenatal!metatarsals!(Fig.!3.9)!(MacRae*et*al.!2006b;!Chagin*et*
al.! 2010).! This! may! be! due! to! a! number! of! factors! such! as! the! less! differentiated!
nature! of! the! cells! and! hence! a! greater! proliferative! capacity! within! the! prenatal!
metatarsals.! More! differentiated! cells! are! also! more! likely! to! require! a! more!
sophisticated!growth!factor!cocktail!than!that!which!can!be!supplied!by!serum!free!
conditions.! Also,! the! greater! size! of! the! cultured! postnatal! bone! may! limit! their!
growth!due!to!the!poor!diffusion!of!nutrients!into!the!cells!of!the!bones.!!Despite!this!
decrease! in!growth! rate,!postnatal! bones! responded! to!GH! in! a! similar!manner! to!





provides! compelling! evidence! to! support! the! notion! that! GH! can! regulate! linear!




































The! regulatory! role!of! SOCS2! in! linear!bone!growth! is!well!defined.!A!number!of!





Aside! from! increased! longitudinal! growth,! Socs2&/&! mice! also! have! an! altered!
trabecular! and! cortical! bone! phenotype.! The! effects! of! SOCS2! ablation! on! bone!
architecture! are! however! far! less! conclusive.! Two! independent! studies! have!
assessed!the!Socs2&/&!bone!phenotype,!and!have!produced!largely!conflicting!results!
(Lorentzon* et* al.! 2005;! MacRae* et* al.! 2009).! MacRae! and! colleagues! reported! an!
anabolic!bone!phenotype!with!no!changes!in!BMD,!while!Lorentzon!and!colleagues!
highlight! a! largely! catabolic! bone! phenotype! (Lorentzon* et* al.! 2005;!MacRae* et* al.!
2009).!The!difference!in!sex!and!age!of!mice!analysed!may!account!for!the!difference!
in!results.!There!is!therefore!the!need!for!a!comprehensive!study!to!assess!the!bone!
phenotype! of! Socs2&/&! mice! which! encompasses! different! ages! and! sexes.!
















The! current! dogma! states! that! systemic! IGFR1! is! critical! for! the! maintenance! of!
cortical! bone,!whereas! locally! (osteoblast)!derived! IGFR1! regulates! trabecular! bone!
formation.! Alteration! of! systemic! IGFR1! levels! predominantly! alters! cortical!
geometry,!with!minimal!changes!to!trabecular!bone!(Sjogren*et*al.!2002;!Yakar*et*al.!
2002b;!Yakar*et*al.!2010;!Elis*et*al.!2010).!Interestingly,!hepatic!overexpression!of!Igf1!
in! global! Igf1&/&! mice! compensates! for! the! lack! of! skeletally! derived! IGFR1! after!
puberty!(Elis*et*al.!2010).!Interpretation!of!some!of!these!observations!is!complicated!
by!the!4.5! fold! increase! in!systemic!GH!levels! in!LID!mice! (Yakar* et*al.!2002).!This!
increase!in!GH!level!may!contribute!to!the!bone!phenotype!of!the!LID!mouse,!and!
mask! the! effects! of! low! circulating! IGFR1! levels! in! this,! and! other! mouse!models!
(Yakar*et*al.!2002).!!Studies!with!the!GHR!antagonist,!pegvisomant,!highlight!that!in!





al.! 2007b).!These!mice!present!with!a! catabolic!bone!phenotype!with!no! reports!of!










osteoblast! bone! formation! and! osteoclast! bone! resorption.! GH! stimulates! both!
osteoblasts! and! osteoclasts.! Evidence! to! date! suggests! that! GH! stimulates! bone!








GH!signalling! in!osteoblasts! is!mediating! the!bone!phenotype! (Metcalf* et*al.!2000).!






































II. Identify! the! SOCS! proteins! involved! in! regulating! GH! signalling! in!
osteoblasts.!!
!
III. Compare! the! temporal! activation! levels! of! key! GH! induced! signalling!
proteins!in!primary!osteoblasts!from!WT!and!Socs2&/&!mice.!!!
!
IV. Confirm! the! importance! of! SOCS2! in!mediating!GH! signalling! through!
the!generation!of!a!SOCS2!over!expressing!osteoblastRlike!cell!line.!!
!
V. Quantify! the! relative! expression! levels! of! Igf1! in! WT! and! Socs2&/&!
osteoblasts!following!GH!treatment.!!
!












as! the!weight!gained!per!day!between!calcein! injections.!Tibiae,! fixed!overnight! in!
4%!paraformaldehyde!(PFA)!were!embedded!in!methylmethacrylate!as!described!in!
section! 2.4.9.! Sections! stained!with! aniline! blue! solution! (Appendix! I)! for! 20mins,!
washed! in! tap! water! and! then! cover! slips! mounted.! As! calcein! binds! to! newly!


















cells! were! generated! as! described! in! section! 2.2.1.! Cells! were! cultured! in! 6! well!
plates! in! osteoblast! medium! until! 80R90%! confluent.! Prior! to! stimulation! all! cells!
were! serum! starved! in! 0.1%! BSA! for! 24hrs.! Cells!were! treated!with!GH! or! IGFR1!














cells! were! plated! for! immunocytochemistry! (sections! 2.2.1! &! 2.2.3).! Following!




Six! week! old!mice! sacrificed! for!microRCT! analysis! also! had! their! liver! and! right!





2.5.2,! and! qPCR! analysis! completed! as! detailed! in! section! 2.5.3.! Results! were!




Conditioned! medium! was! collected! from! primary! WT! and! Socs2&/&! osteoblasts!
following! 48hrs! GH! treatment! and! stored! at! R80°C.! IGFR1! and! IGFBP3! levels! in!









!A! gene! expression! profiling! for! JAK/STAT! target! genes! (84! target! genes)! was!
performed! on!WT! and! Socs2&/&! osteoblasts! using! RT2! profiler! PCR! arrays! (Qiagen,!
Manchester,!UK).!In!accordance!with!previous!studies,!osteoblasts!were!challenged!
with!GH!for!4hrs! to!detect!genes!directly! stimulated!by!STAT! translocation! to! the!
nucleus,! and! not! those! downstream! of! secondary! messengers! (Greenhalgh* et* al.!
2005;!Govoni* et* al.! 2006).! Following!manufacturer’s! protocol,! RNA!was! extracted,!
and!1!zg!RNA!was!reverse!transcribed!with!the!RT2!profiler!PCR!array!first!strand!




!Cell! proliferation!was!measured! in!MC3T3! cells,! and!WT! and!Socs2&/&! osteoblasts,!
following! GH! or! IGFR1! treatment.! Cells! were! incubated! with! 0.2zCi/ml! [3H]R
thymidine! (Amersham,! Buckinghamshire,! UK)! for! the! final! 12hrs! of! incubation.!
Cells! were! washed! in! αMEM! and! fixed! in! iceRcold! 5%! trichloroacetic! acid! for!
15mins.! Following! 2! PBS! washes! (2x5mins)! cells! were! lysed! in! 0.1M! NaOH! for!
15mins.! Lysed! cells! were! transferred! to! a! scintillation! vial! and! mixed! with! 3ml!
scintillation! fluid! (optiPhase!HiSafe!2,!Fisons!Chemicals,!Loughborough,!UK).!The!






measures! 2! way! ANOVA! for! which! suitable! postRtests! for! multiple! comparisons!
were! conducted.! ! All! other! results! within! the! chapter! were! analysed! using! the!
Student’s! tRtest! or! a! suitable! nonRparametric! test! if! the! data! were! not! normally!
















p<0.001)! and! 17!weeks! of! age! (26%;! p<0.001)! (Fig.! 4.1).! The! increased!weight! of! 6!
week!old!Socs2&/&!mice!was!associated!with!an!increase!in!weight!gain!(Fig.!4.1).!Male!
Socs2&/&!mice!gained!0.6g!of!weight!per!day! compared! to! 0.3g!per!day!observed! in!
WT! (p<0.001)! (Fig.! 4.1).! At! 17! weeks! of! age! no! difference! in! weight! gain! was!




The! increase! in! body! weight! observed! in! Socs2&/&! mice! is! likely! a! consequence! of!
enlarged! organs! including! cartilage! and! bone! of! the! skeleton.! To! investigate! the!
latter,!appositional!growth!was!assessed! in!male!Socs2&/&!mice!at!6!and!17!weeks!of!
age!(Fig.!4.2).!At!6!weeks,!periosteal!MAR!of!the!tibia!was!increased!by!42%!in!Socs2&
/&! mice! (p<0.01)! (Fig.! 4.2).! Endosteal!MAR! remained! comparable! to!WT!mice! (Fig.!
4.2).!At! 17!weeks,! double! calcein! labelling!was! rarely! observed! in!WT!and!Socs2&/&!















































































bone! area! (Ct.Ar)!was! also! increased! by! 27%! (p<0.001)! and! 28%! (p<0.001)! in! tibia!
from! 6! and! 17!week! old!male!Socs2&/&!mice,! respectively.! ! These! changes!were! not!
noted! in! the!equivalent!Socs2&/&! female!mice! (Tables!5.1!&!5.2).! Increases! in!marrow!
space!were!far!less!marked,!with!only!6!week!old!female!(p<0.001)!and!17!week!old!
male!(p<0.001)!Socs2&/&* * *tibia!showing!increased!medullary!area!(Ma.Ar).!Analysis!of!

































! ! 6!weeks! ! 17!weeks!
( ( WT( ( Socs2&/&( ( WT( ( Socs2&/&(
Trabecular! ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (
BV/TV((%)! ( 9.7( ±( 0.25( ( 12.7( ±( 0.88b( ( 8.0( ±( 0.38( ( 9.9( ±( 0.52a(
Tb.N((1/mm)! ( 2.4( ±( 0.09( ( 2.7( ±( 0.13a( ( 1.6( ±( 0.10( ( 1.4( ±( 0.09(
Tb.(Th((mm)! ( 0.04( ±( 0.001( ( 0.05( ±( 0.002b( ( 0.05( ±( 0.002( ( 0.07( ±( 0.001c(
Tb.Sp((mm)! ( 0.22( ±( 0.01( ( 0.23( ±( 0.01( ( 0.28( ±( 0.01( ( 0.33( ±( 0.03a(
SMI! ( 2.0( ±( 0.04( ( 2.0( ±( 0.05( ( 2.4( ±( 0.28( ( 2.3( ±( 0.10(
BMD((g/cm3)( ( 1.48( ±( 0.006( ( 1.47( ±( 0.01( ( 1.56( ±( 0.01( ( 1.57( ±( 0.01(
! ( ( ( ( ( ( ( ( ( ( ( ( (
Cortical! ( ( ( ( ( ( ( ( ( ( ( ( (
Tt.Ar((mm2)! ( 0.6( ±( 0.02( ( 0.7( ±( 0.01b( ( 0.7( ±( 0.02( ( 0.8( ±( 0.04a(
Ct.Ar((mm2)! ( 0.4( ±( 0.01( ( 0.5( ±( 0.01( ( 0.6( ±( 0.004( ( 0.6( ±( 0.02(
Ma.Ar((mm2)! ( 0.19( ±( 0.008( ( 0.26( ±( 0.008c( ( 0.16( ±( 0.008( ( 0.12( ±( 0.039(
Ct.Th((mm)! ( 0.21( ±( 0.005( ( 0.20( ±( 0.002( ( 0.26( ±( 0.009( ( 0.27( ±( 0.007(
J((mm4)! ( 0.05( ±( 0.003( ( 0.07( ±( 0.003a( ( 0.08( ±( 0.007( ( 0.09( ±( 0.007a(
BMD((g/cm3)( ( 1.34( ±( 0.007( ( 1.32( ±( 0.006( ( 1.44( ±( 0.005( ( 1.41( ±( 0.006(b(























! ! 6!weeks! ! 17!weeks!
! ( WT( ( Socs2&/&(( ( WT( ( Socs2&/&(
Trabecular! ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (
BV/TV((%)( ( 15.4( ±( 0.69( ( 20.6( ±( 1.72b( ( 14.9( ±( 1.9( ( 19.6( ±( 1.07a(
Tb.N((1/mm)( ( 3.4( ±( 0.01( ( 4.0( ±( 0.25( ( 3.0( ±( 0.41( ( 3.5( ±( 0.19(
Tb.(Th((mm)( ( 0.04( ±( 0.001( ( 0.05( ±( 0.002b( ( 0.05( ±( 0.002( ( 0.06( ±( 0.001b(
Tb.Sp((mm)( ( 0.17( ±( 0.01( ( 0.16( ±( 0.01( ( 0.2( ±( 0.01( ( 0.18( ±( 0.01(
SMI( ( 1.9( ±( 0.05( ( 1.7( ±( 0.08( ( 1.7( ±( 0.18( ( 1.5( ±( 0.05(
BMD((g/cm3)( ( 1.44( ±( 0.01( ( 1.46( ±( 0.03( ( 1.55( ±( 0.006( ( 1.45( ±( 0.06(
! ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (
Cortical! ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (
Tt.Ar((mm2)( ( 0.8( ±( 0.03( ( 1.0( ±( 0.03b( ( 0.9( ±( 0.06( ( 1.3( ±( 0.04c(
Ct.Ar((mm2)( ( 0.6( ±( 0.01( ( 0.7( ±( 0.03c( ( 0.7( ±( 0.03( ( 0.9( ±( 0.02c(
Ma.Ar((mm2)( ( 0.23( ±( 0.016( ( 0.25( ±( 0.015( ( 0.25( ±( 0.029( ( 0.41( ±( 0.018c(
Ct.Th((mm)( ( 0.25( ±( 0.008( ( 0.28( ±( 0.011b( ( 0.27( ±( 0.003( ( 0.28( ±( 0.003(
J((mm4)( ( 0.10( ±( 0.003( ( 0.15( ±( 0.012a( ( 0.13( ±( 0.016( ( 0.24( ±( 0.014c(

















The( alterations( in( bone( phenotype( observed( in( Socs2&/&( mice( are( likely( to( have( a(
biomechanical( impact.( To( assess( this,( 3A( point( bending( was( carried( out( on( the(




Tibia( from(6(week(old(male(Socs2A/A(mice(showed(a(41%(increase( in(work( to( failure(
(p<0.05),(indicating(that(more(energy(was(required(to(reach(failure(point((Fig.(4.3(&(
Table(4.3).(At(17(weeks(of(age,(work( to( failure( (90%,(p<0.05)(was(still( increased( in(
male( Socs2&/&( mice.( In( addition,( there( was( also( an( increase( in( failure( load( (32%,(
p<0.05)((Fig.(4.3(&(Table(4.3).(This(highlights(that(not(only(increased(energy,(but(also(





The( increased( body( weight( (section( 4.5.1),( tibial(MAR( (section( 4.4.2),( and( altered(
bone( phenotype( (section( 4.4.3)( observed( in( 6( week( old( Socs2&/&( mice( was( not(
associated(with(an( increase( in( Igf1(expression( in( livers( from(both(male(and(female(
mice((Fig.(5.4).((An(increase(in(Igfbp3(levels(was(observed(in(male(Socs2&/&(compared(
to( sex( matched( WT( livers( (Fig.( 5.4).( A( similar( increase( in( Igfbp3( levels( was( not(



























































! ! 6!weeks! ! 17!weeks!
( ( WT( ( Socs2&/&( ( WT( ( Socs2&/&(
Female!! ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (
Failure(Load((N)! ( 5.6( ±( 0.51( ( 5.7( ±( 0.45( ( 9.3( ±( 0.54( ( 10.0( ±( 0.90(
Work(to(Failure((mJ)! ( 2.4( ±( 0.31( ( 2.0( ±( 0.22( ( 3.0( ±( 0.27( ( 3.0( ±( 0.26(
Load(to(Maximum((N)! ( 2.7( ±( 0.35( ( 2.1( ±( 0.27( ( 5.5( ±( 0.8( ( 5.7( ±( 0.50(
Maximum(Stiffness((N/mm)! ( 11.1( ±( 1.32( ( 12.5( ±( 0.95( ( 18.2( ±( 1.47( ( 22.7( ±( 3.42(
Male! ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (
Failure(Load((N)! ( 8.0( ±( 0.39( ( 9.4( ±( 0.57( ( 11.1( ±( 2.46( ( 14.6( ±( 1.59a(
Work(to(Failure((mJ)! ( 2.6( ±( 0.23( ( 3.6( ±( 0.34a( ( 3.3( ±( 0.71( ( 6.2( ±( 2.35a(
Load(to(Maximum(Stiffness((N)! ( 4.4( ±( 0.33( ( 4.7( ±( 0.41( ( 6.2( ±( 1.62( ( 6.8( ±( 1.21(



















Analysis( of( Igf1, and( Igfbp3( mRNA( expression( levels( in( livers( extracted( from( 6( week( old(
female(and(male(WT(and(Socs2&/&(mice.,Data(are(presented(as(mean(±(SEM((n≥5)(relative( to(






































Having( identified( SOCS2( as( the( predominant( GHOregulated( SOCS( protein( in(
osteoblasts,( it( was( next( determined( if( the( absence( of( SOCS2( increased( the(
phosphorylation( status( of( STAT1,( 3,( and( 5( (pOSTAT)( in( response( to( GH.( ( In(WT(
osteoblasts,( STAT3( was( not( activated( in( response( to( GH,( whereas( increased( pO
STAT1(was(observed(following(15mins(of(GH(exposure,(but(not(at(later(time(points.(
In( contrast,( pOSTAT5(was( increased( by(GH( at( all( time( points( studied.( It(was( also(
noted( that( phosphorylation( of( STAT5( decreased( with( prolonged( GH( stimulation(
(Fig.(4.6).(When(compared(to(WT(osteoblasts,(Socs2O/O(osteoblasts(showed(increased(
and( prolonged( phosphorylation( status( of( STAT1,( 3( in( response( to( GH( (Fig.( 4.6).(
Activation(of(STAT1(was(extended(in(Socs2&/&,osteoblasts,(and(was(observed(after(15(
and(30mins(GH(exposure.(A(similar(response(was(observed(with(STAT3(activation.(
The( difference( in( activation( patterns( was( most( evident( with( STAT5.( Greatly(
increased(pOSTAT5(was(observed( in( response( to(GH(stimulation(at( all( time(points(













osteoblasts( (Fig.( 4.8).( IGFO1( treatment( also( failed( to( activate( STAT( 5;( a( potent(
mediator( of(GH( signalling( (section( 4.5.7).( The( failure(of( IGFO1( to( stimulate( STAT3(
and(5(was(also(observed(in(Socs2&/&(primary(osteoblasts((Fig.(4.8).(
(
4.5.9! Regulation! of! GH! or! IGFK1! induced! AKT! and! ERK1/2! signalling! in!
osteoblasts!by!SOCS2!!!
The(ERK1/2(and(AKT(pathways(are( also( responsible( for(mediating(GH(and( IGFO1(
action.( In( WT( osteoblasts,( GH( stimulated( ERK1/2( (pOERK1/2),( but( not( AKT(
activation( (pOAKT)( after( 15mins( GH( exposure.( ( A( similar( activation( pattern( was(
observed(in(Socs2&/&(osteoblasts((Fig.(4.9).((
(
IGFO1( treatment( stimulated( both(AKT( (pOAKT)( and( ERK1/2( (pOERK1/2)( activation(
following( 15mins( exposure.( By( 30mins,( pOERK1/2( had( returned( to( basal( level,(
whereas( pOAKT( levels( remained( elevated.( Again,( the( activation( patterns( were(
similar( in( Socs2&/&( osteoblasts( (Fig.( 4.9).( Taken( together,( these( results( indicate( that(

































A.( Socs1,( 2,( and( 3, mRNA( expression( levels, in( WT( osteoblasts( following( 24hours! GH(
(500ng/ml)(or(IGFO1((50ng/ml)(exposure.(Samples(were(initially(normalised(to(housekeeping(
gene( atp5b.( Data( are( presented( as( mean( ±( SEM( (n=3)( relative( to( untreated( samples.((
Significance(from(untreated(samples(denoted(by(c(p<0.001.(B.(Western(blotting(of(SOCS1,(2,(




















Western( blotting( of( phosphorylated( (PO)( STAT1,( 3,( and( 5( in( WT( and( Socs2&/&( osteoblasts(

















































following( 20mins( GH( (500ng/ml)( exposure.( Scale( bars( =( 50cm.(Nucleus( –Blue;( pSTAT5( –(
















Western( blotting( of( phosphorylated( (PO)( STAT3( and( 5( in( WT( and( Socs2&/&( osteoblasts(











Figure! 4.9! SOCS2! does! not! regulate! GH! or! IGFK1! induced! AKT! or! ERK1/2!
signalling!in!osteoblasts!!
Western(blotting(of(phosphorylated((PO)(AKT(and((PO)(ERK1/2(in(WT(and(Socs2&/&(osteoblasts(











To( fully( appreciate( the( role( of( SOCS2( in( GH( signalling( in( osteoblasts,( MC3T3(
osteoblast( like( cells( overexpressing( SOCS2( were( produced.( To( confirm( SOCS2(
overexpression( in( cells( containing( the( SOCS2( plasmid,( 5( overexpressing( colonies(
were(selected,(and(Socs2,expression(levels(measured.(Socs2(mRNA(varied(from(a(10(
fold( increase( (SOCS2+( colony( 3),( to( a( 103( fold( increase( (SOCS2( +( colony( 5)( in( the(
overexpressing( colonies( (Fig.( 4.10A).( The( presence( of( the( overexpressed( SOCS2(
attached( to( the( FLAG( epitope( was( confirmed( in( colony( 5( by( western( blot.( The(
overexpression( of( SOCS2( was( not( observed( in( colony( 3( at( the( protein( level( (Fig.(
4.10B).((
(
Cells( expressing( the( control( plasmid( showed( STAT5( activation( at( all( time( points(
studied( (15O120mins),( although( phosphorylation( decreased( with( prolonged( GH(
stimulation.(This(activation(profile(was(greatly(decreased(in(SOCS2(overexpressing(
cells(with(only(negligible(levels(of(pOSTAT5(observed(at(60(and(120mins((Fig.(4.10C).(
The( decreased( pOSTAT5( in( GH( treated( SOCS2( overexpressing( cells( was( further(




































overexpression( plasmid( (SOCS2+)( compared( to( cells( containing( the( control( plasmid.( B.(
Confirmation( of( SOCS2( overexpression( in( colonies( 3( and( 5( by(western( blotting.( The( extra(
SOCS2(produced(in(over(expressing(cells(was(a(higher(weight(than(physiological(SOCS2(due(
to( attachment( to( the( FLAG( epitope.(C.(Western( blotting( of( phosphorylated( (PO)( STAT5( in(

































A.! Representative( immunofluorescence( detection( of( pSTAT5( in( SOCS2( overexpressing( or(













Socs2( expression(was(greatly( enhanced( in(WT(osteoblasts( following(GH( treatment(
(p<0.001).(Aside(from(highlighting(that(GH(treatment(up(regulates(gene(expression(
in(WT(osteoblasts,(these(results(also(strengthen(previous(protein(data((section(4.5.6).(
In( WT( osteoblasts,( GH( caused( a( small( but( significant( increase( in( Igf1, (1.32( fold,(
p<0.01)(and(Igfbp3((1.53(fold,(p<0.001)(expression((Fig.(4.12A).(In(Socs2O/O(osteoblasts,(
the( increase( in( both( Igf1, (2.39( fold,( p<0.001)( and( Igf1bp3( (2.83( fold,( p( <0.001)(
expression(was(of(a(slightly(greater(magnitude((Fig.(4.12A).(Protein(analysis(of(IGFO
1( and( IGFBP3( in( the( conditioned(medium(was(used( to( confirm( transcript(data.( In(
Socs2O/O( osteoblasts,( GH( treatment( increased( IGFO1( and( IGFBP3( levels( by( 1.14( fold(




(Akp2)( revealed( no( alteration( in( expression( in( response( to( GH,( in( WT( or( Socs2&/&(
osteoblasts( (Fig.(4.12C).(These(markers(were(also(assessed(in(a(population(of(more(
mature(osteoblasts( (cultured(for(5(days(post(confluency(before(GH(challenge).(GH(
stimulated( an( increase( in( Socs2( expression( in( WT( osteoblasts( (6.7( fold;( p<0.001),(
similar(to(that(observed(in(previous(experiments(with(less(mature(osteoblasts((Fig.(
4.13A).(Enhanced(Igf1(expression( in(response(to(GH(in(Socs2&/&(osteoblasts(was(also(
confirmed( in( the(more(mature( cells.(GH( treatment(did(not( alter( the( expression( of(
Spp1(or(Akp2,in(mature(WT(osteoblasts.(Similar(results(were(obtained(with(regards(
to( Spp1( in( Socs2&/&( mature( osteoblasts,( however( Akp2, expression( significantly(
decreased(after(GH(challenge(in(these(cells((O2.9(fold,(p<0.001)((Fig.(4.13B).((((
!
4.5.12! Identification!of!osteoblast!genes!associated!with! the! JAK/STAT!pathway!
stimulated!by!GH!
In(order(to(gain(a(full(appreciation(for(the(regulatory(role(of(SOCS2(on(GH(induced(
osteoblast( gene( expression,( a( RT2( profiler( assay( was( used( to( analyse( 84( genes(





control( in(WT( osteoblasts,( to( ensure( that( the( GH(was( potent.( In( this( study( Socs2(
expression( increased( 5( fold( in( response( to( 4hrs( GH( treatment( (p<0.01).( In( WT(
osteoblasts,( the( RT2( profiler( assay( revealed( a( significant( increase( in( 7( genes(
following(4hrs(GH(treatment((Sh2b2,(Bcl2l1,(Gata3,(Fr2,(Fcgr1,(Gbp1(and(Socs2).(Only(
2(genes( showed(a(greater( than(2( fold( increase( (Fcgr1,( 4.46( fold,(p<0.05;(Socs2,( 4.55(
fold,(p<0.01)((Fig(4.14(&(Table(4.4).(In(Socs2&/&(osteoblasts,(1(gene((Cdkn1a)!showed(a(
significant( increase,( and(2(genes( (Sla2( and(Stat4)( significantly(decreased( following(
GH( treatment.(Only(Stat4( showed(a( greater( than( 2( fold( change( (O6.1( fold,( p<0.01).(




To(directly(address( the(higher(bone(mass(noted( in( the(Socs2&/&(mice,( Igf1,and( Igfbp3(
mRNA(expression(was(quantified(in(femurs(from(mice(previously(analysed(for(cCT(
(section( 4.5.3).( The( transcript( levels( of( Igf1, and( Igfbp3( in( Socs2O/O( and( WT( bones,(
extracted(from(6(week(old(male(and(female(mice(remained(similar((Fig.(4.15).(These(









(50ng/ml).( A( number( of( reports( investigating( the( effects( of( IGFO1( on(
osteoblast/osteoblast(like(cell(proliferation(used(a(concentration(of(100ng/ml((Kim,et,
al.(2005;(DiGirolamo,et,al.(2007).(When(plated(at(a(density(of(5x103cell/cm2,(GH(and(
IGFO1( (50ng/ml( and( 100ng/ml)( failed( to( stimulate( MC3T3( cell( proliferation.( Cells(





24hrs( exposure( to( GH( (105%;( p<0.05),( IGFO1(50ng/ml)( (103%;( p<0.05)( and( IGFO1(
(100ng/ml)( (247%;( p<0.05)( (Fig.( 4.16A).(Due( to( the( enhanced( level( of( proliferation(
































levels( in( WT( and( Socs2&/&( osteoblasts( following( 48hrs( GH( (500ng/ml)( treatment.( Data( are(
presented( as( mean( ±( SEM( (n=5)( relative( to( control( samples.( Significance( from( control(
samples( denoted( by( a( p<0.05,( c( p<0.001.( B.! Protein( analysis( of( IGFO1( and( IGFBP3( from(
conditioned( medium( from( WT( and( Socs2&/&( osteoblasts( following( 48hrs( GH( (500ng/ml)(
treatment.( Data( are( presented( as( mean±( SEM( (n=5).( Significance( from( untreated( samples(
denoted( by( c( p<0.001.( C.! Spp1( and( Akp2, mRNA( expression( levels( in( WT( and( Socs2&/&(

















osteoblasts( following( 48hrs(GH( (500ng/ml)( treatment( .Data( are( presented( as(mean( ±( SEM(
relative(to(untreated(samples((n=5).(Significance(from(untreated(samples(denoted(by(a(p<0.05,(
c( p<0.001.( B.! Analysis( of( Spp1( and( Akp2( mRNA( expression( levels( in( WT( and( Socs2&/&(












Figure! 4.14!No! alteration! in! Igf1%mRNA!expression! levels! in! bone! from! 6!week!
old,!male!and!female!Socs2+/+!mice!
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Socs2&/&( osteoblasts( following( 4hrs( GH( treatment.( Graphs( represent( the( means( of( 3(
experimental(replicates.(Genes(are(plotted(against(one(another(to(visualise(gene(expression(








( ! ! Fold!! p! ! ! ! Fold!! p!
Gene( No.! Ref.!Seq.! Change!! value! Gene! No.! Ref.!Seq.! Change!! value!
Sh2b2, ( NM_018825( 1.33( 0.025( Cdkn1a, ( NM_007669( 1.42( 0.033(
Bcl2l1, ( NM_009743( 1.45( 0.010( Fcgr1, 3( NM_010186( 3.71( 0.076(
Fr2, ( NM_010169( 1.35( 0.023( Sla2, ( NM_029983( O1.66( 0.034(
Gata3, ( NM_008091( 1.45( 0.020( Stat4,, 4( NM_011487( O6.08( 0.023(
Gbp1, ( NM_010259( 1.72( 0.003( ( ( ( ( (
Socs2, 1( NM_007706( 4.55( 0.020( ( ( ( ( (

































Figure! 4.16! WT! and! Socs2+/+! osteoblasts! do! not! respond! to! GH! with! increased!
proliferation!
!A.!Proliferation((as(measured(by(thymidine(uptake)(of(MC3T3(osteoblast(like(cells(plated(at(
5x103( cell/cm2( or( 1x104( cell/cm2( and( treated(with(GH( (500ng/ml),( IGFO1( (50ng/ml)( or( IGFO1(
(100ng/ml)(for(24hrs.(Data(presented(as(mean(±(SEM((n≥6).(Significance(denote(by(a(p<0.05.(









Results( presented( in( this( chapter( confirm( the( anabolic( bone( phenotype( of( Socs2&/&(










Socs2&/&( mouse( exhibits( several( features( of( deregulated( GH( signalling,( including(
collagen(accumulation(in(the(dermis,(and(the(production(of(major(urinary(proteins(
(Metcalf, et, al.( 2000;(Greenhalgh, et, al.( 2005).(Analysis( of( the(Socs2&/&( phenotype( has(
focused(primarily(on(its(regulation(of(longitudinal(bone(growth((Metcalf,et,al.(2000;(
Greenhalgh,et,al.(2002a;(Pass,et,al.(2012).(The(bone(phenotype(of(Socs2&/&(mice(remains(
a( matter( of( debate( (Lorentzon, et, al.( 2005;( MacRae, et, al.( 2009).( Therefore,( in( this(
chapter,(an(in(depth(analysis(of(the(bone(phenotype(of(Socs2&/&(mice(was(performed.(
To(gain(a( full(appreciation(of( this(phenotype,(male(and(female,( juvenile(and(adult(
mice( were( analysed.( Furthermore,( primary( osteoblast( and( SOCS2( overexpressing(
osteoblast(like(cell(cultures(were(used(to(delineate(the(local(actions(of(GH.(
(
Socs2&/&( mice( are( indistinguishable( from(WT( littermates( until( 4O6( weeks( of( age,( at(
which(point(the(overgrowth(phenotype(becomes(apparent.(By(12(weeks,(male(Socs2&
/&( mice( are( reported( to( be( 40%( heavier( than( male( WT( mice.( The( overgrowth(
phenotype(of(female(Socs2&/&(mice(is(less(evident.(At(12(weeks,(female(Socs2&/&(mice(are(
only( 28%(heavier( (Metcalf, et, al.( 2000).( In( this( study,(Socs2&/&,male( and( female(mice(
were(significantly(heavier(than(WT(mice(at(both(ages((Fig.(4.1).(Increased(in(weight(










2010).( The( level( of( bone( turnover( decreases( with( increased( age.( ( Consistent( with(
this,( analysis( of(MAR( in( tibia( from( 17( week( old( mice,( revealed( a( lack( of( double(
calcein( labelling.( Studies( using( similarly( aged( mice( have( also( reported( severely(
reduced(MAR(in(older(animals((Sheng,et,al.(1999;(Baldock,et,al.(2006).((
(
The( GH/IGFO1( pathway( is( a( critical( regulator( of( osteoblast( function,( bone(
homeostasis,( and( ultimately( bone( mass( (Giustina, et, al.( 2008).( Global( GH(
overexpression( results( in( increased( midshaft( cross( sectional( area,( an( observation(
that(is(more(evident(in(males((Eckstein,et,al.(2004).(Conversely,(GH(deficiency(leads(
to( decreased( cortical( periosteal( circumference,( cross( sectional( area,( and( thickness.((
Trabecular(bone(volume,(number,(and(thickness(however(remain(unchanged((Sims,
et,al.(2000;(Sjogren, et,al.(2000).(Alterations( in(systemic(IGFO1(levels( in(these(models(
make( it( difficult( to( delineate( the( relative( contributions( of( GH( and( IGFO1.((
Overexpression(of(GH(in(osteoblasts(results(in(increased(cortical(area(and(strength,(
despite( no( increase( in( systemic( IGFO1( levels( (Baker, et, al.( 1992;( Tseng, et, al.( 1996).(
Conversely,( IGFO1(overexpression(in(osteoblasts(reveals(an( important(role(for( local(
IGFO1( in( regulating( trabecular( architecture.(There(were(minimal( effects( on( cortical(
geometry,(suggesting(that(GH(effects(are(not(all(mediated(through(IGFO1((Zhao,et,al.(
2000).( Furthermore,( GH( stimulates( periosteal( bone( formation( rate( in( global( Igf1&/&(
mice((Bikle,et,al.(2001).(((
(
MicroOCT( analysis( revealed( a( bone( phenotype( which( had( similarities( to( both(
previous( studies( analysing( the( Socs2&/&( mouse( skeletal( phenotype( (Lorentzon, et, al.(
2005;(MacRae,et,al.(2009).(The(architecture(of(Socs2&/&(mice(tibiae(was(consistent(with(





Socs2&/&( tibiae( had( increased( trabecular( BV/TV( and( Tt.Ar,( resembling( previous(
analysis(on(7(week(old(female(mice((Tables(4.1(&(4.2((MacRae,et,al.(2009).(Similar(to(
the( GH( excess( models,( male( Socs2&/&,mice( displayed( a( more( pronounced( anabolic(
cortical(bone(phenotype((Table(4.1(&(4.2)(((Eckstein,et,al.(2004).(The(increased(Ct.Th(
and(Ct.Ar(observed(in(male(Socs2&/&(mice(provided(greater(support(to(the(cortex,(thus(
increasing( bone( strength( (Fig.( 4.3( &( Table( 4.3)( (Davison, et, al.( 2006).( The( gender(
specific(differences(observed(may(be(a(consequence(of(the(reported(regulatory(role(
of( oestrogen( on( SOCS2( expression.( This( relationship( merits( further( investigation(
(Leung,et,al.(2003;(Bolamperti,et,al.(2013).(The(cortical(bone(phenotype(has(also(been(
studied( in(4(and(15(week(old(male(mice.( In(4(week(old(mice( the(ablation(of(Socs2(
was(shown(to(decrease(Ct.Ar(and(Ct.Th.(This(is(however(before(the(initiation(of(the(
overgrowth( phenotype.( Therefore,( the( effects( of( enhanced( GH( are( unlikely( to( be(
seen( in(bone((Lorentzon, et,al.(2005).(By(15(weeks(of(age( there(was(no(alteration( in(
the( cortical( bone( phenotype( observed( in( Socs2&/&( mice( (Lorentzon, et, al.( 2005).(
Differences( observed( between( these( studies( may( be( a( result( of( the( scanning(
equipment( used.( Lorentzon( and( colleagues( used( a( pQCT( scanner,( operating( at( a(
resolution( of( 70cm( (Lorentzon, et, al.( 2005).( The(present( study( and( that( of(MacRae(
and(colleagues(used(a(microOCT(scanner(which(allowed(scanning(at(a(much(higher(
resolution( of( 5O10cm( (MacRae, et, al.( 2009).( ( Current( data( does( show( an( age(
dependent(decrease(in(cortical(BMD(in(Socs2&/&( tibiae((Tables(4.1(&(4.2).(Adult(mice(







Pass( et, al., 2012).( It( is( therefore( possible( that( the( method( used( in( this( thesis( to(










Several( studies(have( reported(no( increase( in( basal( systemic( IGFO1( levels( in(Socs2&/&,
mice.(This( suggests( that( the(Socs2&/&,overgrowth(phenotype( is( a( result( of( increased(
endogenous(GH(signalling(at(a(local(level((Metcalf,et,al.(2000;(Lorentzon,et,al.(2005;(
MacRae, et, al.( 2009).( In( agreement( with( this,( the( present( study( confirms( that( the(
increased( growth( observed( in( juvenile,( male( and( female( Socs2&/&( mice( was( not(




study( (Fig.( 4.4).( The( gender( specific( effects( of(GH(on( Igfbp3( expression(have( been(












overgrowth(phenotype( is(minimised( (Greenhalgh, et, al.( 2002).( ( These(data( suggest(
that( like(growth(plate( chondrocytes(and( linear(bone(growth(STAT5(mediates(GHs(






that( there( are( additional( GH( actions( on( osteoblasts( that( are( STAT5( independent(
(Sims, et, al.( 2000).(GH( treatment( also( induced( ERK1/2( activation.( Previous( studies(
have(shown(ERK1/2(signalling(to(mediate(important(actions(in(osteoblasts(((Lai,et,al.(
2001;(Xiao,et,al.(2002).(There(was(however(no(evidence(for(a(SOCS2(regulatory(role(
in( this( pathway( (Fig.( 4.9).( It( is( therefore(proposed( that( the( high( bone(mass( of( the(
Socs2O/O(mouse(was(not(due(to(increased(GH(signalling(through(the(ERK1/2(pathway.((
(





advocates( that(SOCS2( regulates(STAT(activation(only( in(osteoblasts( (Fig.( 4.9).(The(
specificity(of( SOCS2( in( the( regulation(of( STAT( signalling( suggests( that,( at( least( in(
osteoblasts,( SOCS2( does( not( regulate( signalling( via( targeting( the( GHR( for(
proteasomal( degradation( (Vesterlund, et, al.( 2011).( Proteasomal( degradation(would(
result( in( enhanced( signalling( of( all( pathways( downstream( of( the( GHR( in( Socs2&/&(
osteoblasts.( A( role( for( SOCS1( and( 3( in( negatively( regulating( the( osteoblast( STAT(
response( to( GH( was( not( supported( by( these( data,( and( confirms( previous(
observations( in( growth(plate( chondrocytes( (Fig.( 4.5)( (Pass, et, al.( 2012).( SOCS2(was(
shown(to(have(no(regulatory(role( in(IGFO1(induced(AKT(and(ERK1/2(signalling.(A(
previous( study( has( indicated( that( IGFO1( may( stimulate( STAT3( signalling,( and(
therefore(be(a(possible(target(for(SOCS2(regulation((Zong,et,al.(2000).(IGFO1(did(not(












in( bone( however( remains( undefined.( The( increased( STAT5( activation( and(
translocation(into(the(nucleus(following(GH(treatment(observed(was(associated(with(
a( modest( increase( in( Igf1( and( Igfbp3, expression.( Previous( studies( on( cultured(
osteoblasts( have( reported( that( GH( has( either( no( effect( on( Igf1( expression( in( rat(
osteoblasts,(or(causes(a(slight( increase( in(expression( in(mouse(calvarial(osteoblasts(
and(in(MC3T3(osteoblast(like(cells((Morel,et,al.(1993;(Schmid,et,al.(1994;(DiGirolamo,
et,al.(2007).(The(difference(in(results(may(be(due(to(the(difference(in(GH(incubation(
time,( as( longer( GH( treatment( was( associated( with( increased( Igf1, expression.( GH(
also( stimulates( Igfbp3( expression( in(mouse( calvarial( osteoblasts( (DiGirolamo, et, al.(
2007).(It(was(proposed(that(the(increased(STAT5(phosphorylation(and(translocation(
into(the(nucleus(would(likely(result( in(higher(Igf1(expression,(and(thereby(offer(an(





Socs2O/O( mice,( with( an( overgrowth( phenotype,( increased( bone( mass,( and( strength,(
had( unchanged( levels( of( bone( Igf1( and( Igfbp3.( This( is( consistent( with( previous(
quantification( of( Igf1, expression( in( bone( form(Socs2&/&(mice( (Metcalf, et, al.( 2000).( It(




GH(in(Socs2&/&(mice((Zhao, et,al.(2000).( If( the(Socs2&/&(phenotype(was(solely(mediated(
through((local(IGFO1(then(similarities(would(be(expected(between(these(models.(((
(
To( assess( the( full( impact( of( enhanced( GH( induced( STAT( signalling( in( Socs2&/&(
osteoblasts,(a( JAK/STAT(signalling(pathway(PCR(array(was(completed((Fig(4.15(&(






them,( nuclear( coOfactors,( coOactivators( associated( with( STAT( proteins,( STATO
inducible( genes,( and( negative( regulators( of( the( pathway.( Attempts( to( identify(
alternative( changes( in(gene( expression(associated(with( enhanced(STAT( signalling,(
that(are(both(stimulated(by(GH(and(negatively(controlled(by(SOCS2(were(however(






on( osteoblasts( are( less( understood.( Osteoblasts( extracted( from( human( trabecular(
explants( plated( at( a( subconfluent( density( show( increased( proliferation( (160%)( in(






It( was( hypothesised( that( the( noted( increase( GH( signalling( in( Socs2&/&( osteoblasts(
would( lead( to( increased( proliferation( in( response( to( GH.( GH( did( not( however(
stimulate( osteoblast( proliferation( in( WT( or( Socs2&/&( osteoblasts( at( any( time( point(
studied( (Fig.( 4.16).( Increased( proliferation( in( response( to( GH(may( require( longer(
incubation( times( in( excess(of( 24(hours( (DiGirolamo, et, al.( 2007).(The(present( study(
however( reported( no( increase( in( proliferation( up( to( 48( hours.( Factors( thought( to(









vivo( calvarial( culture(method( allows( the( long( term( assessment( of( osteoblasts( in( a(










































































































































GH( predominantly( exerts( its( actions( through( the( secondary(messenger( IGFO1.( ( A(
number(of(tissues(including(liver,(growth(plate,(and(muscle(all(respond(to(GH(with(
increased(IGFO1(production((Isgaard,et,al.(1988a;(Isgaard,et,al.(1988b;(Le(Roith,et,al.(
2001).(The( importance(of( IGFO1( in(mediating(GH( induced(growth( is( clear,(as( Igf1&/&(
mice(do(not(respond(to(GH((Liu(&(LeRoith(1999).((There(is(however(little(evidence(






/&( skeletal( phenotype( is( evident( despite( normal( systemic( IGFO1( levels( and( Igf1(
expression( in( bone( (Metcalf, et, al.( 2000;( Lorentzon, et, al.( 2005;(MacRae, et, al.( 2009).(
Results( presented( in( chapter( 4( confirm( that( the( anabolic( bone( phenotype( of( the(
Socs2&/&( mouse( is( not( associated( with( an( increase( in( liver( or( bone( Igf1( expression.(
Conversely,(primary(osteoblast(cultures(revealed(a(larger(increase(of(Igf1(expression(
in(GH(treated(Socs2&/&(osteoblasts.(Under(basal(conditions,(SOCS(levels(remain( low.(
Following(GH( stimulation,( SOCS( levels( increase( rapidly( (SOCS1(&( 3( and(CIS)( or(
gradually( (SOCS2),( forming( a( negative( feedback( loop( (Adams, et, al.( 1998;( TolletO












The( JAK/STAT( pathway( is( of( primary( importance( in( mediating( GHs’( actions.(
Similar( to(Ghr&/&( mice,( Stat5b&/&( mice( are( indistinguishable( from(WT(mice( until( 2O3(
weeks(of(age((Udy,et,al.(1997;(Lupu,et,al.(2001).(This(is(similar(to(Socs2&/&(mice(which(
have( comparable( growth( rates( to( WT( mice( during( early( postnatal( development.(





mice(at( this(age,(while( female(growth(remains( largely(unaffected((Udy, et,al.(1997).(
STAT5b( is( essential( in( mediating( GH( action( in( liver,( and( Stat5b&/&( mice( have( low(
circulating( IGFO1( levels(despite(elevated(GH( levels( (Udy, et, al.( 1997).( (Stat5a&/&(mice(
show(no( reduction( in( growth(with( IGFO1( levels( comparable( to(WT( (Teglund, et, al.(
1998).( Stat5a/b&/&( double( knockout( mice( are( however( growth( retarded,( and( have(
reduced( serum( IGFO1( levels.( These(mice( share(many( similarities( to(Ghr&/&( and(GHO
deficient((lit/lit)(mice((Donahue(&(Beamer(1993;(Zhou,et,al.(1997;(Teglund,et,al.(1998).(
In( these( mouse( models,( the( decrease( in( growth( is( attributed( to( the( reduction( of(
systemic( IGFO1( levels.( The( role( of( STAT5( in(mediating( GH( action( in( bone( is( less(
understood.(GH(induces(STAT5(activation(in(osteoblasts((DiGirolamo,et,al.(2007).(In(
addition,(results(presented(in(chapter(4(highlight(enhanced(GHOSTAT5(signalling(in(













































MicroOCT( analysis( was( carried( out( on( femurs( from( mice( treated( as( outlined( in(
section(2.4.5(using(a(Skyscan(1272(scanner((Bruker).(This(scanner(is(different(to(the(
Skyscan( 1172( used( in( chapters( 4( and( 6( and( therefore( scanning( parameters( were(
adjusted(such(that( for(cortical(bone(analysis,( the(rotation(angle(was(set( to(0.4°.(All(
other(scanning(parameters(remained(the(same.(Analysis(was(completed(as(outlined(









Protein( was( extracted( from( bone( and( liver( samples,( and( western( blot( analysis(
carried( out( on( as( previously( described( in( section( 2.6.( Primary( and( secondary(
antibodies( are( detailed( in( Appendix( II.( ( Densitometry( of( western( blotting( was(












































Left( femur( and( liver( were( dissected( from(male( and( female(WT( and( Socs2&/&( mice(
following( 14( days( GH( treatment.( Both( were( snap( frozen( in( liquid( nitrogen( and(
stored( at( O80°C.(Before(being( snap( frozen( femurs(had( the( epiphyses( removed(and(
marrow( spun( out( by( centrifugation.( RNA( was( extracted( as( described( in( section(
2.5.1.( cDNA( was( prepared( from( all( RNA( as( outlined( in( section( 2.5.2,( and( qPCR(





After( 14( days( GH( treatment,( immediately( following( sacrifice( blood(was( collected(
from(male(and(female(WT(and(Socs2&/&(mice(by(cardiac(puncture.(Blood(was(stored(in(
serum(tubes((Greiner(BioOOne,(Gloucestershire,(UK)(on(ice(for(over(30mins(to(allow(






studies,( experimental( data( were( analysed( using( a( repeated( measures( 2Oway(
ANOVA( for( which( suitable( postOtests( for( multiple( comparisons( were( conducted.(













Growth( of( male(WT( and( Socs2&/&( mice( was( similar( from( 14( O( 27( days( of( age( (Fig.(
5.2A).(GH(treatment((starting(at(14(days(of(age)(did(not(alter(growth(of(WT(mice(at(






Following( 14( days( GH( treatment,(WT(mice( did( not( show( any( signs( of( enhanced(
growth((Fig.(5.3(&(Table(5.1).(Final(measurements((weight,(nose(to(rump(length,(tail(
length,(femur(length(and(tibia(length)(were(unaltered(in(WT(mice(treated(with(GH(
compared( to(vehicle( treated(mice( (Table(5.1).(GH( treated(Socs2&/&(mice(were(visibly(
larger( than( vehicle( treated(mice( (Fig.( 5.3).,GH( treatment( resulted( in( a( significant(





Socs2&/&(mice.( These(mice( had( increased( Ct.Ar( (20%;( p<0.01)( and( polar(moment( of(
inertia((J)((43%;(p<0.05)((Table(5.2).(No(changes(in(cortical(geometry(were(observed(
in( GH( treated( WT( mice( (Table( 5.2).( ( Consistent( with( the( lack( of( an( overgrowth(
























A.!Weight( gain( of(WT(and(Socs2&/&( ( !mice( from(14O27(days( of( age.(B.(Growth( (%( change( in(
weight)(of(WT(and(Socs2&/&(mice( in( response( to(GH( (3mg/kg)( treatment( from(14O27(days(of(




































































































































WT( Vehicle(( 14.0( ±( 0.69( 75.2( ±( 0.62( 54.2( ±( 1.58( 11.1( ±( 0.21( 14.7( ±( 0.26(
! GH( 14.4( ±( 0.61( 75.1( ±( 1.81( 54.7( ±( 0.98( 11.4( ±( 0.20( 14.5( ±( 0.15(
Socs2&/&( Vehicle(( 15.0( ±( 0.71( 75.1( ±( 1.46( 54.2( ±( 1.96( 11.2( ±( 0.18( 14.6( ±( 0.21(



















! WT! ! Socs2&/&(
! Vehicle( GH( ( Vehicle(( GH(
Tt.Ar!(mm2)! 1.33( ±( 0.051( 1.30( ±( 0.070( ( 1.27( ±( 0.050( 1.45( ±( 0.070(
Ct.Ar!(mm2)! 0.45( ±( 0.023( 0.43( ±( 0.023( ( 0.41( ±( 0.009( 0.49( ±( 0.017b(
Ma.Ar!(mm2)! 0.88( ±( 0.032( 0.87( ±( 0.048( ( 0.86( ±( 0.050( 0.96( ±( 0.061(
Ct.Th!(mm)! 0.12( ±( 0.003( 0.12( ±( 0.003( ( 0.12( ±( 0.004( 0.13( ±( 0.004(
J!(mm4)! 0.17( ±( 0.018( 0.15( ±( 0.017( ( 0.14( ±( 0.007( 0.20( ±( 0.015a(














To( identify( the( downstream( signalling( pathways( involved( in( mediating( GHs’(
actions( on( body( (section( 5.5.1)( and( bone( growth( (section( 5.5.3)( in( Socs2&/&( mice,(
activation(of(signalling(proteins(were(measured(in(liver(and(bone(samples.((
(
At( 24( days( of( age( (Socs2&/&( mouse( growth( rate( increases( in( response( to( GH,( WT(
mouse( growth( rate( unaltered( in( response( to( GH),( liver( pISTAT5( levels( increased(
significantly( in(WT( (p<0.05)( and( Socs2&/&( (p<0.001)(mice.( This( increase(was( greatly(
exaggerated( in( liver( samples( from( Socs2&/&( mice( (Fig.( 5.4).( Minimally( increased( pI
AKT(levels(were(present( in( liver(samples(from(GH(treated(WT(mice((p<0.05).(This(





observed( in( bone( from(WT(mice,( but( this( was( likely( due( to( 1( of( the( 3( mice( not(



















mice( (p<0.05).(A( similar( response(was( observed( in(Socs2&/&( liver,( but( did( not( reach(





in( response( to(GH( (p<0.001).( ( A( similar( trend(was( observed( in( bone( from(Socs2&/&(
mice,(however(this(did(not(reach(significance((p<0.053)((Fig.(5.5).(PIAKT(levels(in(the(
bone( were( not( detected( at( this( age( and( pIERK1/2( levels( were( not( elevated( in(
response(to(GH((Fig.(5.5).((
(
These( data( confirm( an( age( dependent( regulatory( role( of( SOCS2( on( GHIinduced(
STAT5( signalling( in( bone( and( liver,( and( suggest( a( possible( mechanism( for( the(
increased(growth(observed(in(GH(treated(Socs2&/&(mice.((
(
5.5.6$ Regulation$ of$GH$ induced$mRNA! expression$ levels$ in$ liver$ and$ bone$ by$
SOCS2$in$male$mice$$
GH( treatment( increased(Socs2( levels( in( liver( (2.73fold;( p<0.05),( but( not( bone( from(
WT(mice((Fig.(5.6A).(Igf1(and(Igfbp3(levels(were(unaltered(in(response(to(GH(in(WT(
and( Socs2&/&( liver( or( bone( (Fig.( 5.6B&C).( The( lack( of( increase( in( hepatic( Igf1(

















A.$ Western( blotting( of( phosphorylated( (PI)( STAT5,( AKT( and( ERK1/2( in( liver( or( tibia(
extracted(from(24(day(old(WT(and(Socs2&/&(mice(following(15mins(GH((3mg/kg)(treatment.(βI
















A.$ Western( blotting( of( phosphorylated( (PI)( STAT5,( AKT( and( ERK1/2( in( liver( or( tibia(
extracted(from(17(day(old(WT(and(Socs2&/&(mice(following(15mins(GH((3mg/kg)(treatment.(βI














Figure$5.6$No$alteration$ in$Igf1$ and$Igfbp3$mRNA$expression$ levels$ in$ liver$and$
bone$from$male$Socs2'/'$mice$following$GH$treatment$$$
A./ Socs2(mRNA(expression( levels( in( liver(and(bone( from(male(WT(mice(at( 27(days(of( age(
following(14(days(GH((3mg/kg)(treatment.(B.(Igf1(and(C.(Igfbp3(mRNA(expression(levels(in(




































Vehicle$$ 389.6( ±( 9.90( 351.0( ±( 20.43(
GH$ 367.8( ±( 27.16( 409.3( ±( 21.87(
















The(Socs2&/&( overgrowth(phenotype( is(more(pronounced( in(male(mice(compared( to(
females( (Metcalf/ et/ al.( 2000).( Furthermore,( results( presented( in( chapter( 4( of( this(
thesis( highlight( sex( specific( differences( in( bone( architecture( in( male( and( female(










day(9(of( treatment( (23(days(of(age).(At( this(point,(growth(of(GH(treated(mice(was(
significantly(greater( than(vehicle( treated( (p<0.05).(By(day( 13( (27(days(of( age),(GH(
treated(WT(mice( had( grown( 30%(more( than( vehicle( treated( (p<0.001)( (Fig.( 5.7B).(
This(is(in(contrast(to(male(WT(mice(that(showed(no(alteration(in(growth(in(response(
to(GH((Fig.(5.2B).(GH(treated(Socs2&/&(mice(showed(increased(growth(from(6(days(of(
treatment( (20(days( of( age)( (p<0.05).( By( 13(days(of(GH( treatment( (27(days( of( age),(
Socs2&/&(mice( had( grown( 44%(more( than( vehicle( treated(mice( (p<0.001)( (Fig.( 5.7B).(












(Table(5.4).(This( indicates( that(at( this(age((27(days),(despite( the( increase( in(growth(





liver( pISTAT5( was( not( significantly( increased( in( WT( or( Socs2&/&( mice( after( GH(
challenge( (Fig.( 5.8).(There(was(a( trend( towards( increased(phosphorylation( in(both(
genotypes(by(GH,(however(high( levels(of(variability(meant( that( this(did(not(reach(
statistical(significance((Fig.(5.8).(Contrasting(to(male(results( (section(5.5.4,(Fig.(5.4),(
there( was( no( apparent( exaggeration( of( STAT5( activation( in( the( liver( of( Socs2&/&(
female( mice.( GH( treatment( did( not( result( in( activation( of( the( AKT( or( ERK1/2(
pathways(in(liver(from(WT(or(Socs2&/&(mice((Fig.(5.8).((
(
High( variability( between( bone( samples( meant( that( no( significant( differences( in(
signalling( were( observed( between( WT( and( Socs2&/&( mice( in( response( to( GH.((

























































WT( Vehicle(( 12.7( ±( 0.59( ( 75.6( ±( 0.95( ( 51.4( ±( 2.57( ( 11.0( ±( 0.19( ( 14.3( ±( 0.20(
( GH( 15.2( ±( 0.50b( ( 79.5( ±( 0.76b( ( 55.0( ±( 0.93( ( 11.3( ±( 0.21( ( 14.9( ±( 0.20(
Socs2&/&( Vehicle(( 12.2( ±( 0.75( ( 72.9( ±( 1.58( ( 53.1( ±( 2.95( ( 10.7( ±( 0.28( ( 13.9( ±( 0.29(
















Figure!5.8!No!obviously!enhanced!signalling! in! liver!and!bone! from!24!day!old!
female!Socs2&/&!mice!following!GH!treatment!!
A.! Western( blotting( of( phosphorylated( (PA)( STAT5,( AKT( and( ERK1/2( in( liver( or( tibia(
extracted(from(24(day(old(WT(and(Socs2&/&(mice(following(15mins(GH((3mg/kg)(treatment.(βA



















was( however( no( significant( difference( between( the( levels( of( increase( observed( in(
each(genotype.(A(similar(increase(was(not(observed(in(bone((Fig.(5.9B).(This(increase(

























































Vehicle!! 338.1( ±( 33.96( 297.1( ±( 26.82(
GH! 331.8( ±( 16.23( 336.4( ±( 34.73(
Table!5.5!No!alteration!in!female!serum!IGFS1!
levels!following!GH!treatment((
Serum( IGFA1( levels( in( 27( day( old( female( WT( and(

















significant( increase( in(weight( gain( compared( to( females( (p<0.001).( This( period( of(







female(WT(mice( at( 27(days( of( age.(These(mice(had( increased(Tt.Ar( (18%;(p<0.01),(
Ct.Ar( (28%;( p<0.01),(Ma.Ar( (14%;( p<0.05),( and( polar(moment( of( inertia( (J)( (145%;(
p<0.001)((Table(5.6).(No(changes(in(cortical(thickness(were(observed((Table(5.6).(The(
increase(in(bone(parameters(noted(here(in(GH(treated(female(mice(was(not(observed(
in(GH( treated(male(WT(mice( (Section(5.5.3(&(Table( 5.2).(These(data( are( shown( in(
Table( 5.6( to( make( gender( specific( comparisons( easier.( Despite( the( divergence( in(


















































! Female!! ! Male!!
! Vehicle(( GH( ( Vehicle( GH(
Tt.Ar((mm2)( 1.43( ±( 0.031( 1.69( ±( 0.070b( ( 1.33( ±( 0.051( 1.30( ±( 0.070(
Ct.Ar((mm2)( 0.43( ±( 0.025( 0.55( ±( 0.036b( ( 0.45( ±( 0.023( 0.43( ±( 0.023(
Ma.Ar((mm2)( 1.00( ±( 0.024( 1.14( ±( 0.079a( ( 0.88( ±( 0.032( 0.87( ±( 0.048(
Ct.Th((mm)( 0.11( ±( 0.006( 0.13( ±( 0.007( ( 0.12( ±( 0.003( 0.12( ±( 0.003(




Data(are(presented( as(mean( ±(SEM((n≥5).( Tt.Ar( =( total( area,(Ct.Ar(=( cortical(area,(Ma.Ar(=(marrow(









The( importance( of( STAT5( signalling( in(mediating(GHs( gender( specific( control( of(




female(mice( (p<0.05;( Fig.( 5.11).( An( increase(was( not( observed( in( liver( from(male(
mice.(A(significant(increase(in(total(STAT5(levels(in(female(compared(to(male(liver(
samples(meant( that( for( quantification( pJSTAT5( levels(were( normalised( to( βJactin,(









GH( as( measured( by( activation( of( pJSTAT5( signalling( in( liver( and( bone.( This(













































total(STAT5( levels( relative( to(βJactin( in( liver( from(24(day(old( female(and(male(mice.(Data(
presented( as( mean( ±( SEM( (n=6).( Significance( denoted( by( b( p<0.01.% C.( Quantification( of(
densitometry( analysis( of(western( blotting.( Liver( data( presented( as( pJSTAT5( relative( to( βJ
actin.( Bone( data( presented( as( pJSTAT5( normalised( to( total( STAT5.( All( data( presented( as(









































Following( analysis( of( the( results( presented( in( chapter( 5( the(main( hypothesis(was(























As( reported( in( chapter( 4( of( this( thesis,( Socs2./.( mice( are( characterised( by( their(
overgrowth(skeletal(phenotype(despite(no(elevation(in(systemic(GH(or(IGFJ1(levels(
(Metcalf!et!al.(2000;(Greenhalgh!et!al.(2002a;(MacRae!et!al.(2009).((In(accordance(with(
this,( the( present( study( found( that( the( anabolic( bone( phenotype( observed( in( GH(
treated( male( Socs2./.( mice( was( not( associated( with( an( increase( in( hepatic( Igf1(











the( up( regulation( of( Socs2! expression( in( the( liver( (Greenhalgh! et! al.( 2002).( A(
comparable( increase( in( Socs2( expression( was( noted( in( this( study( (Fig.( 5.6).(
Functioning( STAT5b( signalling( is( essential( for( the( Socs2./.( overgrowth( phenotype,(
and(elevated(hepatic( STAT5(activation(has(been(previously( reported( in( liver( from(
Socs2./.( mice( (Greenhalgh! et! al.( 2002).( Given( that( STAT5b( is( important( for(
upregulating( Igf1( expression( and( numerous( STAT5( binding( sites( have( been(
identified(on(the(Igf1(gene(it(is(surprising(that(enhanced(GH(induced(hepatic(STAT5(
activation(in(male(Socs2./.(mice(did(not(result(in(raised(hepatic(IGFJ1(transcript(and(
systemic( levels( (Fig.( 5.6)( (Davey! et! al.( 1999a;( Davey! et! al.( 2001;( Eleswarapu! et! al.(
2008).( It( has( been( suggested( that( STAT5( proteins( are( weak( activators( of(
transcription,( and( require( coJactivators( to( achieve( this( (Kornfeld! et! al.( 2008).(
Hepatocyte( nuclear( factor( 1α( (HNF1α)( (a( transcription( factor)( upregulates( the( coJ
activator( glucocorticoid( receptor,( which( interacts( with( GH( induced( STAT5( to(




activation( of( a( salmon( Igf1( promoter( construct( requires( the( expression( of( both(
STAT5(and(HNF1α((Meton!et!al.(1999).(It( is(therefore(possible(that(enhanced(IGFJ1(




increased( hepatic( Igf1( levels( are( insufficient( to( increase( systemic( IGFJ1( levels.(
Further( studies( are( required( to( investigate( the( relationship( between( enhanced(
hepatic(STAT5(signalling(and(systemic(IGFJ1(levels.(
(




zero( gravity( conditions,( highlighting( that( it( is( not( a( secondary( effect( of( increased(
weight((Ohlsson!et!al.(1998).(There(is(little(evidence(for(the(effects(of(GH(treatment(
in(mice(with(normal(GH(secretion.(The(present(study(demonstrates(that(exogenous(
GH( is( unable( to( alter( bone( growth( in( young( male( WT( mice( (Table( 5.2).( GH(















apparent( by( the( reduced( linear( growth( rate( of( Ghr./.( mice.( The( sex( of( the( Ghr./.(




the( authors( therefore( combined( sexes( for( future( analysis( (Lupu! et! al.( 2001).( The(
present( study( has( shown( a( sex( specific( response( to( GH( that( manifests( at(
approximately(3(weeks(of(age((Fig(5.10).(Young((17(day(old)(male(and(female(mice(
display( similar( GH( induced( signalling( and( no( alteration( in( growth.( A( time( point(
selected( after( 3( weeks( of( age( (24( days)( highlights( that( female( mice( are( more(
responsive(to(GH(treatment.(These(mice(have(elevated(pJSTAT5(levels(in(liver(and(
bone((Fig(5.11).(This(increased(STAT5(activation(is(likely(responsible(for(mediating(
the( increased( growth( and( anabolic( bone( phenotype( that( is( not( observed( in( male(
mice.( Interestingly,( the(switch(from(GH(unresponsive(to(GH(responsive(growth(in(
females( coincides( with( the( point( at( which( male( and( female( growth( diverges(
(Goedbloed( 1980;( Lupu! et! al.( 2001).( The( sexual( dimorphic( growth( pattern( is(
generally(considered(to(arise(due(to(differences(in(GH(secretion(patterns((Jansson!et!
al.( 1985;(Chowen! et! al.( 2004).( In(male(mice,( this( consists(of(pulses(of(GH(secretion(
with( minimal( interpulse( GH( levels.( In( females,( there( are( also( pulses( of( GH,( but(
these( occur( more( frequently( than( in( males( (Macleod! et! al.( 1991).( ( The( extended(
interpulse(interval(in(males(results(in(sexually(dimorphic(liver(gene(expression(and(
growth(patterns(that(emerge(at(puberty((Davey!et!al.(1999b).(It(is(therefore(possible(
that( the( twice( daily( injections( of( female( mice( more( closely( resembles( the( male(
secretion(pattern,( and( therefore( stimulates( female( growth( to( a(male( level.( Further(
studies(assessing(the(differences(in(continuous(and(intermittent(GH(to(young(female(
mice( are( needed( to( investigate( this.( A( sex( specific( response( to( GH( has( also( been(







Ghr./.( mice( show( limited( radial( bone( expansion( during( puberty,( and( no( sexual(
dimorphism.( This( indicates( that( GH( is( key( in( determining( pubertal( bone( growth(
(Callewaert!et!al.(2010).((The(sex(specific(effects(of(GH(treatment(on(young(mice(have(
not( previously( been( demonstrated.( The( anabolic( bone( phenotype( of( GH(
overexpressing(mice( is(more( evident( in(males.( These(mice( have( increased( cortical(
crossJsectional( area( (apparent( from( 6( weeks( of( age).( There( are( no( changes( in(
transgenic(females((Eckstein!et!al.(2004).(Similarly,(Socs2./.(mice((characterised(by(the(
overgrowth( phenotype( due( to( enhanced( GH( signalling)( show( sex( specific(
alterations(in(the(skeletal(phenotype((chapter(4).(The(data(presented(here(shows(that(
female(mice( are( responsive( to(GH(with( increased(growth(and(an(anabolic( cortical(
bone(phenotype( (Fig.(5.10(&(Table(5.6).(This( sex(specific(difference(may(be(an(age(
dependent( effect.( (Although( analysis( of( bone(was( not( completed( in( the( study,( an(
increase( in(weight( is( observed( in( 3(week( old( GH( overexpressing( female,( but( not(
male(mice.(Analysis( of( older(mice( reveals( a(bone(overgrowth(phenotype( in(males(
(Eckstein!et!al.(2004).((
(
Lower( Socs2( transcript( levels( in( bone( from( female( mice( indicate( that( sex( specific(
differences( in( the( expression( of( Socs2( may( be( responsible( for( the( difference( in(
responsiveness(to(GH(treatment((Fig(5.13).(Socs2!levels(have(previously(been(shown(
to(be(equally(expressed(in(male(and(female(rat(liver,(muscle,(and(fat((TolletJEgnell!et!
al.( 1999).(A( similar( result(was(obtained(with( regards( to( liver( in( the( current( study.(
Oestrogen( has( been( implicated( in( the( upregulation( of( GH( signalling( in( human(






STAT5( levels(were(measured(relative( to(βJactin.(This(was( required(as( total(STAT5(





2.5( week( old( mice( (Martinez! et! al.( 2013).( The( lack( of( a( sex( specific( difference( in(
STAT5(activation(is(similar(to(the(results(obtained(in(17(day(old(mice(in(the(present(
study( (Fig.( 5.12).( This( suggests( that( these( effects( are( age( dependent,( manifesting(
after(3(weeks.(It(was(hypothesised(that(these(differences(may(be(due(to(the(role(of(
sex(steroids(in(regulating(GH(action.(The(role(of(oestrogen(is(still(a(matter(of(debate.((
Oestrogen( has( previously( been( shown( to( limit( appendicular( bone( growth( in( rats,(
through( inhibition( of( GHJdependent( mechanisms( (Zhang! et! al.( 1999).( Studies( on(
mice( however( reveal( that( oestrogens( inhibit( cortical( bone( growth( despite( no(
alteration( in( systemic( IGFJ1( levels.( The( authors( concluded( that( oestrogen’s( effects(
are( therefore( independent( of( the( GHJIGFJ1( axis( (Callewaert! et! al.( 2010).( This(
conclusion( fails( to( address( the( possibility( of( oestrogen( regulating(GH( at( the( local(
level( (bone).( Ovariectomy( of( GHJtransgenic( mice( impairs( development( of( bone(
mass,( thus(suggesting( that( sex(hormones(are( required( for(GH(to(exert( its(anabolic(
actions( (Sandstedt! et! al.( 1996).( In(males,( oestrogens( are( thought( to( promote( radial(
bone( expansion( through( stimulation( of( the( GHJIGFJ1( axis( (Venken! et! al.( 2006;(
Callewaert!et!al.(2010).((It(is(widely(accepted(that(androgens(stimulate(bone(growth(
independent( of( the( GHJIGFJ1( axis( (Venken! et! al.( 2006;( Callewaert! et! al.( 2009;(
Callewaert!et!al.(2010).((
(
The( mechanisms( behind( the( GH( unresponsive( phase( (embryonic( and( early(
postnatal)( in(mice(are(poorly(understood.(STAT5(activation( is(present( in( liver(of(1(
week(old(mice(following(GH(treatment.(The(levels(of(phosphorylation(however(are(
less( compared( to( older( mice.( This( may( be( due( to( the( lower( levels( of( GHR,( or(
increased(levels(of(CIS(and(PTP1B((negative(regulators)((Martinez!et!al.(2013).( (The(
current( study( found( STAT5( phosphorylation( in( liver( and( bone( from( 17( day( old(
animals( following( GH( treatment.( It( therefore( appears( that( young( mice( are(








In(conclusion,( the(present( study(highlights( the( importance(of(SOCS2( in( regulating(
GH( induced(bone(growth.( Identification(of( two(models( (Socs2./.!model( and(young(
female(WT(model)(allows(assessment(of( the( importance(of( IGFJ1( in(mediating(GH(
action.(The(increased(growth(and(anabolic(bone(phenotype(observed(in(male(Socs2./.(
and( female(WT( and(Socs2./.( mice,( despite( no( elevation( in( systemic( IGFJ1( levels( or(
bone( Igf1( transcript( levels,( suggests( an( important( role( for( local( GH( action(
independent(of(IGFJ1(in(regulating(bone(mass.(The(activation(of(the(STAT5(pathway(







































IBD( is( the( term( used( to( describe( inflammatory( conditions( of( the( gastrointestinal(
tract;(ulcerative(colitis((UC),(and(Crohn’s(disease((CD).( (UC(is(limited(to(the(colon,(
and( characterised( by( lamina( propria( inflammation,( and( bowel( epithelium(
destruction.( CD( can( affect( the( entire( digestive( system,( and( is( characterised( by(
transmural( inflammation( and( fibrosis( (Sartor( 1997).( The( aetiology( of( IBD( remains(






addition( to( the( wellJrecognised( gut( inflammation,( there( are( a( number( of( extraJ
intestinal(manifestations(associated(with(IBD.(Adults(with(IBD(are(at(increased(risk(
of(developing(osteoporosis(with( a( relative( risk(of( fracture( that( is( 40%(higher( than(
normal( (Compston! et! al.( 1987).(Children(with( IBD(may( also( have( a( higher( risk( of(
fractures,( especially( in( the( vertebrae( (Laakso! et! al.( 2012;(Wong! et! al.( 2014).( Recent(
studies( in(children(have(shown(that(trabecular(bone(density,(reduced(at(diagnosis,(
showed( inadequate( improvement( despite( control( of( the( underlying( inflammation(
(Dubner! et! al.( 2009).( In( addition,( these( patients( have( thinner( and( smaller( bones(
(Dubner! et! al.( 2009;( Tsampalieros! et! al.( 2013).( Peak( bone(mass( is( compromised( in(




generated.(These( include(several(geneJknockout( strains(which(develop(colitis( (Il2./.(
and(Il10./.((Sadlack!et!al.(1993;(Kuhn!et!al.(1993)),(and(models(where(inflammation(is(
chemically( induced( (dextran( sodium( sulphate( (DSS)( model( and( trinitrobenzene(
sulfonic(acid((TNBS)(model((Morris!et!al.(1989;(Okayasu!et!al.(1990)).(Colitis(develops(




Berg! et! al.( 1996).( ILJ10( deficiency( alone( leads( to( a( disruption( of( the( intestinal(
immune(response(due(to(a(failure(in(regulating(the(actions(of(CD4+(T(cells(and(the(
production(of(proinflammatory(cytokines((Cohen!et!al.(2004).(The(onset(and(severity(
of( colitis( varies( depending( on( mouse( strain.( Mice( on( a( 129/SvEv( and( Balb/C(
background,( develop( severe( colitis( more( rapidly( than( mice( on( a( C57BL/6(
background( (Berg! et! al.( 1996).( Chronic( inflammation( can( also( be( induced( in( Il10./.(
mice( challenged( with( nonJsteroidal( antiJinflammatory( drugs( such( as( sulindac(
sulfone(and(piroxicam.(Piroxicam(treatment(is(thought(to(enhance(apoptosis(of(the(
intestinal(epithelium(and(facilitate(adhesion(and(invasion(of(intestinal(bacteria(into(
the( mucosal( tissue( (Hale! et! al.( 2005).( These( drugs( have( little( effect( on( WT( gut(
inflammation(when(used(alone( (Berg! et! al.( 2002;(Hale! et! al.( 2005).( Inflammation( in(
the(Il10./.(mice(closely(resembles(CD((MacDonald(1994;(Rennick!et!al.(1997).((((((((
(
Chemically( induced(models( are( the(most(widely( studied( due( to( the( simplicity( of(
induction,( and( the( relatively( low( cost( involved.( These( models( differ( in( their(
inflammation( characterisation.( DSS(mice( display( a( UC( like( colitis,( whereas( TNBS(
mice(have(a(more(CD(like(colitis.(Nevertheless,(both(models(share(many(similarities(
with(the(human(conditions((Boismenu(&(Chen(2000).(DSS(induced(inflammation(is(
the(result(of(deterioration(of( the(epithelial(barrier( through(an(increase( in(epithelial(
cell(apoptosis(and(a(decrease(in(proliferation((Araki!et!al.(2010).(The(barrier(exists(as(
a( physiological( and( immunological( barrier( between( the( mucosa( and( lumen.( This(
deterioration( of( the( epithelial( barrier( allows( for( the( influx( of( antigens( and(microJ
organisms,(prompting(an(inflammatory(response((TlaskalovaJHogenova!et!al.(2005).(
Depending( on( treatment( duration,( DSS( can( be( used( to( induce( chronic( or( acute(
inflammation.( Chronic( inflammation( is( observed( a( number( of( weeks( after( initial(
DSS(treatment,(or(can(be(stimulated(through(cyclical(administration(of(DSS.(Acute(
inflammation(is(observed(soon(after(DSS(treatment((Cooper!et!al.(1993;(Dieleman!et!
al.( 1998;(Melgar! et! al.( 2005;( Yan! et! al.( 2009).( Similar( to( human( IBD,( DSS( induced(











increased( proinflammatory( cytokine( levels( (Perse( &( Cerar( 2012;( Holgersen! et! al.(
2014).(Proinflammatory(cytokines,(including(ILJ1β,(ILJ6(and(TNFα(have(been(shown(
to( stimulate(SOCS2(expression( in(a(number(of( tissues( (Greenhalgh(&(Hilton(2001;(
RicoJBautista!et!al.(2006;(MacRae!et!al.(2009).(Given(that(SOCS2(has(been(identified(
as(critical(regulator(of(GH(induced(bone(accrual((chapters(4(&(5),(it(is(possible(that(
SOCS2(may( act( as( a( central(mediator( through(which( proJinflammatory( cytokines(

















The( osteoporotic( phenotype( in( experimental( mouse( models( of( colitis( mice( is(









III. Quantify( relative( levels( of(Socs2( expression( in( bone( from(DSS( induced(
colitic(mice.(
(
IV. Determine( the( effects( of( SOCS2( ablation( on( the( gut( pathology( of( DSS(
induced(colitic(mice.(
(















MicroJCT( analysis( of( trabecular( and( cortical( bone( of( tibia( from( Il10./.( mice( was(
carried(out(on(a(Skyscan(1272(scanner((Bruker)((same(scanner(used(in(chapter(5)(and(
therefore( there(were( appropriate(modifications( to( the( protocol( outlined( in( section(
2.4.7.( The( rotation( step( for( trabecular( scans( was( changed( to( 0.3°( and( for( cortical(
scans(to(0.4°.(Two(images(were(not(averaged(at(each(rotation(angle.(The(remainder(




The(colon(was(dissected( from(WT(and(Socs2./.(mice(±(DSS( treatment( (6(per(group)(
and(fixed(and(stored(in(10%(neutral(buffer(formalin.(Each(colon(was(divided(into(5(
transverse( segments( including( proximal( to( distal( portions.( Embedding,( staining,(
and(sectioning(of(tissue(was(completed(by(the(Easter(Bush(Pathology(Department.(
In( brief,( samples(were( embedded( using( the( following( protocol( –( 70%( ethanol( for(
1hr,( 95%( ethanol( for( 1hr,( 5(washes( in( absolute( ethanol( for( 1hr( each,( 3(washes( in(
xylene(for(1hr(each.(Finally,(embedded(in(paraffin(wax(for(4hrs,(wax(changed(every(
1hr( 20mins.( 5sm( sections( were( cut( and( mounted( on( Superfrost( slides( (Thermo(
Scientific,( UK).( ( Sections( were( dewaxed( and( dehydrated( through( graded( alcohol(
solutions,( immersed( in( Harris( haematoxylin,( followed( by( 1%( eosin( before( being(
cleared( and( mounted( in( DePeX( (VWR).( Gut( pathology( was( assessed( on( sections(
from( all( 5( gut( segments( with( the( help( of( Professor( Elspeth( Milne( (Pathology(












Immediately( following( sacrifice( blood( was( collected( from(WT( and( Socs2./.( mice( ±(
DSS(treatment(by(cardiac(puncture.(Blood(was(stored(in(serum(tubes((Greiner(BioJ
One)(on(ice(for(over(30mins(to(allow(for(clotting.(Following(10mins(centrifugation(at(





Left( femur(and(gastrocnemius(muscle(were(dissected( from(WT(and(Socs2./.(mice( ±(
DSS(treatment.(Both(were(snap(frozen(in(liquid(nitrogen(and(stored(at(J80°C.(Before(
being( snap( frozen( femurs( had( the( epiphyses( removed( and( marrow( spun( out( by(







studies,( experimental( data( were( analysed( using( a( repeated( measures( 2Jway(
ANOVA( for( which( suitable( postJtests( for( multiple( comparisons( were( conducted.(
Final( measurements,( microJCT,( IGFJ1( ELISAs,( and( histology( scoring( data( were(
analysed( using( a( 2Jway( ANOVA( for( which( suitable( postJtests( for( multiple(
comparisons( were( conducted.( All( other( results( within( the( chapter( were( analysed(
using( the( Student’s( tJtest( or( a( suitable( nonJparametric( test( if( the( data( were( not(



























































were( kindly( obtained( from(Dr(Thomas(Lindebo(Holm( (Novo(Nordisk,(Denmark).(
Gut( inflammation( had( been( previously( confirmed( in( these( mice( by( the( Novo(
Nordisk(scientists(as(part(of(a( separate(study.( (MicroJCT(analysis( revealed( limited(
changes( in(bone(architecture( in( Il10./.(mice(treated(with(piroxicam,(but( there(was(a(
6%(decrease( (p<0.01)( in( trabecular( thickness( in(untreated( Il10./.( tibiae( compared( to(
WT.( This( decrease( was( exacerbated( with( piroxicam( treatment,( where( trabecular(
thickness(had(decreased(by(a(further(7%((p<0.05).(Piroxicam(treatment(of(WT(mice(
did(not( alter( trabecular( thickness,(highlighting( that( the(bone(phenotype(was( Il10./.(
specific( (Table(6.2).(BV/TV,( trabecular( separation,(number,( and(pattern( factor,( and(
structural(model(index(remained(comparable(between(all(groups((Table(6.2).((
(
Markers( for( cortical( geometry( such( as( total( area,( bone( area,( marrow( area,( polar(
moment( of( inertia,( and( cortical( thickness( were( similar( between( all( groups( (Table(
6.3).( As( a( result( of( the( minimal( changes( to( bone( architecture,( the( Il10./.( ( ( mouse(























! WT! ! Il10%/%'
! Control( Peroxicam( ( Control( Peroxicam(
BV/TV! 11.72( ±( 0.670( 12.58( ±( 0.504( ( 11.75( ±( 0.368( 11.69( ±( 0.446(
Tb.Th!(mm)! 0.047( ±( 0.001( 0.048( ±( 0.0005( ( 0.044( ±( 0.001a( 0.041( ±( 0.001ab(
Tb.Sp!(mm)! 0.22( ±( 0.005( 0.22( ±( 0.006( ( 0.22( ±( 0.004( 0.22( ±( 0.008(
Tb.N!(1/mm)! 2.49( ±( 0.133( 2.62( ±( 0.099( ( 2.65( ±( 0.063( 2.82( ±( 0.098(
Tb.Pf!(1/mm)! 27.68( ±( 1.225( 25.94( ±( 0.845( ( 26.17( ±( 1.265( 25.23( ±( 0.538(

































! Control( Peroxicam( Control( Peroxicam(
T.Ar!(mm2)! 0.90( ±( 0.012( 0.90( ±( 0.009( 0.90( ±( 0.021( 0.87( ±( 0.021(
Ct.Ar!(mm2)! 0.58( ±( 0.011( 0.57( ±( 0.003( 0.58( ±( 0.013( 0.55( ±( 0.017(
Ma.Ar!(mm2)! 0.31( ±( 0.008( 0.33( ±( 0.010( 0.32( ±( 0.020( 0.32( ±( 0.011(
MMI!(mm4)! 0.12( ±( 0.003( 0.12( ±( 0.002( 0.11( ±( 0.005( 0.11( ±( 0.006(















2005;( Perse( &( Cerar( 2012).( Previous( background( strain( characterisation( using( a(
Mouse(384(SNP(panel( (Charles(Rivers(Laboratories)(of( four(mice( from(the(original(
SOCS2( colony( (G0)( showed( them( to(be(76%(C57BL/6( (Table( 6.4).( (To( increase( line(
purity,( a( breeding( programme( was( set( up( that( involved( 5( generations( of(
backcrossing( to( pure( C57BL/6( mice( (Fig.( 6.1).( To( ensure( the( Y( chromosome( was(
derived(from(the(C57BL/6(line,(1(mating(consisting(of(a(male(C57BL/6(crossed(with(a(
female(Socs2,/,(were(included.(Only(male(offspring(were(used(for(future(mating((G2).(
Following( 4( generations( of( backcrossing( (G4),( 5( mice( were( further( background(
strain(characterised(as(described(above.(Two(mice(were(selected(with(high(C57BL/6(






reported( that( the( Socs2,/,! overgrowth( phenotype( becomes( apparent( between( 4^6(
weeks(of(age((Metcalf!et!al.(2000;(MacRae!et!al.(2009).(In(accordance(with(this,(both(
male(and(female(Socs2,/,(mice(were(significantly(heavier( than(age(and(sex(matched(
WT( mice( at( 4( weeks( (p<0.001;( Fig.( 6.2).( This( increase( in( body( weight( was( still(
evident(at(6(weeks,(where(Socs2,/,!male(mice(were(44%(heavier(than(male(WT(mice(

























































































The( severity( of( colitis( induced( by( DSS( is( dependent( on( a( number( of( factors,(
including( DSS( concentration( and( duration,( as( well( as( the( genetic( influences(
discussed(above((Melgar!et!al.(2005;(Perse(&(Cerar(2012).(It(was(therefore(necessary(
to( conduct( a( pilot( study( to( investigate( which( concentration( and( duration( of( DSS(
treatment(was(appropriate(for(the(newly(established(SOCS2(colony.(WT(mice(were(
given(2.5%,(3%,(3.5%,(or(4%(DSS(for(5(days,(or(3%(DSS(for(4(days,(followed(by(a(13(







8^9( a( proportion( of( the( mice( had( lost( close( to,( or( over( 25%( body( weight( and(
therefore( the( experiment(was( stopped(and( the(mice(humanely( culled( (Fig.( 6.3).( In(
some(cases’(this(severe(decrease(in(weight(was(coupled(with(loose(stool(consistency,(
bloody(stool,(and(a(hunched(posture.(Mice(given(3%(DSS(for(4(days(began(to( lose(
weight( around( day( 5.( Weight( loss( continued( until( approximately( day( 8.( At( this(
point,(the(weight(of(DSS(mice(was(approximately(87%(of(starting(weight.((This(was(
followed(by(a(recovery(phase,(with(weight(increasing(from(day(9(onwards((Fig.(6.3).(
These( results( indicate( that( that( for( the( mice( to( be( used( in( the( colitis( studies( the(



































the( effects( of( IBD( on( bone( development( in( Socs2,/,( mice( (Fig.( 6.4).( In( addition( to(
mouse( weight( being(measured( throughout( the( experiment,( food( levels( were( also(
measured(at(three(points.(Previous(studies(have(shown(that(weight(loss(observed(in(
DSS(treated(mice(may(be(attributed(to(a(reduction(in(food(intake((Harris!et!al.(2009).(
Based( on( data( collected( in( section( 6.5.3,( the( experiment( was( divided( into( three(
stages( ^( DSS( intake( (1),( weight( loss( (2),( and( recovery( (3)( (Fig.( 6.4).( To( ensure(
differentiation( between( a( reduced( food( intake( and( an( inflammation( induced(
phenotype,( non( DSS(WT( and( Socs2^/^!mice( were( pair( fed( with( DSS( mice( using( a(





To( investigate( the( effects( of( DSS( induced( colitis( on( bone( development( and( the(
possible( role(of( SOCS2( in(mediating(bone( loss,( 8^9(week(old(male(WT(and(Socs2,/,(
mice(were(treated(with(DSS(as(outlined(in(section(6.5.4.(During(DSS(treatment,((0^4(
days)(no(significant(weight(loss(was(observed(in(WT(or(Socs2,/,(mice((Fig.(6.5A).((All(




did( not( show( any( significant( alterations( in( body( weight( (Fig.( 6.5A).( WT( mice(
showed( high( variation( in( susceptibility( to( DSS,( as(measured( by(weight( loss( (Fig.(
6.5B).(Maximum(body(weight(loss(ranged(between(^6%(and(^21%(in(DSS(treated(WT(
mice(before(recovery,(and(2(out(of(the(8(experimental(animals(fell(below(^25%,(and(
therefore( had( to( be( culled( (Fig.( 6.5B).( Body( weight( loss( observed( in( Socs2,/,( mice(






During( the( period( of( DSS( treatment,( water( intake( per( gram( of( body(weight( was(
similar( in( WT( and( Socs2,/,( mice( (Fig.( 6.6A).( Food( levels( measured( during( the(
experiment( revealed( no( difference( in( food( intake( during(DSS( intake,(weight( loss,(






were(observed( in(nose( to( rump( length,( tibia( length,(or( femur( length(between(DSS(
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DSS( for( 4( days.( Data( are( presented( as( mean( ±( SEM( (n=6).( Significance( from( genotype(































A.(Water( consumption( by(DSS( treated(WT( and(Socs2&/&(mice( during(DSS( treatment.(Water(
consumption( normalised( to( body( weight.( Data( presented( as( mean( ±( SEM( (n≥5).(B.( Food(

































! WT! ! Socs2&/&(
! Control( ( DSS(Treated( ( Control(( ( DSS(Treated(
Weight!(g)! 23.5( ±( 0.34( ( 22.6( ±( 0.38( ( 32.6( ±( 0.38a( ( 31.5( ±( 0.46(
N!to!R!Length!(mm)! 88.7( ±( 1.11( ( 87.9( ±( 1.40( ( 100.5( ±( 1.15a( ( 103.2( ±( 1.35(
Tail!Length!(mm)! 72.5( ±( 1.09( ( 72.0( ±( 0.82( ( 76.0( ±( 1.56( ( 77.6( ±( 1.24(
Left!Tibia!(mm)! 17.7( ±( 0.14( ( 17.6( ±( 0.16( ( 18.7( ±( 0.18a( ( 18.9( ±( 0.10(





















Histological(analysis(of( the( colon( from(WT(and(Socs2&/&(DSS( treated(mice,( revealed(




of( sections( there(were( also( signs( of( crypt( loss.( These( signs( of( acute( inflammation(
were(often(concomitant(with(signs(of(chronic(inflammation.(Aside(from(acute(phase(
cells( such( as( neutrophils( in( the( lamina( propria,( there( were( also( high( levels( of(
mononuclear(leucocytes(which(are(associated(with(chronic(inflammation((Fig.(6.8A).(
Atypical( crypt( regeneration( (Fig.( 6.8A)( and( transmural( inflammation( were( also(
noted(in(colons(from(DSS(treated(mice,(indicating(chronic(inflammation.((((((((((((((((((((((%
(
Scores( for( inflammation( severity( and( extent( of( inflammation( were( significantly(
increased( in(DSS( treated(mice( (Fig.( 6.8B).(The(histological( scores( for( inflammation(
severity( (WT:( 6.8,( Socs2&/&:( 5.2)( and( extent( of( inflammation( (WT:( 7.3,( Socs2&/&:( 5.9)(





on( crypt( damage/regeneration( score( was( dependent( on( genotype( (Fig.( 6.8B).( The(




total( pathology( scores( (Fig.( 6.8B).( Taken( together,( these( results( indicate( that( the(






animals( revealed( that( despite( obvious( gut( pathology( (section( 6.5.8),( there(was( no(








significant( differences( were( observed( in( Socs1( and( 3( mRNA( levels( (Figure( 9A).((
Analysis( of( bone( sample( revealed( increased(Socs2( (2.7( fold;( p<0.05)( and(Socs3( (4.1(
fold;(p<0.05)(levels(in(DSS(treated(mice.(No(difference(was(observed(in(Socs1(levels(


































Representative(H&E( stained( sections( of( colon( from( control(WT( and(Socs2&/&(mice(marking(
major(anatomical(features.(L(=(lumen,(M(=(mucosa,(C(=(crypt,(MM((dotted(line)(=(muscularis(






































A.%Representative( H&E( stained( sections( of( colon( from( DSS( treated(WT( and( Socs2&/&.( ( M( =(
mucosa,( LP( =( lamina(propria.(Arrows( indicate( points( of( atypical( crypt( regeneration.( Scale(
bar(=100cm.(B.(Histological(scoring(of(DSS(treated,(and(control(WT(and(Socs2&/&(colons.(Data(




































WT( mice( at( endpoint( of( DSS( study.( ( All( data( are( presented( as( mean( ±( SEM( relative( to(
untreated( (control)( samples( (n≥4)(Significance( from(untreated( (control)( samples( is(denoted(
by(a(p<0.05,(b(p<0.01.(
% IGF=1%(ng/ml)%
% Control(( ( DSS(Treated(
WT% 263.8( ±( 6.2( ( 243.6( ±( 10.8(














had( significantly( decreased( BV/TV( (41%;( p<0.001),( trabecular( thickness( (16%;(
p<0.01),( trabecular( number( (30%;( p<0.001),( and( resulting( increased( trabecular(
separation( (19%;( p<0.01)( (Fig.( 6.10B).( Increased( trabecular( pattern( factor( (40%;(




DSS( induced(Socs2&/&(mice(also( showed(altered( trabecular(architecture( compared( to(
control(mice.( The( level( of( trabecular( deterioration(was( however( far( less( than( that(
observed(in(WT(mice((Fig.(6.10).(DSS(treated(Socs2&/&(mice(had(significantly(decreased(
BV/TV( (21%;( p<0.01),( trabecular( number( (14%;( p<0.05),( and( increased( trabecular(
pattern( factor( (20%;( p<0.05).( Trabecular( thickness,( trabecular( separation,( and(
structural( model( index( were( not( significantly( different( from( control( mice( (Fig.(
6.10B).(Analysis(of(BV/TV(revealed(a(significant(interaction(between(treatment(and(
genotype( (p<0.05).( ( This( indicates( that( the( effect( of( treatment( was( dependent( on(
genotype.( Taken( together,( these( results( highlight( that( the( absence( of( SOCS2( is(





this( point,( the( anabolic( bone(phenotype( (characterised( by( increased( cortical( tissue(































A.(Representative(3D(microUCT( ( reconstructions(of( tibial( trabecular(bone( from(control( and(
DSS( treated,(WT( and( Socs2&/&( mice.(B.%Percentage( change( of( trabecular( parameters( in( DSS(
treated( mice( relative( to( genotype( matched( controls.( Data( are( ( presented( as( mean( ±( SEM(





! WT! ! Socs2&/&(
! Control(( DSS(Treated( ( Control(( DSS(Treated(
Tt.Ar!(mm²)! 0.84( ±( 0.001( 0.82( ±( 0.002( ( 1.03( ±( 0.003b( 1.01( ±( 0.003(
Ct.Ar!(mm2)! 0.54( ±( 0.014( 0.54( ±( 0.012( ( 0.67( ±( 0.028b( 0.65( ±( 0.022(
Ma.Ar!(mm²)! 0.30( ±( 0.005( 0.28( ±( 0.005( ( 0.37( ±( 0.009b( 0.36( ±( 0.001(















utilising( this(model(on(Socs2&/&(mice(highlighted(a(key(role( for(SOCS2( in(regulating(
this(process.(Despite(no(apparent(differences(in(gut(inflammation(Socs2&/&(mice(were(
partially( protected( from( bone( deterioration( following( DSS( induced( colitis.( IBD( is(
often( associated( with( secondary( osteoporosis( and( increased( risk( of( fracture(
(Bjarnason( et(al.(1997;(Dinca( et(al.(1999;(Ali( et(al.(2009).(Poor(bone(health(cannot(be(
solely( attributed( to( steroid( medication,( and( poor( nutrient( intake( and( absorption.(
Inflammatory(activity(itself(also(has(a(role(to(play((Tilg(et(al.(2008;(Ali(et(al.(2009).(It(
is(well(established(that(IBD(is(associated(with(GH(resistance,(likely(to(contribute(to(
the( bone( loss( observed( (Tenore( et( al.( 1977;( Wong( et( al.( 2010).( A( number( of(
proinflammatory( cytokines( have( been( shown( to( upregulate(Socs2(gene( expression(





MicroXCT( analysis( of( piroxicam( treated( Il10&/&( mice( revealed( minimal( bone( loss(
(Tables(6.2(&(6.3).(Il10&/&(mice(have(previously(been(shown(to(have(decreased(BMD(
and( BMC.( However,( this( was( only( found( to( be( significant( when( genders( were(




result( in( a( greatly( altered( bone( phenotype( (Lin( et( al.( 1996;( Hamdani( et( al.( 2008;(
Holgersen(et(al.(2014).(In(the(present(study,(piroxicam(was(administered(for(12(days.(




piroxicam(may(benefit( from( extending( this( period,( to( allow( time( for( the(potential(
negative(effects(of(inflammation(on(bone(turnover(to(be(elucidated.(((((((((((((((
(
To( assess( the( potential( role( for( SOCS2( in( mediating( the( bone( loss( phenotype(
observed( in( IBD,( it(was( necessary( to( establish( the(DSS( induced(model( for( colitis.(
There(are(a(number(of(factors(that(contribute(to(the(susceptibility(of(a(mouse(to(DSS,(
and( each( needs( to( be( carefully( addressed( in( order( to( establish( a( working( and(
reproducible(model((Perse(&(Cerar(2012).(The(responsiveness(to(DSSXinduced(colitis(
is( different( among( inbred( mouse( strains( (Mahler( et( al.( 1998;( Melgar( et( al.( 2005).(
C57BL/6( mice( are( more( susceptible( to( DSS( than( other( mouse( strains( including(
BALB/c( (Melgar( et( al.( 2005).( As( previous( characterisation( of( the( SOCS2( colony(
revealed( a( mixed( background( (consisting( of( approximately( 75%( C57BL/6)( it( was(
important( to( increase( the(purity(of( the( strain.(This(was(done(successfully( to(allow(
the(DSS(studies(to(be(completed((Fig.(6.1,(6.2(&(Table(6.4.(
(
The(molecular(weight( of( the(DSS( used( to( induce( colitis( is( important.( A( study( by(
Kitajima(and(colleagues(revealed(that(varying(molecular(weights(of(DSS((5kD,(40kD(
and( 500kD)( contributed( to( varying( levels( of( inflammation,( localised( to( different(
areas(of(the(colon((Kitajima(et(al.(2000).(A(molecular(weight(of(500kD(was(unable(to(







use( to( induce(colitis( in( the(SOCS2(colony.(Previous( reports(on(C57BL/6(mice(have(
used(concentrations(of(3%X5%(for(5(days,(resulting(in(severe(weight(loss(associated(
with(inflammation(followed(by(a(period(of(weight(gain((Melgar(et(al.(2005;(Harris(et(





optimal,( with( higher( concentrations( resulting( in( high( mortality,( and( lower(
concentration( having( little( effect( on( health.( It( must( however( be( noted( that( these(
early( studies(were(done( on( a(mixed( strain( of(mice( and( it(was(unclear( if( a( similar(
result(would(be( seen( in( a(genetic( strain( (~98%(C57Bl/6)( that(was( recognised( to(be(
more( susceptible( to( DSS.( ( The( mice( used( in( the( present( study( were( highly(
susceptible( to(DSS( treatment,(as(concentrations(of(3%,(3.5%,(and(4%(for(5(days(all(
resulted( in( a( high(mortality( rate.( Lowering( the( number( of( days( to( 4( had( a( large(
effect(on(disease( severity( (Fig.( 6.3).(Mice(on( this( treatment( regime(still( lost(weight(
following(DSS(treatment,(however(5(days(after( treatment(stopped(the(mice(started(
to( regain(weight(and(show(signs(of( recovery.(Although( it( is( likely( that( the(altered(
level(of(susceptibility(to(DSS(observed(in(this(study(is(a(result(of(increased(purity(of(
mouse( strain,( there( are( a( number( of( variables( that( contribute( to( alter( DSS(
susceptibility.( Increased( stress( levels( have( been( implicated( in( relapsing( chronic(
inflammation( (Melgar( et( al.( 2008).( No( studies( have( been( carried( out( on( stress( in(
relation(to(the(initiation(of(DSS(induced(inflammation,(however(it(may(be(possible(
that( the( increased( stress( of( being( moved( to( a( new( environment( (shared( cage( to(
singly(housed)(may(also(have(contributed(to(increased(susceptibility.(
(
Histologic( scoring( in( the( present( study(was( carried( out( using( a( validated( scoring(
scheme,( allowing( an( in( depth( assessment( of( the( mucosal( integrity( (Table( 6.1)(
(Dieleman( et( al.( 1998;( Williams( et( al.( 2001).( ( Acute( and( chronic( colitis( are(
characterised(by(distinct(pathological( changes( to( the( colon.(Acute( inflammation( is(
associated(with(an(influx(of(neutrophils(into(the(lamina(propria,(and(in(some(cases(
epithelial(degeneration.(Chronic(inflammation(on(the(other(hand(is(associated(with(
mononuclear( leukocyte( infiltration,( crypt( architectural( disarray,( and( crypt(
regeneration( (Melgar( et( al.( 2005;( Perse( &( Cerar( 2012).( In( this( study,( histological(
analysis(revealed(signs(of(both(acute(and(chronic(inflammation,(suggesting(that(the(
current(experimental(design(was(sufficient(to(induce(chronic(inflammation((Fig.(6.8).(




C57BL/6( mice( following( a( single( treatment( of( DSS( (Melgar( et( al.( 2005).( Little(
difference(was(observed(between(the(severity(of(inflammation(in(the(WT(and(Socs2&/&(
mice((Fig.(6.8).(This(indicates(that(the(absence(of(SOCS2(does(not(protect(against(the(
deterioration( of( mucosal( integrity.( There( have( been( reports( that( increased( GH(
activity( promotes( mucosal( repair( during( inflammation.( A( small( clinical( trial( of(
patients(with(active(CD(reported(that(GH(therapy(improved(the(CD(activity(index,(
and(decreased(the(need(for(other(medication((Slonim(et(al.(2000).(Furthermore,(GH(
transgenic( mice( display( a( similar( extent( of( colon( pathology( during( the( onset( of(
inflammation( compared( to(WT(mice,( but( show( improved(mucosal( repair( over( an(
extended( time( period( (Williams( et( al.( 2001).( ( Increased(mucosal( repair( in( the( GH(
transgenic(mice(may(have(been(a(result(of(increased(systemic(IGFX1(Mathews(et(al.(
1988;( Howarth( et( al.( 1998;( Metcalf( et( al.( 2000;( MacRae( et( al.( 2009).( Socs2&/&( mice(
however(show(no(alteration(in(systemic(IGFX1.((((
(
GH( resistance( during( inflammation( is( associated( with( decreased( systemic( IGFX1(
levels( (Katsanos( et( al.( 2001).( In( states( of( systemic( inflammation,( proXinflammatory(
cytokines(upregulate(SOCS(expression((Colson(et(al.(2000).(ILX6(inhibits(hepatic(GH(
signalling(through(the(upregulation(of(CIS(and(SOCS3((Denson( et(al.(2003).(TNFXα(
also(down(regulates(hepatic(GHR((Denson( et( al.( 2001).( In( the(present(study,( IGFX1(
levels(were(not(altered(in(DSS(treated(WT(and(Socs2&/&(mice((Table(6.6).(This(suggests(
inflammation(does( not( result( in( hepatic(GH( resistance.( It(must( however( be( noted(
that( systemic( IGFX1( levels( were( measured( at( the( end( of( the( experiment.( At( this(
point,(the(DSS(treated(animals(presented(with(severe(inflammation(of(the(colon,(but(
had( shown( recovery( of( weight( loss.( Previous( studies( have( shown( decreased(
systemic(IGFX1(levels(immediately(following(DSS(treatment,(increasing(over(period(
of(weeks( (Harris( et( al.( 2009).( To( therefore( fully( assess( the( importance( of( systemic(
IGFX1( levels( during( inflammation,( IGFX1( levels( would( have( to( be( measured( at(
numerous( points( during( the( initiation( and( progression( of( colitis.( In( keeping(with(







The( importance( of( SOCS( proteins( in( regulating( local( GH( signalling( during(
inflammation(has(been(investigated(in(muscle(during(uraemia.(In(this(model,(there(
were(increased(Socs2(mRNA(levels((Guarnieri(et(al.(2004;(Cheung(et(al.(2008).(Given(
the( known( regulatory( role( of( SOCS2( on( GH( signalling,( it( is( conceivable( that( the(
inhibited(GH(action(may(be(responsible(for(the(associated(muscle(wasting((Cheung(





bone( is( evident( from( the( anabolic( bone( phenotype( discussed( in( chapter( 4( and( 5.(
Socs3(mRNA( levels(were( also( increased( in( bone( from(WT(mice( treated(with(DSS.(
Due( to( the(embryonic( lethality(of( the(Socs3&/&(mouse,( it( is(difficult( to(determine( the(
potential( role( of( SOCS3( in( bone( turnover,( but( it( may( have( a( contributory( role(
(Roberts( et( al.( 2001).( SOCS3(has(been( identified(as( a(potent( regulator(of( osteoclast(
function(It’s(precise(role(however(remains(unclear.(SOCS3(has(been(shown(to(have(
both(inhibitory(and(stimulatory(roles(in(osteoclastogenesis((Fox(et(al.(2003;(Wong(et(
al.( 2006).( Also,( the( increased( Socs3( may( act( together( with( higher( Socs2( levels( to(
inhibit( GH( action( in(DSS( colitis( and( inhibit( bone( formation.(No( alteration( in( Igf1(
expression(was( observed( in( bone( samples( from(DSS( treated(mice.( ( This( indicates(
that( the( increase( in( Socs2( does( not( result( in( deregulated( Igf1( expression.( These(
results( are( not( surprising,( as( previous( data( discussed( in( chapter( 4(&( 5( show( that(
SOCS2(is(a(critical(regulator(of(GH(action(on(bone,(independent(of(local(IGFX1.((((
(
The( lack( of( evidence( for( a( protective( role( of( SOCS2( in(mucosal( integrity,( coupled(





effects( of( SOCS2( on( GH( promotion( of( bone( formation( (chapter( 4).( DSS( induced(
colitis( results( in( bone( loss( in( juvenile( (4(weeks( old)( and( adult( (9(weeks( old)(mice(
(Hamdani(et(al.(2008;(Harris(et(al.(2009).(In(juvenile(mice,(the(adverse(trabecular(and(
cortical(bone(phenotype(was(associated(with(decreased(serum(osteocalcin(and(IGFX
1,( and( increased(TNFα.(Trabecular(deterioration( is( also( apparent( in( older( animals(
treated(with(DSS,(however(cortical(bone(remains(unchanged((Hamdani( et( al.(2008;(
Harris(et(al.(2009).(Taken(together,(these(studies(suggest(that(there(is(an(age(specific(
effect( of( inflammation( on( bone( loss.(During( early( puberty( (3( to( 5(weeks)( there( is(
extensive( radial( bone( expansion,( up( to( a( point( where( adult( bone( size( is( reached(
(Callewaert( et( al.( 2010).(Decreased( bone( formation(during( this( critical( period(may(
well(be(the(cause(behind(the(bone(loss(observed(in(juvenile(mice((Harris(et(al.(2009).(
The( present( study( found( a( severe( trabecular( bone( loss( phenotype( in( WT( mice(
treated( with( DSS,( consistent( with( previous( reports( in( adult( mice( (Fig.( 6.10)(
(Hamdani( et( al.( 2008).( This( was( associated( with( a( loss( of( trabecular( architecture,(
including( alterations( to( trabecular( pattern( factor( and( structural( model( index(
(discussed( in( chapter( 4).( Trabecular( pattern( factor( is( an( index( of( connectivity( of(
trabecular(bone.(A(higher(trabecular(pattern(factor;(as(observed(in(DSS(treated(WT(
mice,(signifies(a(more(disconnected(trabecular(structure((Hahn(et(al.(1992).(Bone(loss(
observed( in( Socs2&/&(mice( treated(with( DSS(was( far( less( than( that( observed( in(WT(
mice,(with(a(number(of(parameters(comparable(to(nonXtreated(bone((Fig.(6.10).(This(
highlights( that( the( absence( of( SOCS2( is( partly( protective( against( the( bone( loss(
phenotype(associated(with(DSS( induced( inflammation.(Complete(protection(of( the(
skeleton(was( not( observed( however,( and( this( is( likely( due( to(many( other( cellular(
mechanism( including( increased( osteoclastic( resorption( and( diminished( GH(
signalling(through(the(elevated(Socs3( levels.(The(effects(of(knocking(out(both(Socs2(
and( Socs3( in( the( DSS( model( would( be( of( great( interest( as( it( may( offer( greater(
protection(to(the(skeleton.(((((
(
In( conclusion,( these( studies( have( identified,( and( established( a(working(model( for(




highlight( that( despite( a( similar( level( of( gut( inflammation,( Socs2&/&( mice( are( partly(

















Recombinant( human( GH( (rhGH)( is( approved( for( the( treatment( of( a( number( of(
disorders(which( result( in( short( stature.( These( include( growth(hormone(deficiency(
(GHD),( Turner( syndrome( (TS),( PraderXWilli( syndrome,( short( stature( homeoboxX




of( an( unsatisfactory( growth( promoting( response( (Allen( 2011;( Bang( et( al.( 2012).( In(
cases( of( GHD( in( children,( one( study( has( indicated( that( approximately( 28%( of(
participants(do(not( respond( to(GH( therapy( (Bang( et( al.( 2011).(There( is( therefore( a(
need(to(better(understand(the(mechanisms(of(GH(actions(to(aid(the(development(of(
new( strategies( in( the( effective( treatment( of( growth( disorders.( Furthermore,( an( in(
depth( understanding( of( the( GH( signalling( pathway( and( its( regulation( has( the(
potential(to(uncover(new(therapeutic(targets.((
(
GH(therapy,(especially(at(high(doses,(has(been(shown(to( increase( insulin( levels( in(
patients(with(idiopathic(short(stature((ISS);(a(disorder(characterised(by(poor(growth(
velocity( despite( little( alteration( in( GH( and( IGFX1( levels.( ( Although( insulin( levels(
appear(to(return(to(normal(after(treatment,(these(have(to(be(monitored(during(long(
term( treatment( (Allen( 2011).( Reports( of( increased( insulin( levels( and( decreased(
insulin( sensitivity(have(also(been(observed( in(a( follow(up(study(of(young(women(
with(Turner( syndrome( treated(with(GH( (Bannink( et( al.( 2009).( Surprisingly,( adults(
with(GHD(have( impaired( insulin( sensitivity,( and( in( these( cases,( low(doses( of(GH(
may(act(to(improve(the(condition((Yuen(et(al.(2005).(The(full(effects(of(GH(therapy(
on( insulin( sensitivity( are( however( still( being( elucidated.( GH( transgenic( mice( are(
insulin( resistant,( similar( to( individuals( with( acromegaly( (Hansen( et( al.( 1986;(
Kopchick(et(al.(1999).((Although(the(anabolic(structural(bone(changes(in(Socs2&/&(mice(





to( study( the( pathways( that( promote( bone( accretion( without( leading( to( insulin(








Roith( et( al.( 2001;( Kaplan( &( Cohen( 2007).( Previous( models( focussing( on( the(
importance( of( systemic( IGFX1( through( the( generation( of( liver( specific( Igf1&/&( mice(
have( been( called( into( question.( This( is( due( to( the( deletion( of( liver( Igf1( that( is(
achieved(with(the(creXlox(method(of(gene(deletion(using(an(albumin(promoter.(This(
results(in(progressive(gene(deletion(long(after(the(post(weaning(growth(spurt((Yakar(
et( al.( 1999;(Tang( et( al.( 2005;(Stratikopoulos( et( al.( 2008).(Furthermore,( increased(GH(
levels( in( these(mice( (as( a( consequence( of( low( serum( IGFX1( levels)(may(mask( the(
potential(effects(of(decreased(systemic(IGFX1((Yakar(et(al.(2009).(Investigation(of(the(




The( Socs2&/&(mouse( is( therefore( a( valuable(model( to( study( the( effects( of( local( GH(


















changes( in( trabecular( BMD( in( young( or( older( mice.( Cortical( BMD( remains(
unchanged( in( young,( but( is( decreased( in( older( animals.( This( suggests( that(
mechanisms( that( are( not( altered( in( the( absence( of( SOCS2( are( responsible( for(
maintaining( BMD.( IGFX1( has( been( identified( as( being( key( in( coupling( matrix(
biosynthesis(to(mineralisation((Zhang(et(al.(2002).(The(evidence(in(this(thesis(points(
towards( a( GH( action( independent( of( IGFX1.( This(may( potentially( account( for( the(
diminished(BMD(in(these(older(mice.((
(
Both( the( architectural( and( biomechanical( data( also( highlights( a( sex( specific(
difference( in( the( bone(phenotype(of( the(Socs2&/&(mice.( This( is( not( surprising( as( the(
overgrowth( phenotype( of( Socs2&/&( male( mice( is( much( greater( than( female( mice((
(Metcalf( et( al.( 2000).( ( In( the( clinical( setting,( in( cases( of( GH( deficiency,( males( are(
generally(considered(to(be(more(responsive(to(GH(than(females((Burman(et(al.(1997;(
Span( et( al.( 2000).( The( results( presented( here( highlight( that( this( is( also( the( case( in(
Socs2&/&( mice( when( GH( action( is( enhanced( above( normal( levels.( It( is( therefore(
important( to(analyse(both(sexes( to(gain(a( full(appreciation(of( the(role(of(SOCS2( in(
GH( regulation.( There( may( however( be( other( factors( involved( in( the( sex( specific(
regulation(of(GH(signalling.(
(
The( use( of( both( ex( vivo( culture( and( in( vivo( techniques( have( shown( GH( to( have(
growth(promoting(effects(on(bone,( independent(of(an( increase( in( IGFX1.(This( is(an(




promote( tumourgenesis.( The( IGFX1R( is( overexpressed( in( ( many( types( of( cancer(
(Baserga( et( al.( 2003).( ( As( IGFX1( is( both( a( promoter( of( proliferation( and( an(
antiapoptotic(agent,(an(uncoupling(of( the( tight(balance(between( these(processes( is(
likely( to( result( in( an( increase( in( cell( growth.(This( is( often( the( first( stage(of( cancer(
development.( Epidemiological( data( suggests( that( increased( systemic( IGFX1( levels(
are(a(major(risk(factor(for(developing(certain(cancers((LeRoith(&(Roberts(2003).(The(
current( literature(on(GH(therapy(and(the(risk(of(cancer,(although(extensive,( is(still(
inconclusive( (Cohen( et( al.( 2000;( Sklar( 2004;( Jenkins( et( al.( 2006).( ( The( overriding(
consensus( is( that( continued( long( term( surveillance( of( affected( individuals( is(
required.(An( increase( in(GH(action( independent( of( increased( systemic( IGFX1(may(
offer(an(attractive(alternative.((((((((((((
(
Results( from(the(third(results(chapter(add(another( tier(of(complexity( to( the(role(of(
GH(on(promoting(growth.(Currently,( there(are(no(reported(clinical(cases( in(which(
females( have( been( shown( to( be( more( responsive( to( GH( than(males.( The( current(
results(however(clearly(demonstrate(that(young(female(mice(are(more(responsive(to(
GH.(This(has(previously(been(demonstrated(in(rats((Rol(De(Lama(et(al.(2000),(and(is(
likely( to( be( an( age( dependent( phenomenon.( Future( work( may( help( to( give( an(
insight( into( the( sexually( dimorphic( response( to( GH( during( the( period( of( rapid(
pubertal( growth.(These(data( also(highlights( the(need( to( consider( the( confounding(
effect(of(sexual(dimorphism(when(studying(growth(in(rodents.((((
(
Aside( from(GH,( SOCS2( levels( can( be( stimulated( by( a( number( of( other( cytokines,(
including(proinflammatory(cytokines,(which(are(upregulated(during( inflammation(
(Starr(et(al.(1997;(MacRae(et(al.(2009;(Perse(&(Cerar(2012).(It(is(therefore(possible(that(
SOCS2( may( play( an( important( role( in( mediating( bone( loss( in( inflammatory(
conditions.(((((((((((
(
Secondary( osteoporosis( is( the( most( common( extra( intestinal( manifestation(




Analysis( of( fracture( prevalence( varies( between( studies.( Two( independent( reports(
using( quantitative( morphometry( of( XXrays( from( CD( patients( have( reported( a(
prevalence(of(14%(and(22%((Klaus(et(al.(2002;(Stockbrugger(et(al.(2002).(Although(the(
pathogenesis(of(IBD(associated(bone(loss(is(multifactorial,(it(is(clear(that(it(is(due(to(a(
combination(of( reduced(bone( formation(and( increased(bone( resorption.(Currently,(
the( primary( therapy( is( the( antiXresorptive( bisphosphonate( drugs( risedronate( and(
alendronate( (Dunn( &( Goa( 2001;( Compston( 2003).( Orally( administered(
bisphosphonates(have(low(absorption(levels( in(healthy(people((1X5%).(These(drugs(
may( therefore(not(be( the(most( suitable( therapy( in( cases(of(deteriorated(gut(health(
(Compston( 2003).( There( is( currently( interest( in( developing( anabolic( agents( to(
promote(bone(formation(in(people(with(IBD.(
GH( is( already( a( widely( used( growth( promoting( treatment( (Allen( 2006).( As(
discussed( previously,( studies( have( also( highlighted( the( potential( use( of( GH(
treatment( in( osteoporosis( (LandinXWilhelmsen( et( al.( 2003;( Biermasz( et( al.( 2004).(





is( however( the( need( for( further( research( into( the( mechanisms( and( possible(
drawbacks(of(these(therapies.(((
IBD( is( associated( with( an( increase( in( the( proinflammatory( cytokines( which(
contribute(to(bone(loss;(either(directly(or(indirectly(through(GH(resistance((Tenore(et(
al.(1977;(Katsanos(et(al.(2001).(The(current(work(has(led(to(the(identification(of(a(link(
between( increased( proinflammatory( cytokine( levels( and( GH( resistance( at( a( local(
level.(Increased(Socs2(expression(levels(in(bone(from(mice(with(DSS(induced(colitis(
were( associated( with( a( decrease( in( bone( health.( An( increase( in( Socs2( expression(
levels(in(response(to(TNFXα;(a(proinflammatory(cytokine(up(regulated(during(IBD;(




Cerar( 2012).( Data( presented( in( this( thesis( indicates( that( an( increase( in( SOCS2( is(
likely( to( inhibit( GH( action( on( osteoblasts,( and( subsequently( bone( formation.( The(
improved( bone( health( observed( in( colitic( Socs2&/&( mice( confirm( SOCS2( as( an(
important(regulator(of(inflammatory(driven(bone(loss.(
(
The( protected( bone( phenotype( of( Socs2&/&( mice( with( colitis( has( a( number( of(
implications( in( the( treatment( of( skeletal( health( of( IBD( patients.( As( described(
previously,(SOCS2( is( a(potent( regulator(of(GH(action,( and( in( showing( that(Socs2&/&(
mice( are(partly(protective( against( bone( loss( in( IBD( the(present( results( have(given(
strength(to( the(emerging(concept( that(GH(therapy(may(be(used(to( treat(secondary(
osteoporosis.(It(has(also(been(suggested(that(GH(may(act(to(improve(disease(activity(
index( (DIA)( in(CD(patients( (Slonim( et( al.( 2000).( ( Furthermore,( another( report( has(
highlighted( that( although( GH( improves( DAI( it( does( not( reduce( mucosal(



















confirms( that( SOCS2( has( a( critical( role( in( regulating( GH( signalling( in( humans(
necessitating(an(improved(knowledge(of(its(mode(of(action.((














likely( that( there(may(still(have(been(RNA(degradation.(Throughout( this( thesis( the(
utmost(care(was(taken(to(ensure(the(highest(quality(RNA(was(gained.(The(quality(of(
the(RNA(was(not(however(measured.(To(assess(quality,(samples(would(have(to(be(

















The( results( presented( in( this( thesis( have( confirmed( a( critical( role( for( SOCS2( in(
regulating( endochondral( bone( growth( and(bone( accrual.( ( Both( ex( vivo( and( in( vivo(
studies( have( suggested( that( this( role( is( independent( of( local( IGFX1( production.(
Further( work( is( however( desirable( to( fully( elucidate( the( importance( of( IGFX1( in(
mediating(GH(action(in(the(Socs2&/&(mouse(model.((
Examination( of(Socs2;obIgf1r(double( knockout(mice( (Zhang( et( al.( 2002)(would( help(
confirm( that( IGFX1/2( signalling( are( not( essential( for(mediating( the(Socs2&/&( skeletal(
phenotype.( ( Data( could( be( collected( to( allow( assessment( with( regards( to( both(
longitudinal(and(radial(bone(growth.(In(addition,(crossing(Socs2&/&(mice(to(osteoblast(
or( chondrocyte( specific( Igf1&/&(mice( and( examination( of( their( offspring(would( give(
further( insight( into( the(specific( importance(of( local( IGFX1(production( in(regulating(
the( bone( phenotype( characteristic( of( Socs2&/&( mice.( Mice( without( osteoblast( Igf1(
expression( could(be(generated(by(breeding( floxed–Igf1(mice(with(mice( expressing(
Cre( recombinase,( under( the( control( of( the( 2.3Xkb( proximal( fragment( of( the( α1(l)X




response( to(GH.(This(was(not(observed( in(vivo.( Identification(of( alternative(genes,(
preferentially( expressed( in( Socs2&/&( osteoblasts( following( GH( treatment( proved(
unsuccessful.( Due( to( financial( constraints( this( was( confined( to( a( PCR( array,(
focussing(only( on(key(genes( associated(with( the( JAK/STAT(pathway.( It(would(be(





genome( sequencing.( Data( analysis( would( help( identify( key( genes( that( are(
differentially(regulated(in(the(absence(of(SOCS2.((





dimorphic( growth,( it( would( be( beneficial( to( assess( the( impact( of( oestrogen( in(
regulating( GH( action.( Serum( analysis( of( oestrogen( levels( at( points( before( and(
during( the( GH( responsive( phase( in( females( would( help( determine( the( serum(
profile.( Furthermore,( assessment( of( the( growth( rate( and( bone( phenotype( of( GH(
treated( ovariectomised( female( mice( would( address( the( role( of( oestrogen( as( a(
potential(regulator(of(GH(action.(
The(work( carried( out( in( chapter( 6( of( this( thesis(was( very( translational( and( could(
potentially(lead(to(the(development(of(new(therapeutics(to(treat(bone(loss(associated(
with( inflammatory(disorders( such( as( IBD.( It( is( for( this( reason( that( future( funding(
would( be( best( placed( further( investigating( the( role( SOCS2( in( IBD(mediated( bone(
loss.(The(following(experiments(would(continue(on(nicely(from(the(work(presented(
in(this(thesis.((
Socs2&/&(mice( are( partly( protected( from( IBD( associated( bone( loss.( These( data( are(
however( collected( from( the( end(of( the( experiment,( and( it( is( therefore(unknown( if(
the(absence(of(SOCS2(expression(limits(bone(loss(or(accelerated(bone(mass(recovery(
during(colitis(progression.(Future(experiments(should(look(to(complete(in(vivo(bone(
scanning;( tracking( the( bone( phenotype( during( the( initiation( and( progression( of(
colitis.(Having(established(the(point(at(which(SOCS2(is(regulating(bone(loss,(studies(
could( then( focus( on( examining( the( functional( role( of( SOCS2( in( the( aetiology( of(
secondary( osteoporosis( in( experimental( colitis.( It( is( likely( that( bone( loss( in(





and( Socs2&/&( mice( would( help( confirm( key(mechanisms( behind( IBD( induced( bone(
loss.(
The(use(of(the(Socs2&/&(model(of(colitis(is(highly(informative,(but(it(would(be(essential(
to( establish( that( a( similar( course( of( events( occurs( in( human( IBD.( This( could( be(
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SOCS1( SOCS1((ab)( goat(polyclonal( 1(in(666(
SOCS2( SOCS2((cs)( rabbit(polyclonal( 1(in(1000(




PXSTAT1( PXSTAT1((cs)( rabbit(polyclonal( 1(in(1000(
STAT1( STAT1((cs)( rabbit(polyclonal( 1(in(1000(
PXSTAT3( PXSTAT3((cs)( rabbit(polyclonal( 1(in(1000(
STAT3( STAT3((cs)( rabbit(polyclonal( 1(in(1000(
PXSTAT5( PXSTAT5((cs)( rabbit(polyclonal( 1(in(1000(




PXAKT( PXAKT((cs)( rabbit(polyclonal( 1(in(1000(























Source## # ## Sequences#(5’W3’)#













qPCR##Analysis## ( ( (
Socs1( MWG(Eurofins(
MWG(Eurofins(
F(
R(
TCCGATTACCGGCGCATCACG(
CTCCAGCAGCTCGAAAAGGCA(
Socs2( MWG(Eurofins(
MWG(Eurofins(
F(
R(
TGGCTGCTCAAGATCAAATG(
TGTCCTCCTGGAAATGGAAG(
Socs3( MWG(Eurofins(
MWG(Eurofins(
F(
R(
GAGTACCCCCAAGAGAGCTTACTA(
CTCCTTAAAGTGGAGCATCATACTG(
Igf1( Invitrogen(
Invitrogen(
F(
R(
Not(available(
Not(available(
Igfbp3( Invitrogen(
Invitrogen(
F(
R(
Not(available(
Not(available(
Akp2( MWG(Eurofins(
MWG(Eurofins(
F(
R(
GGGACGAATCTCAGGGTACA(
AGTAACTGGGGTCTCTCTCTTT(
Spp1( MWG(Eurofins(
MWG(Eurofins(
F(
R(
ATCGTCATCATCATCGTCATCAT(
GAATGGTGTGTCCTCTGGAGGAA(
Gapdh( Primer(Design(
Primer(Design(
F(
R(
Not(available(
Not(available(
Atp5b( Primer(Design(
Primer(Design(
F(
R(
Not(available(
Not(available(
